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ABSTRACT 
 
A Deficit in Parvalbumin-Expressing Interneurons in the Hippocampus Leads to 
Physiological and Behavioral Phenotypes Relevant to Schizophrenia in a Genetic 
Mouse Model 
 
Ahmed Ijaz Gilani 
 
Deficits in hippocampal interneurons, that secrete gamma-aminobutyric acid 
(GABAergic), are implicated in the pathophysiology of schizophrenia. Postmortem 
histological analyses show alterations in the number and/or function of parvalbumin-
expressing (PV+) GABAergic interneurons in the cerebral cortex of these patients. A 
parallel line of research using functional imaging of cerebral blood flow or volume has 
shown that hyperactivity of the hippocampus may contribute to psychotic symptoms as 
well as cognitive deficits in schizophrenia. It is not known if changes in GABA 
transmission, particularly in the number and function of PV+ interneurons, are causally 
related to hippocampal hyperactivity and expression of behavioral and cognitive 
abnormalities in schizophrenia. To help answer this question, we used genetic mouse 
models with deficits in cortical GABAergic interneuron development to test the 
hypothesis that a selective deficit in PV+ interneurons in the hippocampus can lead to 
schizophrenia relevant phenotypes, such as hippocampal hyperactivity, dysregulation of 
the mesolimbic dopamine system, enhanced psychomotor responsiveness to 
amphetamine, and disruption of hippocampus dependent cognition.  
Here I describe my studies primarily on a mouse model with a deletion of the cell-cycle 
gene cyclin D2 (cD2 null). This mutation disrupts interneuron development in the medial 
ganglionic eminence (MGE), leading to a partial and selective deficit in PV+ 
interneurons in the neocortex and the hippocampus. I show that the cD2 null mouse 
   
shows regionally heterogeneous, persistent structural and functional deficits in PV+ 
interneurons, with a relatively larger and more functional deficit in the hippocampus. The 
GABAergic deficit in the hippocampus is associated with signs of disinhibition, such as 
increased cerebral blood volume, as found by functional magnetic resonance imaging 
(fMRI).  
Upon establishing the evidence for hippocampal disinhibition in the cyclin D2 null 
mouse, I examined the relationship between this disinhibition and two areas of neural 
function know to be altered in psychosis and schizophrenia: mesostriatal DA system 
function and hippocampus-mediated cognition. I found that the cD2 null mice showed 
increased dopamine population activity in the ventral tegmental area and enhanced 
psychomotor response to amphetamine. The latter was eliminated by a partial lesion of 
the ventral hippocampus, indicating hippocampal disinhibition as the driver of DA 
neuron dysregulation.  In addition, cD2 null mice showed deficits in cognitive functions 
that recruit and depend on the hippocampus, such as contextual and cued fear 
conditioning.  Lastly, to test for a causal relationship between the PV+ interneuron deficit 
in the hippocampus, and the abnormalities in hippocampal metabolism, imaging 
phenotype, the mesolimbic dopamine dysfunction and contextual learning and memory, I 
examined the effects of replacing GABAergic interneurons in the hippocampus. I used 
transplantation of GABAergic interneuron precursors derived from the medial ganglionic 
eminence (MGE) into the adult hippocampus of cyclin D2 null mutants. MGE-derived 
progenitor cells developed into structurally and functionally mature PV+ and other 
GABAergic cells, and normalized hippocampal hypermetabolism. In addition, the MGE 
   
transplants normalized ventral tegmental area (VTA) dopamine cell activity, normalized 
amphetamine sensitivity and improved hippocampus-dependent learning and memory.  
Taken together, these studies establish the plausibility of a causal relationship between 
hippocampal PV+ interneuron pathology and psychosis-relevant pathophysiological and 
cognitive phenotypes. Moreover, they provide a rationale for limbic cortical GABAergic-
interneuron-targeted treatment strategies in psychotic disorders.
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Section I: General Introduction and Methods 
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Chapter 1:  General Introduction 
 
1.1 A General Introduction to Schizophrenia 
Prevalence and Burden:  
Schizophrenia is a chronic disabling psychiatric condition. The lifetime prevalence of 
schizophrenia is about 0.7%, with relatively little variation across the world. Due to its high 
incidence and chronicity, schizophrenia causes significant morbidity. The economic burden of 
schizophrenia has been estimated to be over $30 billion annually, in the United States alone. 
Schizophrenia usually emerges in late adolescence and early adulthood, however, behavioral and 
cognitive disturbance can be identified in retrospect in some patients (Sadock et al., 2007 )  ( 
Jarskog et al., 2007)  
Symptoms and Course of Illness: 
Schizophrenia is a heterogeneous syndrome characterized by perturbations of perception, 
thinking, language, affect and volition. These symptoms have been divided into positive 
symptoms (additional features that are not present in unaffected individuals), negative symptoms 
(features present in unaffected individuals but reduced in patients with schizophrenia) and 
cognitive symptoms. Positive symptoms include hallucinations (mostly auditory) and delusions. 
Negative symptoms include flat affect, poor attention, lack of motivation and deficits in social 
function. Cognitive disturbances include difficulties with attention, concentration and memory. 
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Like other psychiatric disorders, the diagnosis of schizophrenia is based on symptomatology. No 
biological diagnostic marker is available at the moment.  
Schizophrenia is usually first recognized and diagnosed on the basis in late adolescence 
or early adulthood in males, early-mid adulthood in females, usually in the context of an episode 
of psychosis (Sadock et al., 2007). However, there is evidence that behavioral deficits that 
resemble negative symptoms, as well as cognitive deficits, precede psychotic symptoms and may 
be predictive of the first psychotic break (Corcoran et al., 2007). Moreover, positive symptoms 
appear to take a different course than negative symptoms and cognitive deficits.  Positive 
symptoms wax and wane over time, and generally become less prominent with age. Negative 
symptoms and cognitive deficits, on the other hand, are more persistent, usually stable over time, 
and are refractory to treatment. Importantly, cognitive deficits also predict long-term functional 
outcome in patients with schizophrenia (Sadock et al., 2007). 
Treatment:  
Since the serendipitous discovery of antipsychotic action of chlorpromazine in the early1950s, 
several antipsychotics have been developed (Delay and Denicker 1952, reviewed in Ban 2007). 
Many of the antipsychotic compounds have been selected based on animal screens such as the 
drug’s ability to block apomorphine induced vomiting in dogs or amphetamine induced 
locomotion in rodents. Later, it was found that these screens select for chemical compounds that 
block the dopamine D2 receptor. A correlation was subsequently found between D2 receptor 
affinity and the clinical potency of antipsychotic drugs.  
Current pharmacotherapy for schizophrenia is far from ideal. Firstly, antipsychotic drugs relieve 
positive symptoms but do not adequately treat negative or cognitive symptoms. Secondly, many 
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of these medications have unwanted side effects, most notable of which are movement 
difficulties and prolactinemia (which are associated with traditional antipsychotic agents) and 
metabolic derangements and obesity (associated with the newer/atypical agents). Finally, up to a 
third of the patient population is treatment-refractory. Therefore, better treatment modalities are 
desparately needed for the management of schizophrenia.   
Genetic and Environmental Risk Factors: 
Adoption, twin and family studies provide compelling evidence for the heritability of 
schizophrenia. The risk of developing schizophrenia is proportional to the degree of genetic 
relatedness to a patient. While the life time risk of schizophrenia in the general population is 
about 1%, it reaches close to 50% in identical twins, if one twin has schizophrenia (Cardno et al., 
2001; Sadock et al., 2007). The concordance rate for a fraternal twin or a non-twin sibling is 
close to 12%. Absence of complete concordance indicates interplay of environmental factors, 
and/ or epigenetic factors in the disease.  
Epidemiological studies of schizophrenia risk factors suggest a neurodevelopmental etiology for 
schizophrenia. Many of the environmental factors strongly associated with increased risk of 
schizophrenia (such as maternal influenza infection during gestation and maternal starvation, 
discussed below), occur during the prenatal or perinatal periods of life, implicating a possible 
disruption of a developmental process. Two examples of such prenatal risk factors are maternal 
infection and maternal malnutrition. Second-trimester maternal influenza or rubella infection has 
been associated with increased risk for schizophrenia in the offspring (see meta analysis by 
Khandaker et al., 2013). Similarly, individuals conceived in famine conditions, including at the 
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height of the Dutch Hunger Winter of 1944–1945 and during the Chinese famine of 1959-1961, 
showed an increased risk for schizophrenia (McClellan et al., 2006). 
In addition to early life environmental risk factors, clinical genetic studies have identified a 
number of alleles that increase the risk of schizophrenia (Harrison and Owen, 2003; Rodriguez-
Murillo et al., 2012). Recent data provides a possible point of convergence between these two 
lines of research and suggests that several of the schizophrenia risk alleles may influence the 
development and plasticity of brain circuits (for example see Flames et al., 2004; Harrison and 
Weinberger, 2005; Niwa et al., 2010).  
Importantly, unlike disorders easily recognized as “developmental”, there is a lag of many years 
between the presumed initial insult, which presumably begins to operate in-utero, and the onset 
of behavioral symptoms upon which we diagnose the disease, usually emerge in early adulthood. 
To explain this, Weinberger (Weinberger, 1987) proposed that a neurodevelopmental brain 
lesion early in life may sit clinically silent until it is revealed by, or interacts with developmental 
processes that occur in adolescence or early adulthood, just before the disease manifests 
behaviorally. An elaboration of this is the “two-hit” hypothesis, which, in its several versions 
(discussed later) suggests that abnormal development of the brain during early life (prenatal or 
postnatal), presumably due to genetic or/and environmental factors, may lead to susceptibility to 
schizophrenia. In a subset of those exposed to these risk factors, abnormal maturational 
processes, adverse effects of drugs, or stress, may further exacerbate the pathological process, 
ultimately leading to overt disease. 
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Neural Circuit Pathology in Schizophrenia 
1.2 Overview of Neuropathology and Neural Circuit 
Abnormalities in Schizophrenia 
 
Schizophrenia remains a symptom complex and not a discrete biological disease entity.  
Heterogeneity observed in clinical features (such as presentation, symptoms, response to 
treatment and prognosis) raises the possibility that schizophrenia may constitute a constellation 
of discrete disease entities each with its own unique pathology. As such, multiple neural 
mechanisms have been implicated in its pathogenesis. Different etiologies may be differentially 
involved in each patient, and this may be reflected in the heterogeneity of behavioral symptoms 
as mentioned above. Common features across individuals diagnosed with schizophrenia, 
however, suggest a relatively common set of pathophysiological mechanisms that may underlie 
specific symptom clusters. Identifying and understanding these mechanisms is fundamental for 
finding treatments for patients refractory to currently available treatment modalities. Towards 
this end, animal models have been developed to test ideas about the causal relationships between 
pathophysiology in specific neural systems and the psychopathology of schizophrenia.   
 
As background for the animal models used in this thesis, I present a brief review of the neuro-
histopathology of schizophrenia, the evidence for involvement of the hippocampus, and the 
evidence for dopamine dysregulation.   
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Neuropathological Findings in Schizophrenia 
In order to understand the biological underpinnings of schizophrenia, post-mortem studies of the 
brains of individuals with psychosis have been conducted for more than 100 years. Earlier 
studies showed that there is no gross brain damage, florid degeneration, or hydrocephalus in 
schizophrenia. Starting in the 1980s, studies using more detailed analyses increasingly reported 
subtle alterations, which are significantly more frequent in schizophrenia patients than in healthy 
controls or controls with other mental illnesses. In general, these alterations are not robust 
enough to serve as diagnostic markers; however, these can be useful to generate insights and 
hypotheses about pathogenic or pathophysiological mechanisms, that may, in turn, lead to novel 
targets for pharmacological interventions  (Harrison et al., 2011). There is an ongoing debate 
about the authenticity and specificity of post-mortem histopathological findings in schizophrenia, 
and how they relate to structural imaging studies of this disorder. With that caveat in mind, the 
following are some of the most robust findings: 
Absence of widespread gliosis in schizophrenia: Gliosis is the process of proliferation and 
hypertrophy of astrocytes. It is one of the most robust indicators of a recent or active injury. 
Most postmortem studies in schizophrenia have failed to find evidence for gliosis in 
schizophrenia (Benes et al., 1991). It has recently been suggested the autopsy studies of 
gliosis in schizophrenia have generally been poorly controlled and underpowered to 
satisfactorily address this question (Schnieder and Dwork, 2011), emphasizing the need for 
further research in this area.  
Neurodegeneration versus abnormal neuronal development and synaptic maintenance: 
Florid neural degeneration, of the extent present in classic neurodegenerative diseases such 
   8 
as Alzheimer’s disease, is absent in schizophrenia. However more sensitive analytical 
techniques have revealed subtle changes in brain volume, as well as increases in cell density 
in certain regions, which together suggest that the neuropil is decreased in schizophrenia. In 
support of this idea, reductions in spine density in various cortical regions such as the 
subiculum (Rosoklija et al., 2000) and the auditory cortex (Sweet et al., 2008), have been 
reported. Other reported neuropathological alterations consistent with a disruption of 
neurodevelopment and/or neural activity include decreases in somal size of cortical 
projection neurons and disorganization in the distribution and orientation of these neurons.  
These latter abnormalities have been observed in projection neurons of the hippocampus 
(Arnold, 1999). 
Brain regions implicated in structural imaging studies.    
In vivo brain imaging studies have also revealed macroscopic changes in many regions of the 
brain in schizophrenia including temporal lobe structures, prefrontal cortex and the thalamus. 
There have been reports of reduced overall brain volume and length (around 3-4 % (Wright et 
al., 2000; Harrison et al., 2003)) , enlargement of lateral and third ventricles, and whole-brain-
corrected reduction in gray matter of specific regions, most notably, the hippocampus. Studies 
have found structural changes in un-medicated patients, and at or near time of the first psychotic 
episode, indicating that volume reduction is not an effect of medication exposure. It is not clear 
whether these changes are progressive or stable over time, or how they are affected by treatment. 
Recent longitudinal studies, however, show a reduction in hippocampal volume occurring over 
the course of the first episode of psychosis (Schobel et al., 2013). Other cross-sectional studies 
have provided some support for progressive hippocampal and frontal lobe volume loss as a 
   9 
function of multiple psychotic episodes and refractoriness to antipsychotic treatment (Jarskog et 
al., 2007). 
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1.3 Alterations in GABA Interneuron Function in the 
Hippocampus and Other Cortical Regions in Schizophrenia  
Alterations in markers of GABAergic neurotransmission have been found in various regions of 
the brain in schizophrenia. Two regions that have been studied most extensively, and show the 
most robust changes, are the prefrontal cortex and the hippocampal formation. 
Abnormalities in GABAergic markers in the hippocampus. 
The hippocampus is one of the most severely affected regions in schizophrenia. Alterations in 
many markers of the GABAergic system have been reported in the hippocampus and the 
associated temporolimbic cortex in patients with schizophrenia. A brief overview of the reported 
alterations is given below. 
Alterations in GAD:  The rate-limiting enzyme in GABA synthesis is the glutamic acid 
decarboxylase (GAD). GAD is present in two isoforms, which are coded by two separate 
genes: GAD1 - which codes for GAD67 isoform, and GAD2 - which codes for GAD65. 
In situ hybridization for GAD 65 and GAD 67 mRNA in the hippocampus showed 
deficits in bipolar disorder but not in schizophrenia (Heckers et al., 2002).  
Alterations in GABAergic Interneurons: Benes and colleagues provided some of the 
first evidence for alterations in hippocampal interneurons in schizophrenia  (Benes et al., 
1998). Using morphological criteria, these researchers distinguished pyramidal cells from 
non-pyramidal cells (presumably interneurons, glia were distinguished from neuronal 
cells) in the hippocampus. They reported reductions in density of non-pyramidal cells in 
the CA2 subfield of the hippocampus in patients with schizophrenia as well as those with 
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‘manic depression’ (Benes et al., 1998). No differences were found in the density of 
pyramidal cells in either group  (Benes et al., 1998).  Since then, a number of studies 
have quantified interneurons, as identified by immunological markers of peptides 
expressed by specific interneuron subpopulations.  Zhang and Reynolds (Zhang and 
Reynolds, 2002) quantified Calretinin or Parvalbumin immunoreactive neurons and 
found a reduction in PV+ IN in all sub-regions of the hippocampus and in the dentate 
gyrus in schizophrenia subjects. In the same study, subjects with bipolar disorder showed 
reduction in the CA1 region. No alterations were found in the subjects with major 
depression and no alterations were found in CR cell density in either group. These 
findings have been replicated, by the same group, in an independent sample of patients 
with schizophrenia (Zhang and Reynolds, 2002).  
In an independent collection of brains (Stanley Brain consortium) PV interneuron in CA2 
were found to be reduced in schizophrenia and bipolar disorder (Knable et al., 2004).  
Subsequently in a larger study (described below), parvalbumin deficit was found in all 
regions of the hippocampus and the dentate gyrus (Torrey et al., 2005).  In a recent larger 
study, Konradi et al employed more controlled quantitative methods, and found a 
reduction in PV+ and somatostatin positive (SST+) cells in the hippocampus (Konradi et 
al., 2011). This study used immuno-labeling and real time quantitative PCR (to measure 
mRNA levels), and found a reduction in the expression of somatostatin, parvalbumin and 
GAD 67.  The reduction in these markers was found in various subfields of the 
hippocampus, but was most consistently decreased in the CA2/3 region.  
Over all, there is converging evidence for the number of PV+ and possibly SST+ 
interneurons in the hippocampus. It should however be pointed out that many of the 
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subtypes of GABAergic interneurons in the hippocampus (Freund and Buzsaki, 1996; 
Klausberger and Somogyi, 2008, see below) have yet to be explored by post mortem 
histological studies of schizophrenia.  
Alterations in GABA agonist binding:  Initial studies reported an increase in GABAA 
receptor binding activity in several key corticolimbic regions, including the hippocampal 
formation in postmortem schizophrenic brains. These studies showed increased GABAA 
receptor binding activity throughout the hippocampal formation including the DG, CA 
fields, subiculum, and presubiculum of the schizophrenic group (Benes et al., 1996). 
These changes were thought to be compensatory to a decrease in presynaptic GABA, 
raising the question, whether the number or function of GABAergic cells is reduced in 
these brain regions in the disease. In the hippocampus this change was more pronounced 
in the CA3/4 regions, with relative sparing of the CA1 region. The marked increase of the 
GABAA receptor in CA1 was found primarily on pyramidal. The same group later 
reported reduction in perisomatic GABAergic synaptic inputs to pyramidal cells as 
shown by GAD-65 +ve puncta on pyramidal cell bodies (Todtenkopf and Benes, 1998). 
These changes were also reported to be marked in CA3 but subtle in the CA1 region. 
Which subregion within the hippocampus is most affected? Of all the subfields of the 
hippocampus, CA2/3 has been shown consistently to have alterations in interneurons 
(Benes et al., 1998; Todtenkopf and Benes, 1998; Zhang and Reynolds, 2002; Konradi et 
al., 2011). Deficits in other regions, including the CA1, have also been reported (Zhang 
and Reynolds, 2002; Konradi et al., 2011).  
GABAergic deficits in the other cortical regions: Alterations in GABAergic system in 
psychotic disorders are not restricted to the hippocampus, and have also been reported in 
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other temporolimbic structures, such as the entorhinal cortex (Reynolds et al., 2002), and 
in the prefrontal cortex (Lewis et al., 2005; 2012). 
Alterations in various markers of the GABAergic system have been reported in the 
prefrontal cortex in schizophrenia, particularly in the dorsolateral PFC (Lewis et al., 
2005; 2012). There is a general consensus that the PV expressing basket cells are most 
severely affected of all GABAergic cells, and their function but not density is reduced. 
Most widely reported changes are: presynaptic changes such as reduction in the 
expression of Parvalbumin, GAD 67 and GABA transporter (GAT-1); and post synaptic 
changes, such as an increase in α2 subunit containing GABAA receptor. Lewis et al have 
hypothesized that these alterations result in a reduction in GABAergic neurotransmission 
in the PFC, and these may represent a homeostatic compensatory response by the cortical 
circuit in response to reduced excitation of pyramidal cells (Lewis et al., 2012). 
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1.4 Imaging and Cognitive Studies of Hippocampal 
Dysfunction in Schizophrenia  
Hippocampal volume is reduced in schizophrenia. 
The hippocampus is one of the most affected regions in schizophrenia. Imaging studies have 
consistently shown a decrease in hippocampal volume in schizophrenia (Wright et al., 2000; 
Jarskog et al., 2007; Heckers and Konradi, 2010). The timing of this reduction is unclear. Some 
studies suggest that volume reduction is present by the time of the first episode (for review see 
(Heckers and Konradi, 2010)).  
Hippocampal volume change in schizophrenia is subtle. While reduction in mean hippocampal 
volume is consistently associated with schizophrenia, wide variations are reported even in 
unaffected subjects (for review see (Heckers and Konradi, 2010)). Volumetric measurements of 
the temporal lobe, particularly the hippocampal formation, have revealed reductions in these 
areas in subjects with schizophrenia as compared to matched healthy controls (Shenton et al., 
1992). Although reduction in hippocampal volume is a robust finding in schizophrenia, the 
source of this volume reduction is unclear. Earlier studies found evidence for cell loss (for 
example, Falkai and Bogerts, 1986), while many recent studies have failed to replicate this 
deficit in either the pyramidal cell layer (Heckers et al., 1991b) or in the extra-pyramidal-cell 
layers (Konradi et al., 2011). 
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Brain imaging techniques estimate a resting or basal hypermetabolic state in the 
hippocampus in schizophrenia 
A large number of studies over the years have shown that cerebral blood flow (CBF) and 
cerebral blood volume (CBV) are correlates of brain function and metabolism (Small et al., 
2011). Brain metabolism can be estimated using functional imaging by using various techniques 
including: 1) Cerebral Blood Flow and glucose uptake (PET and SPECT exogenous tracer 
techniques as well as by Magnetic Resonance Imaging), 2) endogenous tracer techniques (the 
oxyhemoglobin to deoxyhemoglobin BOLD fMRI signal), and 3) cerebral blood volume (CBV, 
relying on exogenous contrast agent fMRI using paramagnetic contrast agents including 
gadolinium). CBV provides a sub-millimeter resolution functional maps, hence it is preferred for 
the analysis of hippocampal sub regions. Acute as well as chronic changes in brain metabolism 
can be measured with these techniques. Multiple studies, using these imaging techniques, have 
reported increased baseline hippocampal blood flow in schizophrenia (Benes et al., 1998; 
Jarskog et al., 2007; Schobel et al., 2009; Heckers and Konradi, 2010; Schobel et al., 2013). 
Abnormal hippocampal function during cognitive testing in schizophrenia: Patients with 
schizophrenia show cognitive deficits consistent with abnormal hippocampal circuit function in 
schizophrenia.  In particular, there is clear evidence for deficits in verbal recall and episodic 
memory (see meta-analysis by (Aleman et al., 1999)). Functional imaging studies have shown 
that patients with schizophrenia show a loss of dynamic regulation of the hippocampus by 
cognitive demands (as evidenced by induced increases in CBF) (Heckers and Konradi, 2010). As 
an example, in a study by Heckers and colleagues (Heckers et al., 1998), patients with 
schizophrenia showed increased baseline cerebral blood flow (CBF). Hippocampal activity was 
then measured while the patients performed a word stem completion task, which recruits the 
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hippocampal in normal subjects. The patients performed poorly on the task as compared to the 
controls. More importantly, they failed to mount an increase in blood flow during the 
performance of the task. This and other pieces of evidence suggest that a hyperactive 
hippocampal network may be functionally deficient. 
Recent evidence from clinical studies of amnestic mild cognitive impairment (aMCI) - a high 
risk state for Alzheimer’s dementia- has shown evidence for increased baseline hippocampal 
hyperactivity, reducing which leads to improvement of hippocampus dependent memory  
(Bakker et al., 2012). 
Dopaminergic Dysfunction in Schizophrenia 
Several lines of evidence, from behavioral pharmacology to brain imaging studies, implicate 
dopamine (DA) dysfunction in psychosis.  Below, I present a brief introduction of the 
dopamine systems in the brain and review the evidence linking dopamine dysfunction with 
schizophrenia.  
 A brief introduction to DA systems innervating the forebrain: A majority of dopaminergic 
neurons in the brain are concentrated in the mesencephalon (Mendez, 2005). Traditionally, 
mesencephalic dopaminergic regions has been divided into two distinct areas (Mendez, 2005): 
1) The substantia nigra pars compacta (SNC) 
2) The ventral tegmental area (VTA) 
The VTA and substantia nigra pars compacta dopamine cells are present in close proximity 
to each other and have similar histological structure and cell compositions, however various 
differences occur in the input and output connections of these regions. It has been suggested 
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that there is a dorsal-ventral divide in the DA neurons that stretch across the dorsal substantia 
nigra pars compacta and contiguous ventral tegmental area (for review see (Bentivoglio and 
Morelli, 2005; Björklund and Dunnett, 2007; Haber et al., 2012)). The dorsal tier includes a 
band of neurons stretching across the dorsal substantia nigra pars compacta and contiguous 
ventral tegmental area. The ventral tier consists of cells of the ventral substantia nigra pars 
compacta and a corresponding ventral group of ventral tegmental area neurons. 
Fibers from these dopamine neurons form three major projection pathways:  
1) Nigrostriatal dopamine system: Dopaminergic fibers in this pathway project to the 
caudate nucleus and the putamen, also referred to as the dorsal or neostriatum. 
Traditionally, this pathway has been assigned a motor function - due to its association 
with Parkinson’s disease. More recently, the nigrostriatal DA system has also been 
implicated in associative learning and habit formation. 
2) Mesolimbic dopamine system: This pathway projects to cortical and subcortical 
regions involved in emotional regulation and reward (traditionally referred to as the 
limbic areas). The output regions of the mesolimbic dopamine pathway include: the 
septum, the hippocampus and the ventral striatum – which includes the nucleus 
accumbens, the medial and ventral portions of the caudate and putamen, the striatal cells 
of the olfactory tubercle and the anterior performated substance. This pathway is believed 
to play a role in motivation and reinforcement learning. 
3) Mesocortical dopamine system: This pathway projects to the neocortical mantle with 
the highest projections to the frontal cortex. This pathway is believed to support cognitive 
functions.  
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Previously, it was thought that dopaminergic neurons from the midbrain that project to the 
striatum along the nigrostriatal pathway come almost exclusively from the substantia nigra, 
while those that innervate the cortex and the ventral striatum come from the VTA (for review see 
(Björklund and Dunnett, 2007; Haber et al., 2012)). Recent studies show that the cells of origin 
of the three major dopaminergic pathways (discussed above), are intermixed across the 
substantia nigra – VTA complex and that this intermixing is especially prominent in primates 
(for review, see (Björklund and Dunnett, 2007)). For example, the Substantia nigra contains not 
only the neurons projecting to the striatum, but also the neurons that innervate the cortical and 
limbic areas. Similarly, the DA neurons of the VTA project to the caudate and putamen (for 
review, see (Bjorklund 2007)).   
 
Figure 1-1: Mesolimbic and mesocortical dopaminergic pathways in the mouse brain. 
Schematic representation of a coronal section of the mouse brain. Mesocortical and mesolimbic 
dopamine pathways are shown. Adapted from (Hyman, 2007). Redrawn using Allen Mouse Brain 
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The original formulation of the DA hypothesis of schizophrenia: excess [striatal] 
DA in schizophrenia 
The original dopamine hypothesis of schizophrenia posited that excessive dopamine activity 
leads to schizophrenia. The theory is based on two key observations: 1) the relationship between 
DA D2 receptor blocking properties and the efficacy of drugs such as the antipsychotics; and 2) 
the pharmacology of amphetamines.    
Antipsychotic drugs are antagonists at the dopamine receptors: The first indication of the 
role of dopamine in schizophrenia came from the serendipitous discovery of antipsychotic 
property of chlorpromazine, initially designed as an antihistamine (Delay and Denicker 1952, 
reviewed in Ban 2007). Later, Carlson and Lindquest proposed that hyperactivity of DA 
transmission was responsible for the positive symptoms in schizophrenia (Carlsson and 
Lindqvist, 1963). It was found that the antipsychotic action of these medications correlated 
with the extent of dopamine receptor activity (Seeman and Lee, 1975). Although many of the 
antipsychotic compounds affect neurotransmitters other than dopamine, D2 receptor 
antagonism is the unifying property that is shared across all anti-psychotic medications.  
Psychostimulants induce dopamine efflux: The second indication that dopamine 
dysfunction may be involved in psychosis came from the finding that drugs that induce large 
increases in dopamine efflux, such as amphetamine and cocaine, can produce psychosis in 
normal subjects, and exacerbate psychotic symptoms in patients with schizophrenia. In 
addition, patients with schizophrenia are more sensitive to the psychotogenic effects of many 
DA-enhancing drugs, and show psychotic symptoms at lower doses (Lieberman et al., 1987). 
While hallucinations and delusions are not usually fully manifested with a single 
amphetamine administration, repeated high dose exposure in non-schizophrenic subjects may 
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induce a paranoid psychosis, quite similar to that in schizophrenia (Connell 1958) (for review 
see (Guillin et al., 2007)). 
Evidence for striatal DA abnormalities from brain imaging studies 
The DA hypothesis has been supported and expanded by studies using positron emission 
tomography (PET) imaging methods that are sensitive to amphetamine-induced dopamine efflux 
in the striatum (Boileau et al., 2006). These studies have used the displacement of radio-labeled 
[11C]Raclopride to estimate dopamine release. This ligand has high specificity but low affinity 
for the Dopamine D2 receptor, and is easily displaced by dopamine. Accordingly, amphetamine 
leads to decreases in [11C]raclopride or [123I]IBZM binding that is proportional to the 
concomitant increase in extracellular DA, and thus presumably due to DA release (Laruelle, 
2000). Using this paradigm, it has been shown that patients with schizophrenia (including drug-
naive) show a greater amphetamine-induced DA efflux in the striatum (Abi-Dargham et al., 
1998; Laruelle, 2000). This finding has, in turn, been hypothesized to reflect increased phasic 
activity in the DAergic projections from the midbrain to the striatum (Abi-Dargham et al., 2000). 
Schizophrenia patients may also have higher tonic (baseline) levels of DA in the striatum. In 
experiments in which endogenous dopamine was depleted using administration of the tyrosine 
hydroxylase inhibitor alpha- methyl-para-tyrosine (AMPT), Abi-Dargham and others have found 
higher baseline occupancy of striatal D2 receptors by endogenous DA in schizophrenia. 
Consistent with the above data are multiple studies using [18F] or [11C] DOPA showing 
increased rates of DOPA uptake, a correlate of synthesis in the DA terminal, in the striatum of 
schizophrenia patients (for review see (Guillin et al., 2007)). Generally, these changes are 
thought to represent an increased capacity or level of DA release in the striatum, and not an 
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increase in DAergic innervation of this region since dopamine transporter (DAT) density, which 
correlates closely with the density of dopaminergic terminals in the striatum, has not been found 
to be changed in histological and in vivo PET imaging studies (for review (Guillin et al., 2007)) 
(Laruelle et al., 2000).   
In addition to presynaptic alterations generally considered to indicate an increase in DA release, 
there is also in vivo imaging and post-mortem evidence for modest but reliable increases in DA 
D2 receptors in the striatum (Guillin et al., 2007). This effect was initially attributed to the effect 
of chronic antipsychotic use (Burt et al., 1977; Guillin et al., 2007). Later, PET and SPECT 
imaging studies found a small (12% in a meta-analysis by Guillin et al (Burt et al., 1977; Guillin 
et al., 2007)) but significant elevation of striatal D2 receptors in untreated patients with 
schizophrenia. 
The modified dopamine hypothesis: mesocortical hypo-dopaminergia 
/mesolimbic hyper-dopaminergia  
The resistance of both cognitive and negative symptoms to antipsychotic treatment suggested 
that increased dopamine might not be involved in the development of these symptoms. 
Functional imaging studies implicated frontal and temporomedial cortex in these symptoms 
(Guillin et al., 2007). These, and other findings led to the modification of the dopamine 
hypothesis, which in its current formulation states that the DA systems in schizophrenia are 
characterized by an imbalance between subcortical and cortical DA systems: subcortical 
mesolimbic DA projections might be hyperactive resulting in hyperstimulation of D2 receptors 
and positive symptoms. Additionally, mesocortical DA projections to the PFC might be deficient 
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(resulting in hypostimulation of D1 receptors), a condition contributing to negative symptoms 
and cognitive impairment (for review see Guillin et al., 2007)  
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1.5 Limitations of Clinical Studies and a Need for Animal 
Models  
Limitations of neuropathological and imaging studies in 
schizophrenia 
Although clinical imaging studies and post-mortem neuropathological studies are valuable in 
elucidating the neurobiological underpinnings of schizophrenia, their role is limited for various 
reasons described below: 
Clinical findings are correlational: By their very nature, findings of most clinical studies are 
correlational. It is not possible to find out if a certain alteration found in any one group of 
patients is pathological and contributes to the disease process, or has nothing to do with the 
disease process. Any given finding could represent one of 4 possible scenarios (Lewis and 
Gonzalez-Burgos, 2008): 
1. Cause: An upstream factor related to the pathogenesis of the illness. 
2. Consequence: A deleterious effect of a cause. 
3. Compensation: A response to either a cause or consequence that helps restore 
homeostasis(partially or completely) in the brain 
4. Confound: A product of factors frequently associated with, but not a part of the 
disease process (or an artifact of the approach used to obtain the measure of interest).  
Effects of confounding factors: It is often not possible to control the various environmental 
and drug exposures in a particular patient. Furthermore, observations may be made after a 
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life long disease process. Hence, the possible effect of confounding factors such as drug 
treatment, co-morbid disease conditions, impoverished lifestyle, poor diet and illicit drug 
exposures – are often difficult to control in clinical studies.  
Wide variance among samples: Wide variations are usually found across different studies, 
and even within the same study, across different subjects. Although the cause of this variance 
is not entirely clear, it is possible that the current diagnostic criteria for schizophrenia 
encompasses several biologically distinct disease entities, resulting in noisy findings.  
 
Limitations of post-mortem studies of GABAergic deficits: 
It is evident from the above-mentioned studies that there are various reports of dysfunction in the 
GABA system in the hippocampus. These findings warrant caution due to various reasons. 
Firstly, several studies have employed different techniques, ranging from ligand binding, 
immunohistochemistry and expression analysis employing PCR, microarrays and in situ 
hybridizations. Secondly, different sub fields of the hippocampus have been reported to have 
deficits in GABAergic transmission. Various discrepancies exist in the available literature on the 
subject. Several studies have failed to replicate earlier reports. Reynolds and colleagues reported 
deficits in PV+ cells all over the hippocampal formation (Zhang and Reynolds, 2002), Benes and 
colleagues have repeatedly found deficits predominantly in the CA2/CA3 regions, with relative 
sparing of the CA1 ( Benes et al., 1998; Todtenkopf and Benes, 1998). Thirdly, post-mortem 
studies are conducted in patients with different etiologies underlying their disease. The etiology 
of reduced PV+ interneuron density in the hippocampus in patients with schizophrenia , is 
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unclear at the moment, and it remains unknown whether this alteration represents developmental 
hypoplasia or an atrophic process.  
Clinical studies generate hypotheses that require animal models to be fully 
tested.  
In general, neuropathological and brain-imaging findings in schizophrenia lack the strength and 
consistency to serve as diagnostic markers (perhaps due to the limitations discussed above). 
However, these findings have led to a number of conceptual models of the pathophysiology of 
schizophrenia that have been useful in guiding research in animal models. For example, 
alterations in PV+ interneuron subpopulation in schizophrenia has led to the idea that reduction 
in the function of these neurons may be involved in the pathophysiology of psychosis ( Lisman et 
al., 2008; Lodge and Grace, 2011). This specific hypothesis can be tested in animal models by 
selectively targeting PV+ interneurons in selected regions of the brain and then observing the 
physiological and behavioral effects of this manipulation. 
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1.6 A Conceptual Model of Abnormal Hippocampal 
Activity and Dysregulation of Striatal Dopamine in 
Psychosis 
Hippocampal regulation of the VTA dopaminergic system:  
There is little evidence for structural or histopathological abnormalities in the dopamine system 
in schizophrenia (discussed in section 1.4). This has given rise to the idea that the primary 
dysfunction may lie upstream of the dopamine pathway. One candidate ‘dysregulator’ of the DA 
system, particularly the mesostriatal system, is the anterior (ventral in rodents) hippocampus. 
Evidence for this is summarized below.  
Increased locomotor response to amphetamine: The response to amphetamine (AMPH) 
is exaggerated in the presence of a hyperactive/ disinhibited ventral hippocampus 
(vHIPP) (White et al., 2006; Lodge and Grace, 2007). Excitotoxic lesion or inactivation 
of the vHIPP through local injection of lidocaine leads to reduction in amphetamine 
response while acute pharmacological excitation of the vHIPP by local injection of N-
Methyl-D-aspartic acid (NMDA) leads to an increase in locomotor response to 
amphetamine (White et al., 2006). These data are consistent with the idea that glutamate 
input from the vHIPP modulates locomotion via the nucleus accumbens (NAc). 
Increased VTA DA cell activity: NMDA mediated activation of the vHIPP leads to 
increased DA cell population activity (Floresco et al., 2001; 2003). Increased DA 
population activity has also been observed in animal models that are expected to have 
hippocampal disinhibition, such as the MAM E17 rat model (Lodge and Grace, 2007), a 
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developmental rodent model that recapitulates many of the neuropathological features of 
schizophrenia (Moore et al., 2006). Moreover, vHIPP inactivation reverses elevated DA 
neuron population activity in the MAM E17 model (Lodge and Grace, 2007).  
Increased DA efflux in the nucleus accumbens: Electrical stimulation or NMDA 
mediated activation of the vHIPP leads to increased DA efflux in the nucleus accumbens 
(Legault and Wise, 1999; Legault et al., 2000) (discussed below). 
Chemical stimulation of the ventral striatum increases dopamine concentration in the nucleus 
accumbens (NAc) (Legault and Wise, 1999; Legault et al., 2000). Legault et al (Legault et al., 
2000) showed that chemical stimulation of the ventral subiculum (vSub) increased NAc DA 
concentration and that this effect relied on cell activity in the VTA, as inactivation through 
Tetrodotoxin (TTX) injection eliminated this effect.  
Activation of the ventral Subiculum did not increase burst firing of dopamine neurons, however, 
inactivation of the vSub attenuated bursting. In the study by Todd and Grace (Todd and Grace, 
1999) and Floresco et al (Floresco et al., 2001) chemical stimulation of the ventral subiculum 
(vSub) /Entorhinal cortex (EC) did not affect DA cell firing rate, however blockade of vSub/ EC 
cell firing by TTX injection decreased the firing rate of DA neurons. Legault et al (2000) 
however found that half of the VTA DA neurons showed increased DA cell firing by NMDA 
injection (Legault et al., 2000).  
Floresco et al (2001) suggest that vSub exerts its effect on the activity of DA neurons in the VTA 
via glutamatergic mechanisms localized within the NAc. Glutamatergic receptor blockade in the 
NAc attenuated the effect of vSub stimulation on DA cell activity (Floresco et al., 2001). 
These data suggest that the increase in meso-accumbens DA release after chemical stimulation of 
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the vSub is mediated in part by increased firing of VTA DA neurons. This idea is supported by 
previous data that basal striatal DA efflux correlates strongly with DA neuron population activity 
(Moore et al., 1998; Floresco et al., 2003) but not with either the average firing rate or burst 
firing level of individual nigrostriatal DA neurons (Moore et al., 1998). 
Other studies have shown that vSub stimulation increased the number of spontaneously active 
VTA dopaminergic neurons (Todd and Grace, 1999; Floresco et al., 2001).  
Candidate circuits mediating hippocampal regulation of midbrain DA neuron 
activity ventromedial striatal DA release?  
Various studies have tried to elucidate the neuroanatomical circuit mediating hippocampal 
regulation of the dopamine neurons. Various elements of the proposed circuits involved in 
hippocampal regulation of VTA DA cells are described below.  
Direct projection of the Hippocampal formation to the nucleus accumbens: The CA1 as 
well as the subiculum projects directly to the nucleus accumbens (Raisman et al., 1966; 
Kelley and Domesick, 1982) through the fornix. Studies in the rat, using the anterograde 
tracer Phaseolus vulgaris leucoagglutinin (PHA-L) showed that the subiculum projects 
not only to the entire nucleus accumbens - which constitutes a major part of the so-called 
ventral striatum, but also projects to the medial, ventral, rostral and caudal parts of the 
caudate-putamen complex. The projections to the ventral and caudal parts of the caudate-
putamen are prominently derived from the ventral subiculum, whereas the projections to 
the rostral part of the caudate-putamen are derived from the dorsal subiculum 
(Groenewegen et al., 1987). 
Direct projection of NAc to the VTA: Various studies have found evidence for direct 
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NAc projections to the VTA. Earlier work showed that stimulation of the NAc evokes 
short-latency inhibitory responses in VTA neurons (Maeda and Mogenson, 1980), 
suggesting the presence of a direct NAc GABAergic projection to the VTA neurons. 
More recently, a study has found that a significant number of NAc medium spiny neurons 
(MSNs) directly project to the VTA (Xia et al., 2011). Xia et al expressed the light-
sensitive channel rhodopsin-2 in the rat NAc and made electrophysiological recordings 
from VTA neurons ex vivo (Xia et al., 2011). This study showed that the NAc neurons 
directly target non-dopaminergic VTA neurons acting thorough the GABAA receptors. 
These VTA neurons include non-DA neurons including those that project back to the 
nucleus accumbens.  
Two scenarios could be imagined regarding indirect effect on DA neurons. First, this 
feedback could indirectly inhibit VTA dopamine neurons if the NAc MSNs target VTA 
glutamate neurons, which make local collaterals onto dopamine neurons (Dobi et al., 
2010). Alternatively, if NAc afferents affect the GABAergic neurons - that make local 
contacts with dopamine neurons (Omelchenko and Sesack, 2009) - activation of this 
projection could increase dopamine neuron firing. Such a GABA–GABA–DA loop has 
been demonstrated in the substantia nigra (Grace and Bunney, 1985; Chuhma et al., 
2011).  
Nucleus accumbens to VP pathway: The Ventral pallidum receives a dense GABAergic 
projection from the NAc (Zahm and Heimer, 1990) and in turn provides a direct 
GABAergic projection to the VTA (Swanson et al., 1984; Zahm and Heimer, 1990) 
(Swanson et al., 1984; Zahm and Heimer, 1990). Unlike NAc medium spiny neurons, the 
ventral pallidal neurons show high rates of tonic activity and therefore supply a potent 
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GABAergic inhibitory influence over DA neuron firing (Yang and Mogenson, 1985; 
Zahm and Heimer, 1990; Floresco et al., 2003). Stimulation of either the NAc or its 
glutamatergic afferents (including the vSub) can inhibit VP neuronal firing (Yang and 
Mogenson, 1985). The decrease in VP activity would then be expected to cause a 
reduction of the GABAergic inhibition over the VTA, thereby leading to VTA DA cell 
activity (Yang and Mogenson, 1985; Floresco et al., 2003).  
Ventral Pallidum to pedunculopontine tegmental nucleus pathway: The VP sends 
projections to the pedunculopontine tegmental nucleus (PPTg) (Swanson et al., 1984; 
Zahm and Heimer, 1990). PPTg sends glutamatergic and cholinergic inputs to the VTA 
DA neurons, activation of which leads to increased burst firing of VTA DA neuron 
(Floresco et al., 2003). 
VTA to Nucleus accumbens non-DA cell pathway: The VTA consists of DA cells, 
glutamatergic cells that make local collaterals onto the dopaminergic cells (Dobi et al., 
2010) and GABAergic cells that make local contacts with the DA cells (Omelchenko and 
Sesack, 2009). In addition, GABAergic neurons of the VTA can form long range 
projections (Carr and Sesack, 2000a; 2000b); a significant proportion of NAc-projecting 
VTA neurons are GABAergic and stain positive for GAD67 (Carr and Sesack, 2000a; 
2000b).  
Dorsal CA3 - Lateral septum - VTA pathway:	  Luo and colleagues, using track tracing 
and in vivo electrophysiological methods, have identified a novel pathway that mediates 
hippocampal regulation of VTA dopamine neurons (Luo et al., 2011). In contrast to the 
pathway from the ventral subiculum, CA3 cells from the dorsal hippocampus project to 
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the VTA through the lateral septum as a relay. Luo and colleagues showed that 
stimulation of the CA3 had an excitatory effect on the VTA dopamine (DA) neurons, and 
inhibited non-DA neurons. (Luo et al., 2011). DA neuron excitation was likely mediated 
by disinhibition because local antagonism of γ-aminobutyric acid receptors blocked 
responses to CA3 stimulation. Although retrograde tracers injected into the VTA labelled 
the dorsal, intermediate and the ventral hippocampus - only those from the dorsal 
hippocampus seemed to use the lateral septal relay - suggesting that the ventral 
hippocampus projections to the VTA dont pass through the septum. 
 
 
Figure 1-2: Hippocampal regulation of the mesolimbic dopamine system:  
Schematic representation of one of the proposed circuits presumed to underlie hippocampal regulation of 
VTA Dopamine activity. For additional proposed circuits see text. 
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Regional differences in Dopamine Receptor dysfunction in schizophrenia 
Older imaging studies lacked the spatial resolution to differentiate between the various sub-
regions of the striatum. Hence it was not clear if regional differences existed in dopamine 
receptor dysfunction in schizophrenia. The most prominent theoretical model generated from 
rodent models was that psychotic symptoms were driven by increased dopamine 
neurotransmission in the ‘mesolimbic system’ projecting to the ventromedial striatum and that 
antipsychotic efficacy was achieved through the blockade of ventromedial striatal D2-like 
receptors.  On the other hand, blockade of D2 receptors in the dorsal striatum (dorsal caudate and 
putamen) was thought to lead to Parkinsonian-like extra-pyramidal side effects of antipsychotic 
drugs. More recent studies suggest that the striatal subregion in which excess DA release is most 
tightly correlated to psychotic symptoms is the rostral caudate, part of the ‘associative striatum’, 
so named due to inputs from frontal cortical regions involved in cognitive processing more so 
than movement generation (Joel and Weiner, 2000; Kegeles et al., 2010).  Thus, it is likely that 
there is a DA subsystem that may be differentially important for psychosis.  This may be due to 
unique properties of the neurons in the midbrain that project to the rostral caudate in the primate 
(e.g. the balance between intrinsic firing patterns and indirect regulation by the hippocampus and 
limbic basal ganglia) and/or due to local regulation of DA at the terminal region in the rostral 
caudate.  In any case, determining the rodent homologue of this dopamine system will be 
important for furthering research in this field.   
We hypothesize that rostromedial striatum in the rodent, including the medial caudate, has some 
homology with the rostral caudate of the primate.  We further hypothesize that this region is 
innervated by DA neurons of the VTA and medial substantia nigra (SN) that are, in turn, 
regulated by hippocampal output through the circuits shown in figure 1-2. A combination of 
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tract-tracing methods (with cell-specific markers) and in vivo electrophysiology will be needed 
to test this hypothesis.  
Linking hippocampal interneuron pathology to DA dysregulation in 
schizophrenia.  
The evidence presented above strongly implicates hippocampal hyperactivity in the pathogenesis 
of psychosis in schizophrenia. Interestingly, evidence from neuropathological literature, 
presented in the previous section would suggest that PV+ interneuron deficit could produce 
disinhibition in the hippocampus and could potentially explain the hypermetabolic phenotype 
seen in schizophrenia patients, as well as the relation of hippocampal over activation producing 
excess striatal DA and related behavioral abnormalities in rodent models. However, so far there 
has been no evidence linking GABA interneuron pathology and chronic hippocampal 
disinhibition to DA system disinhibition. One major aim of this thesis has been to test the 
plausibility of causal links among GABA interneuron pathology (determined post-mortem), 
hippocampal disinhibition and related cognitive deficits (assessed by functional imaging and 
cognitive neuroscience studies), and excess striatal DA and related behavioral abnormalities 
(assessed in neurochemical PET and pharmacological studies). In the next section, I will briefly 
describe the necessary background on the important functional features of the GABAergic 
interneurons and their development and then introduce the mouse models of interneuron deficit 
used in this study 
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1.7 Parvalbumin-expressing Interneurons of the Cerebral 
Cortex 
GABAergic interneurons of the cortex 
Cortical GABAergic interneurons are neurons that use GABA for fast synaptic 
neurotransmission.  
GABAergic regulation of the level and pattern of activity in cortical projection 
neurons. 
GABAergic interneurons exert a number of effects on their target neurons and cortical network 
activity.  At synapses, GABA is released in an action-dependent manner from the terminals, e.g. 
of PV+ interneurons synapsing on the soma of a hippocampal projection neuron. GABA at the 
GABAA receptor gates a chloride conductance with a rapid onset and a rise time of few hundred 
microseconds. In most neurons, this chloride conductance hyperpolarizes the membrane or 
stabilizes it at a resting potential or -60 to -70 mV, the reversal potential of the chloride 
conductance in neurons. As a result, Cl- flux through the channel can be either depolarizing or 
hyperpolarizing.  In either case, it can act as a shunt for strong hyperpolarizing (inhibitory) or 
strong depolarizing (excitatory) conductances.  There are some notable cases in which GABA 
may depolarize the membrane enough to excite a neuron (Ben-Ari, 2002; Cossart et al., 2005).  
One example of this is the axo-axonic synapse formed by the PV+ interneuron contact with the 
pyramidal neuron. In other cells, GABA mediated hyperpolarization may de-inactivate voltage-
gated sodium channels, hence leading to renewed excitability of the cell. Overall, however, the 
common effect of GABAA –mediated chloride conductances is to stabilize the membrane in a 
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particular state that in most cases shunts excitatory inputs and makes the neuron resistant to spike 
firing.  
The effect of the GABA-mediated chloride conductance may be thought of as holding the 
postsynaptic cell ‘at the ready’, such that when the chloride conductance ceases in the context of 
active excitatory inputs, the cell fires immediately and robustly.   In this way, GABA tone, and 
intermittent interruptions thereof, can serve to gate inputs to the cell.  Information between 
cortical areas is transmitted via axonal projections of glutamatergic pyramidal cells, but they 
alone may not produce the required high degree of temporal precision between brain regions. 
Together with other state-modulating inputs (e.g. monoaminergic inputs from brainstem, 
midbrain and basal forebrain), GABAergic inputs can reset neurons so they respond more 
reliably and precisely to a given glutamatergic input. This property of GABA interneuron-
mediated inhibition also allows for synchronization of activity across cortical projection neurons  
(Klausberger and Somogyi, 2008).  GABA may also modulate which inputs to a neuron are 
processed. For example, in hippocampal and other cortical projection neurons, activity of 
interneurons innervating the distal dendrites can functionally “eliminate” a dendritic segment 
while leaving excitatory inputs to other portions of the cells unshunted and free to propagate to 
the soma (Miles et al., 1996; Klausberger and Somogyi, 2008).  
Perisomatic- and distal dendrite-targeting inhibitory interneurons play different 
roles in cortical circuit 
Multiple subtypes of GABAergic interneurons exist, which differ in their expression of calcium 
buffer proteins or neuropeptides, dendritic arborization, firing characteristics, shape and position 
of the soma and pattern of axonal projections (Freund and Buzsaki, 1996) (Markram et al., 
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2004). Broadly speaking, GABAergic interneurons can be divided into two large groups ( Miles 
et al., 1996). These two types of GABAergic cells affect the postsynaptic cell differently and 
play different roles in the cortical circuit.  
Distal dendrite targeting cells: These neurons innervate the distal dendrites of pyramidal 
cells and control the inputs of principal neurons and calcium currents. These cells 
modulate glutamatergic inputs to pyramidal cells. The activity of these cells can help the 
cell to control reception of inputs from various sources. (Miles et al., 1996; Buzsaki, 
2006). 
Perisomatic/ Axon hillock and proximal dendrite targeting cells: Neurons that innervate 
the cell body of pyramidal cells, thereby controlling sodium spikes and the output of the 
cells. The perisomatic synapses can effectively control the probability as well as timing 
of action potential spike firing of pyramidal cells. 
PV+ cells are fast-spiking,  perisomatic-targeting interneurons 
An important class of GABAergic neurons express the calcium-binding protein parvalbumin. 
These cells can be further distinguished from other types of interneurons by properties including 
morphological and electrophysiological properties (Kawaguchi and Kubota, 1997). PV+ 
interneurons constitute about a quarter of all GABAergic cells in the cortex (Freund and Buzsaki, 
1996).  
Morphology and synaptology. Morphologically, PV+ cells can be classified into two major 
groups based upon their axonal targeting patterns: 
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1. Basket cells: These cells innervate the perisomatic or axon initial segment of 
pyramidal cells. This innervation can appear as a ‘basket’ of PV+ fibers around a 
pyramidal neuron soma (figure 1-3). 
2. Chandelier or axo-axonal cells: These cells innervate the axon initial segment of 
pyramidal cells. Their axons and terminal formations resemble chandeliers with low-
power microscopy.   
Electrophysiological properties  
 
Despite morphological differences, the two classes of PV+ interneurons have almost identical 
intrinsic electronic properties. PV+ Interneurons are distinguished by their ability to exhibit a 
very high non-adapting spike firing pattern, which along with the perisomatic location of the 
outputs of PV+ cells ensure a strong inhibition of their target pyramidal cells. Parvalbumin - a 
calcium binding protein- plays a role in conferring the unique electrophysiological properties to 
these cells. Parvalbumin accelerates the initial decay of the post-impulse Ca2+ transient in the 
interneurons, without having a major effect on the intracellular Ca2+ concentrations at rest or the 
peak concentration during activation. Reducing or knocking out parvalbumin affects the kinetics 
of the Ca2+ transient and leads to abnormalities in the firing of PV+ interneurons, increased 
seizure susceptibility and other deficits related to decreased GABAergic function (For review, 
see (Freund and Buzsaki, 1996; Schwaller, 2010). 
Distribution and inputs 
PV+ interneurons have a non-uniform distribution across and within cerebral cortical regions. In 
the hippocampus, more than 80% of all PV+ interneurons are present in the stratum pyramidale 
and stratum oriens. PV+ Basket cell dendrites receive inputs from all major input pathways such 
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as mossy fibers, Schaffer collaterals, commissural and entorhinal afferents. In addition, the 
recurrent collaterals of glutamatergic projection neurons also synapse on the PV+ interneurons.  
 
Figure 1-3: Photomicrograph showing PV+ cell body and “baskets” in hippocampus: 
A PV-immuostained section of the hippocampus showing a PV-immunoreactive cell body and 
PV+neurites surrounding a PV-ve soma (Pyr) presumably a pyramidal cell. The section is counterstained 
with cresyl violet 
PV+ cells are widely connected in the cortical circuit. Around 25-40 basket cells converge on a 
single pyramidal cell in the hippocampus (Buhl et al., 1994). The divergence for axo-axonic cell 
is also enormous, with a single PV cell projecting to as many as 1,200 pyramidal cells) (Soltesz, 
2006). PV+ interneurons have a large number of asymmetrical (~15,000), symmetrical (~1000) 
and electrical synapses (gap junctions) (Freund and Buzsaki, 1996), which may put them in a 
position to act as coincidence detectors and ‘synchronizers’ of cortical activity (see below).  
Importance of PV+ cells in cortical function 
Several structural features of PV cells make them excellent candidates for their proposed roles as 
potent inhibitor and synchronizer of pyramidal cells. Being perisomatic, GABAergic synapses 
made by PV cells can mediate a much stronger inhibitory effect on a pyramidal cell’s membrane 
potential as compared to a distally placed synapse. Similarly, extensive diverging and converging 
connections, frequent gap junctions with other PV cells, a fast firing rate and fast rise and decay 
kinetics of PV cell IPSCs would be ideal for a role in role in coincidence detection, generation of 
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network oscillations and network synchronization (Freund, 2003). In the hippocampus, a single 
chandelier neuron can synchronize the firing of multiple pyramidal neurons (Cobb et al., 1995), 
suggesting that chandelier neurons may help coordinate and entrain pyramidal neuron firing. 
PV+ interneurons are also thought to be critical nodes in the generation of electrical-field 
oscillations in the cortex.  Cortical oscillations represent synchronous activity of a large numbers 
of neurons. Neural networks in the mammalian forebrain demonstrate several oscillatory bands 
covering a wide frequency range. Notable of these are: theta (3-6 Hz), beta (15 -30 Hz) and 
gamma (>30 Hz). PV+ basket cells are ideal candidates for generation of high frequency network 
oscillations particularly in the gamma band. These cells have a high firing rate, are one of the 
most abundant GABAergic neuron sub class in the cortex, are highly interconnected by electrical 
(gap junctions) as well as GABAergic synapses, and are seen to be highly active during gamma 
band oscillations (Buzsáki and Draguhn, 2004). Computational models have suggested that 
networks of interneurons particularly the PV+ interneuron subclass, interconnected by 
GABAergic synapses as well as electrical gap junctions, can generate coherent rhythmic activity 
and synchronize spiking of pyramidal cells, thereby generating gamma oscillations (Wang and 
Buzsaki, 1996). This is supported by recent experiments showing that selective stimulation of 
PV+ interneurons amplifies local field gamma band oscillations selectively in the gamma band, 
while stimulation of pyramidal cells increases power in lower bands (Cardin et al., 2009; Sohal 
et al., 2009). Conversely computational models (Volman et al., 2011) and experimental work 
(Manseau et al., 2010) both suggest that reduced PV expression in interneurons may lead to 
disruption of gamma band activity. 
These findings support the idea that fast-spiking PV+ interneuron activity is critically involved in 
the generation of gamma oscillations  
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1.8 Origins of Cerebral Cortical GABAergic Interneurons 
Majority of GABAergic neurons are born in the Ganglionic Eminences:  
The developing telencephalon can be divided into the pallium (or roof) and the sub-pallium (the 
floor) regions (figure 1-4). While most cortical projections neurons derive from the ventricular 
region of the pallium- migrating radially to the cortical mantle, most cortical interneurons 
originate in the subpallium- migrating tangentially to reach their final position in the cortex and 
the hippocampus. The developing sub-pallium can be divided into medial, lateral and caudal 
ganglionic eminences (Anderson et al., 2001). Together the ganglionic eminences give rise to a 
vast majority of GABAergic interneurons of the cortex. A smaller contributions comes from the 
adjacent preoptic area -which produces about 10% of the interneurons (Gelman et al., 2011). 
Production of GABAergic neurons in the ganglionic eminences has been found in rodents such 
as mice and ferrets as well as in humans.  
 
Figure 1-4: A schematic of a coronal section of the embryonic mouse brain showing the 
ganglionic eminence: 
 Notice the developing neocortex and hippocampus (HIPP) and the medial (MGE) and lateral (LGE) parts 
of the ganglionic eminence.  
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Ventral-dorsal difference in signaling molecule concentration controls neural 
patterning: 
Development of interneurons in the forebrain follows the general rules of neural development, 
first established in the spinal cord and the hindbrain. This paradigm states that speciation-or 
development of unique identity of neurons- results from the effect of signaling molecules from 
certain embryonic structures (such as the notochord), which surround the developing neural tube.  
The notochord secretes inducers, such as Sonic hedgehog (Shh), retinoic acid (RA), noggin and 
chordin, which then diffuse to the neural tube. These chemicals form a concentration gradient 
along the dorso-ventral axis of the tube. Under the effect of this concentration gradient, different 
sets of genes are expressed by different parts of the neural tube. The expression of these genes 
starts a cascade of gene expression ultimately leading to differentiation along distinct paths. 
(Jessell, 2000). The ventral part of the tube under the effect of Shh assumes a motor fate, while 
the dorsal part differentiates into sensory neurons (Purves, 2013).  
Temporal and spatial factors control interneuron development: 
Although many of the details of GABAergic interneuron speciation are not clear, it is generally 
believed that different subtypes of GABAergic interneurons arise from distinct sets of 
progenitors within the ganglionic eminence. As in other regions of the developing brain, the 
initial positional identity of cells in the ganglionic eminence plays a major role in determining 
the final subtype of interneurons. Each progenitor features a unique set of transcriptional 
regulators that sets into motion a certain transcriptional blueprint thereby leading to the 
expression of a particular set of genes-such as ion channels, neurotransmitter receptors, 
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neuropeptides and calcium binding proteins, etc, that are ultimately responsible for the 
molecular, histological and electrical features of an interneuron (Wonders and Anderson, 2006; 
Flames et al., 2007; Batista-Brito and Fishell, 2009). In addition to spatial distinctions, temporal 
distinctions have also been identified, that is: different classes of interneurons may be born from 
the same or similar progenitors at different times (Butt et al., 2005).  
The medial ganglionic eminence (MGE) gives rise to a majority of fast spiking  PV+ cells and 
the regular spiking SST+ cells (Butt et al., 2005). The caudal ganglionic eminence produces 
bipolar interneurons that express vasoactive intestinal peptide (VIP) and/or the calcium-binding 
protein calretinin (CR), and multipolar interneurons that contain neuropeptide Y (NPY) or reelin 
(Xu et al., 2004; Butt et al., 2005). Within the MGE, there is a bias for SST+ interneurons to 
originate from the dorsal MGE, and the PV+ interneurons to originate from the ventral MGE 
(Flames et al., 2007; Wonders et al., 2008).The lateral ganglionic eminence gives rise to the 
projecting medium spiny neurons in the striatum, nucleus accumbens and olfactory tubercle 
(Wichterle et al., 2001).  
Migration of interneurons: 
After development in the GE, the interneurons leave the proliferative zones, migrating 
tangentially along the intermediate and marginal zones, and finally radially toward the inner 
cortical layers. Motogenic factors such as HGF/ SF (Hepatocyte growth factor/ Scatter factor), 
stimulate the cells to leave the ganglionic eminence and begin migration. Disruption of these 
signals leads to aberrant migration. For example disruption of uPAR enzyme function, which 
controls the activation of HGF/SF, leads to reduction in the number of PV IN in the cortex. 
Many factors are thought to guide the interneurons on their way to their final destination, one of 
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which is Neuregulin/ErbB4 signaling. ErbB4 is expressed by certain populations of developing 
interneurons while the migratory route expresses its receptor Neuregulin-1 (Flames et al., 2004).  
GABAergic system may be particularly susceptible to risk factors: 
GABAergic cells follow a protracted course of development. GABAergic interneurons migrate 
long distance to reach their final target in the cortex. Moreover, the migration of IN, 
development of synaptic contacts and their subsequent pruning and maturation takes place later 
than for most other types of neurons. Parvalbumin protein is not expressed completely till later 
2nd/ early 3rd week in mice. Similarly, studies in macaques have shown that pruning of 
GABAergic synapses continues well into adolescence (2-4 years after birth).  
This may make the GABAergic system particularly vulnerable to a wide variety of 
environmental insults during perinatal period (maternal infection, obstetric complications, 
maternal starvation), through childhood and during adolescence (stress, drug exposure such as 
cannabis, etc). These factors may influence the development or migration of interneurons, as 
well as the development or pruning of GABAergic synapses. These explanations are consistent 
with a neurodevelopmental view of schizophrenia (Weinberger, 1987). 
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1.9 Introduction to the Cyclin D2 Null Mouse Model of 
GABAergic Interneuron Deficits 
In the following section, I briefly review the rationale behind using an animal model to 
investigate human disease. I then present a brief introduction to the cyclin D2 null mouse model, 
which I have used in my research. 
Characterization of “cortical PV interneuron deficit” models, particularly with regard to 
disinhibition of the hippocampus and its impact on behavior, is important for increasing our 
understanding of the potential significance of cortical PV interneuron deficits in schizophrenia.  
A number of manipulations in animals designed to model aspects of the etiology or 
pathophysiology of schizophrenia affect PV+ interneuron number or function (Penschuck et al., 
2006; Harte et al., 2007; Berretta et al., 2009; Schobel et al., 2013). However, one important 
limitation in understanding the significance of PV+ interneuron deficits in schizophrenia has 
been the lack of animal models of a selective and partial PV+ interneuron deficit. 
Role of cyclin D2 in GABAergic interneuron development 
Cell cyclins play a pivotal role in cell division: Control of cell division plays an 
important role in brain development. One of the key regulators of cell division is the class 
of proteins called the cell cyclins, called so because of the cyclical nature of their 
production and degradation. The cyclins form activating subunits of the cyclin dependent 
kinases (Cdks). The cyclin- cylin dependent kinase complex phosphorylates important 
proteins in the cell, which in turn lead the cell forward through the cell cycle (Alberts et 
al., 2002). More than a dozen different cyclins have been discovered and classified into 
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multiple classes. Cyclins of type A, B1 and B2 control the advance through the G2 phase 
of the cell cycle. Cyclins D1, D2 and D3 control the progression through the mid G1 
restriction point and cyclin of the E type regulate the G1/S transition. Although there is 
redundancy in each type of cyclin, the expression pattern of different cyclins does not 
always overlap, leading to subtle but definite deficits in knockout conditions (Alberts et 
al., 2002). The activity of Cdks is negatively regulated by cyclin dependent kinase 
inhibitors (CDKIs) such as p21, p27 and p57 (Alberts et al., 2002).   
 
Cyclin D2 regulates cell division: Cyclins D proteins interact with cyclin dependent 
kinases (Cdks) 2, 4, 5, and 6. In proliferating cells, cyclin D-Cdk4/6 complex 
accumulation is of great importance for cell cycle progression. After formation, Cyclin 
D-Cdk4/6 complex partially phosphorylates the retinoblastoma protein (Rb), which is 
then able to induce expression of genes such as the E class cyclins, which are important 
for progression through the S phase of the cell cycle Alberts et al., 2002). 
 
The role of cyclin D1 and D2 in GABAergic interneuron development: In the brain, 
control of cell proliferation and speciation plays a major role in brain size, architecture 
and function. The duration of cell cycle, and notably of G1 phase, determines the balance 
between expansion of progenitor pools and neuronal differentiation (Calegari, 2012).  
Cyclin D1 and cyclin D2 are two G1-phase active cyclins, with non-overlapping patterns 
of expression in the MGE (Glickstein 2007). GABAergic neurons may arise from either 
the ventricular zone (VZ) or the subventricular zone (SVZ) of the ganglionic eminence. 
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Asymmetric neurogenic divisions occur in the Ventricular zone, this yields a neuronal 
daughter cell and a replenished progenitor cell. Symmetric neurogenesis occurs mainly in 
the SVZ, in which both daughters develop into neurons (Glickstein 2009).  
 
CD2 is important for the expansion of intermediate progenitor pool: cD2 is expressed 
as the GABAergic progenitors in the MGE transition from radial glial cells (which stain 
positive for Pax6) in the VZ to the intermediate progenitors (which stain positive for 
Tbr2) in the SVZ. Here the intermediate progenitors undergo ‘transit amplifying’ 
divisions resulting in 2 daughter neurons. cD2 is important for the expansion of the 
intermediate progenitor cell pool through these transit amplifying divisions. Loss of cD2 
is associated with reduced proliferation of both the radial glia like progenitors and the 
intermediate progenitors, as well as enhanced exit through the cell cycle (Glickstein 
2007, 2009). 
Partial depletion of the intermediate progenitors in the cD2 null shows that cD2 is not an 
absolute requirement for the formation of these cells, however in its absence there is 
depletion of these intermediate progenitors (Glickstein 2009). cD2 affects phosphorylated 
retinoblastoma protein (pRb) and p27, two key regulators of the cell cycle. p27 is 
increased, while pRb is decreased in the SVZ in cD2 -/-. The increased expression of p27 
and decreased expression of pRb in cD2null is consistent with a slower progression 
through the G1-phase in the absence of cD2 (Glickstein 2007, 2009).  
Although the same progenitor cells are thought to give rise to both the PV+ as well as 
SSN+ neurons in the MGE, the cD2 null mutation leads to a selective reduction in PV+ 
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neurons (see below), suggesting that the ‘transit amplifying’ cell divisions in the MGE 
preferentially give birth to PV cells (Glickstein 2007).  
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Selective deficit in parvalbumin interneuron density in cD2 null mice   
Using the cD2 null mouse, Glickstein and colleagues (Glickstein et al., 2007) showed that the 
there is a relatively selective reduction of PV+ interneuron density. The PV+ interneuron deficit 
is static and does not increase with age in this model (Glickstein et al., 2007). Stereological 
counting of other interneuron populations in immunostained sections did not show deficits in 
SST. No qualitative difference was seen in the density of interneurons positive for Neuropeptide-
Y (NPY), Vasoactive Intestinal Peptide (VIP), Calretinin (CR) or Calbindin (CB) (Glickstein et 
al., 2007). 
Reduction in cell bodies immunoreactive for Parvalbumin could arise from reduction of PV 
expression in PV cells. One possible solution to this problem is to test for GABA/PV co-
immunolabeling. However, previous experience points out that the immunostaining of GABA is 
notoriously unreliable. GABA is a small neurotransmitter, which is not readily preserved in 
formaldehyde fixed tissue. Although GABA preservation is better in Glutaraldehyde fixed 
sections, it can still be unreliable and hence unfit to rule out small differences in cell densities 
across different groups of mice.  
Glickstein et al (Glickstein et al., 2007) used a mouse strain that expresses GFP in a subset of 
PV+ interneurons (GAD67eGFP) (Ango et al., 2004) . The GAD67eGFP mouse expresses GFP 
under the effect of GAD 67. This mouse was bred with the cD2 line to generate 
cD2+/+::GAD67eGFP and cD2–/–::GAD67 eGFP mice. Stereological counting of GFP +ve cells 
showed a reduction in GFP+ cells in the cD2 null. Moreover, in PV/GFP co-immunostained 
sections, no increase was found in PV-ve - GFP+ cells. These data strongly argued that the 
reduction in PV+ cells in the cD2 null was due to a reduction in PV cell number and not loss of 
PV expression in a subset of PV+ cells (Glickstein et al., 2007).  
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Other effects of cD2 null mutation on brain structure and function 
Deficient adult neurogenesis in DG and olfactory bulb: Various studies have reported 
an almost complete depletion of adult neurogenesis in the dentate gyrus (Kowalczyk et 
al., 2004; Jaholkowski et al., 2009, personal observation, data not shown). Kowalczyk et 
al. (Kowalczyk et al., 2004) showed that neurospheres grown from in vitro expansion of 
neuronal precursors from adult hippocampi express solely cyclin D2, whereas the 
neurospheres derived from 5 day old hippocampi express all three cyclins D. 
These findings suggest that cD2 is the only D-type cyclin (out of D1, D2, and D3) 
expressed in dividing cells derived from neuronal precursors present in the adult 
hippocampus, perhaps explaining the near absence of adult neurogenesis in the cD2 null 
but not in the cD1 null mice.  
 
Microcephaly and cortical thinning: Overall brain size is reduced by about 20% in the 
cD2 null due primarily to cortical thinning (Glickstein et al., 2007). There is evidence for 
disproportionate effect of the mutation on certain brain regions, including the olfactory 
bulb, the hippocampus, cerebellum, amygdala and the entorhinal cortex (Kowalczyk et 
al., 2004). No difference in neuronal packing density was found in the somatosensory 
barrel field cortex (Glickstein et al., 2007; 2009). The superficial layers of the cortex 
were affected disproportionately as compared to the deeper layers - both in packing 
density as well as in PV cell density.  Disproportionate effect of this mutation on 
superficial layers supports the idea that cD2 gene is required to maintain the progenitor 
pool and/or support later neurogenic events (Ross and Risken, 1994; Glickstein et al., 
2007; 2009).  
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Hypomorphic cerebellum: A prominently affected region in the cD2 null is the 
cerebellum, which shows a disproportionate reduction in size in comparison to the overall 
size of the brain. Histological analysis of the cerebellum shows severe loss of granule 
cells and a near total ablation of stellate interneurons (Ross and Risken, 1994; Huard et 
al., 1999). The stellate cells are the last generated interneuron subtype in the cerebellum. 
In the mutant cerebella, young post mitotic interneurons undergo severe delay of their 
maturation and migration. The progenitor pool is precociously exhausted and the number 
of interneurons is significantly reduced. ( Glickstein et al., 2007; 2009, Leto et al., 2011). 
 
Role of cell cycle proteins in post-mitotic neurons	  
CD2 shows high level of expression in various regions in the developing brain. In 
addition to high level of expression in the MGE, cD2 is expressed in the cerebellum, 
dorsal mesencephalon, cerebral cortex and epithalamus (Ross and Risken, 1994; Allen 
Institute, 2013; Gensat-Project, 2013).  
CD2 expression is much limited in the post-natal brain. Various studies have found that 
in the post natal brain, cD2 mRNA is largely limited to the cerebellum (Ross and Risken, 
1994; Schmetsdorf et al., 2007; Allen Institute, 2013). Other studies have reported cD2 
expression in the olfactory bulb, the sub-ventricular zones, the dentate gyrus and CA3 
(Greene et al., 2007; Allen Institute, 2013).       
While most neurons lose the ability to undergo cell division, the expression of many cell 
cycle genes continues. Schmetsdorf at al reported that the adult mouse brain continues to 
express various cyclins, cyclin dependent kinases (CDKs) and cyclin dependent kinase 
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inhibitors (Schmetsdorf et al., 2007). Furthermore, CDKs are properly complexed to their 
respective cyclins and exhibit kinase activity (Schmetsdorf et al., 2007). These findings 
suggest that in post mitotic cell, these proteins may have a cell cycle independent role. 
Several studies have suggested that cell cycle related proteins may be involved in 
memory formation and their dysregulation may be associated with cell death in 
degenerative diseases (Arendt et al., 2000; Greene et al., 2007).  
With respect to cyclin D2, the major cdk partners are cdk4 and cdk 6 (Alberts 2002), 
although negative regulation of cdk5 by cyclin D2 has also been reported (Guidato et al., 
1998).  
Inappropriate expression of cdk4 has been seen to be involved in cell death during 
disease and trauma (Greene et al., 2007). Studies of Alzheimer’s disease have shown 
over-expression of cyclin D, cdk4 and an increase in phosphorylated Retinoblastoma 
protein (pRb) (Arendt et al., 2000).  
Similarly, cdk5 has been found to play important roles in post-mitotic neurons. Cdk5 has 
been implicated in memory formation and plasticity in hippocampal neurons (Angelo et 
al., 2006; Guan et al., 2011). Some of these effects may be explained by the findings that 
in post mitotic neurons, cdk5 phosphorylates neurofilaments and tau protein (Angelo et 
al., 2006). Loss of cdk5 function in the hippocampus leads to severe impairments in 
memory formation and retrieval, while gain of function mutations of cdk5 have been 
associated with increase synapse number and increased long term potentiation (Angelo et 
al., 2006).    
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In light of these findings, the possible role of cD2 null mutation on post-mitotic neurons 
needs to be studied in detail. 
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1.10 Main Hypotheses of the Study 
The cD2 null mice with a relatively selective deficit in PV+ interneuron density - the magnitude 
of which is greatest in the hippocampus - provides a unique opportunity to test the hypothesis 
whether a loss of PV+ interneurons in the hippocampus leads to hippocampal disinhibition, 
increased excitation, and dysregulation of the mesostriatal dopamine system.  
First, I show that the cD2 null mutant mouse exhibits reductions in PV+ interneurons and 
GABA-mediated synaptic inhibition (Chapter 3). I then describe a study utilizing imaging of 
cerebral blood flow, a measure frequently used in schizophrenia, to see whether reduction in 
PV+ interneuron density is associated with signs of hippocampal hyperactivity in vivo (Chapter 
4). I then present experiments showing that hippocampal disinhibition can cause dysregulation of 
the VTA DA neuron activity and related behavioral effects (Chapter 5). Following this, I present 
the evidence that hippocampal disinhibition leads to deficits in hippocampus-mediated cognition 
in the cD2 null (Chapter 6). Lastly, I present experiments in which I used transplants of 
GABAergic precursors derived from the embryonic brain (Chapter 7), to study the effect of 
restoring PV+ cells in the hippocampus on the psychosis-relevant neurophysiological and 
behavioral phenotypes of the cyclin D2 null mutant mouse. 
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Chapter 2: General Materials and Methods 
 
Animals and Treatments: 
All experimental studies were approved by the New York State Psychiatric Institute Animal Care 
and Use Committee following USDA Regulations. Cyclin D2 knockout mice (cD2 null),in which 
exons I and II of the gene were disrupted (Sicinski et al., 1996), were maintained on a C57/BL/6 
background under standard housing conditions. Heterozygous (cD2+/–) mice were bred to obtain 
wild type (CD2+/+) and homozygous null littermates (cD2–/–).  
For the Six3Cre:Smofl/fl mouse model, transgenic mice expressing Cre recombinase under the 
control of a 9-kb genomic promoter fragment of the Six3 gene (Furuta et al., 2000) were mated 
with LoxP-smoothened  mice (Dassule et al., 2000) to generate Six3Cre:Smofl/fl mice. Cre 
negative Six3Cre:Smofl/+ and Six3Cre-negative:Smofl/fl littermates were used as controls. Mice 
were maintained on a C57BL/6J background.   
All animals were maintained on a 12 h light/dark cycle (lights on at 6:00 A.M.) and given ad 
libitum access to food.  
 
Tissue processing and immunohistochemistry: 
Mouse brains were perfused and post fixed for 1 hour in 4% Paraformaldehyde (PFA) in 0.1M 
Phosphate buffer (PB). These were then successively transferred to 10, 20 and 30% sucrose (in 
PB) over three days at 4o C. 
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For all animals, the brain was sectioned in its entirety according to the principles of systematic 
random sampling. Briefly, sectioning was initiated at a random starting point, 40 micron thick 
sections were then collected serially into 5 equal sets (i.e. with a sectioning interval of 5).  Sets 
were processed with the stains described below. 
For Diaminobenzidine (DAB) staining, brains were processed as follows: Sections were 
incubated in anti-parvalbumin antibody (α-PV-235, Swant, Switzerland; 1:1000) for 24 hours, 
followed by incubation in goat anti-mouse IgG (1:200 in PB containing 0.1% BSA and 0.25% 
Triton X-100) and avidin-biotin-peroxidase complex (Vectastain Elite Kit; 1:100 in PB; Vector 
Laboratories, Burlingame, CA). DAB was used as a chromogen. Immunohistochemical stains for 
all genotypes were processed in parallel to control for inter-experiment variability. 
For fluorescent staining, primary antibodies included anti-mouse PV (Swant, 1:1000), anti-rat 
somatostatin (Chemicon/Millipore, Temecula, CA 1:200), anti-rabbit GABA (Sigma-Aldrich, St 
Louis, MO, 1:1000) and anti-rabbit or anti-chicken GFP (Molecular Probes/ Invitrogen, 1:1000). 
Secondary antibodies tagged with Rhodamine Red, DyLight 488, Dylight 405 and DyLight 647 
were used (all from Jackson ImmunoResearch, West Grove, PA, used at 1:200 concentration). 
 
Cell quantification: 
For all experiments the PV+ interneuron numbers and density were obtained by two-dimensional 
modified stereologic counting methods, using a  Zeiss Axioplan2 microscope (Oberkochen, 
Germany) interfaced with Stereoinvestigator (MicroBrightField, Williston, VT). Interneurons 
were counted in CA1 region of hippocampus, and the PFC, using previously defined boundaries 
(Paxinos and Franklin, 2001). Cells were counted in one every 5th stained section (one 40 µm 
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section per 200 µm) throughout the rostro-caudal extent of the hippocampus. Since PV+ 
interneurons have a non-random distribution in the hippocampus, grid and counting frame sizes 
were selected so as to cover most of the area of the region of interest. For each animal, cell 
counts were summed across all sections. Density was calculated by dividing the total cells 
counted by the average area of the region of interest as determined with the Cavalieri estimator.  
Density was compared between genotypes using Independent (Student’s) T-tests.  
In-vitro electrophysiology 
cD2 –/– and sex matched cD2+/+ litter-mates, ages 3-6 weeks were anesthetized with 
ketamine/xylazine anesthesia (90/10 mg/kg), decapitated and immediately transferred to ice cold 
solution containing (in mM) 220 Sucrose, 10 D-glucose, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 
2 CaCl2, 2 MgCl2. Tissue block containing the brain region of interest (either the hippocampus 
or the PFC) was mounted on a vibratome (Leica VT1200, Leica Microsystems, Wetzlar, 
Germany), and 400 µm thick horizontal slices were made. Coronal sections were made for the 
PFC while horizontal slices were made for the hippocampus. Slices were immediately 
transferred to a holding chamber with oxygenated artificial cerebrospinal fluid containing (in 
mM) 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 1 CaCl2, 1 MgSO4 and 10 D-glucose. 
After at least 1 hour of incubation, each slice was transferred to the recording chamber, perfused 
with oxygenated aCSF at 2-3 ml/minute with a gravity-fed system. All incubations and 
recordings were done at room temperature (24ºC).  
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Figure 2-1: Basic scheme of the current clamp experiment: 
 A) Schematic representation of a horizontal section of ventral hippocampus showing CA1 pyramidal cell 
layer. B) Schematic representation of a simplified pyramidal cell-GABAergic interneuron circuit in the 
CA1. Proximal targeting Parvalbumin expressing (PV) and distal dendrite targeting somatostatin 
expressing (SST) GABAergic interneurons are shown flanking the pyramidal cell. An electrolyte filled 
glass electrode connected to voltage/current clamp equipment is also shown. 
 
Pyramidal cells were identified in the PFC or the CA1 region of hippocampus using an upright 
fixed-stage microscope (Zeiss Axioskop FS; Zeiss, Thornwood, NY) with Nomarski optics. 
Whole-cell voltage-clamp recordings were made using an Axopatch 200B amplifier (Molecular 
Devices, Foster City, CA). Data were filtered at 5 kHz, digitized at 10 kHz, and stored directly to 
disk using a Labmaster TL-1 DMA acquisition board (Molecular Devices). Recording pipettes, 
pulled from borosilicate glass tube (1.2 mm external diameter), with 3-5 MΩ resistance, were 
filled with internal solution containing (in mM) 140 CsCl, 2 MgCl2, 0.1 CaCl2, 10 HEPES, 1 
EGTA at pH 7.3 (adjusted with NaOH) and connected to Ag/AgCl electrode attached to 
headstage of AxoClamp 2B amplifier (Axon Instruments, Foster City, CA). The series resistance 
was estimated by applying voltage steps of 5 mV at the beginning and the end of each recording 
session. Access resistance was periodically tested, and the cell was discarded if the access 
resistance changed by more than 10% or becomes >20 MΩ. Series resistance was typically 
between 20 and 40 MΩ and were compensated offline to avoid adding excessive baseline noise. 
A B 
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Currents were measured using whole cell voltage clamp at -70mV, at which GABAergic currents 
were expected to be inward. GABAergic nature of current was confirmed by bath application of 
gabazine (20µM, SR 95531 hydrobromide) in a selected set of recordings. Data was recorded 
using custom written macros in Igor Pro (WaveMetrics, Lake Oswego, OR). Five second sweeps 
(100 in total) were collected and saved individually as Igor binary files. All sweeps were 
concatenated and converted to Axon Binary Files using ABF Utility software (Synaptosoft, 
Leonia, NJ). Analysis was done in MiniAnalysis software (Synaptosoft). LoPass Elliptic filter 
with a cutoff frequency of 1000Hz was applied before analysis to filter out high frequency noise. 
GABAA miniature inhibitory postsynaptic currents (mIPSCs) were isolated with the addition of 
tetrodotoxin (TTX, 1.0 µM), 2-amino-5-phosphonopentanoic acid (5-AP, 50 µM) and 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX, 40 µM) in perfusion solution. Threshold amplitude for 
mIPSC detection was set to three times the root mean square of noise. Other criteria to detect 
peaks were inward direction of peak, suitable area threshold, a maximum limit for decay time, 
rise time shorter than the decay time, etc. Events picked up by the program were visually 
inspected to weed out aberrant events. Total average mIPSC frequency, amplitude, 10-90 rise 
time and decay time were calculated, frequency distributions were obtained. At least 100s of 
record was analyzed for each cell.  
For miniature excitatory post synaptic current (mEPSC) measurement, Gabazine (10 µM) 
replaced AP5 and CNQX. The internal solution contained 140 mM potassium gluconate and a 
holding potential of -80mV was used.   
Event frequency, amplitude and decay time for mIPSCs or mEPSCs were averaged across cells 
for each subject. Each characteristic was compared across genotypes using Independent 
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(Student’s) T-tests. Multivariate analyses including frequency, amplitude and decay times as 
variables yielded results consistent with the T-tests.  
In vivo imaging 
Previously described (Moreno et al., 2006; Schobel et al., 2013) design and procedures of 
imaging were used. Briefly, four sets of axial T2-weighted images were acquired sequentially to 
generate high-resolution (86µm×86µm) cerebral blood volume (CBV) maps of the rodent brain. 
Each set consisted of 24 images, acquired over 16 min. The contrast agent Gadodiamide was 
injected (13 mmol/kg i.p.) after a pre-contrast set was acquired. As previously described (3), 
rCBV was mapped as changes in the transverse relaxation rate (R2) induced by the contrast 
agent. rCBV maps were measured from steady-state T2-weighted images as CBV R2 = 
ln(Spre/Spost)/TE, where TE is the effective echo time, Spre is the signal before the contrast 
administration, and Spost is the signal after the  
Spost is the signal after the regions of interest used for rCBV measurement are outlined. HP, 
hippocampus, mPFC, medial prefrontal cortex, CBL, cerebellum. 
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Figure 2-2: Structural MRI of the mouse brain. 
Regions of interest: hippocampus (Hp), medial prefrontal cotex (mPFC) and cerebellum (CBL) are 
outlined.  
contrast agent reaches steady-state. The derived maps were normalized to the maximum 4-pixel 
signal value of the posterior cerebral artery. Visualized anatomical landmarks were used together 
with standard atlases (Paxinos and Franklin, 2001) to define the region of interest. The 
hippocampal region of interest included the CA fields, subiculum and dentate gyrus with the 
ventral border approximated to be the dorsal border of the medial entorhinal cortex. The borders 
of the PFC region of interest extended anteriorly and laterally from the genu of the corpus 
callosum to the pial surface at about 1.5 mm lateral to the midline; slices at and dorsal to the 
dorsal surface of the caudate were used.  For the cerebellum, the entire structure was included. 
Independent t-tests were used for comparisons of hippocampal, medial prefrontal and cerebellar 
rCBV between genotypes. For comparisons between live- versus killed-cell MGE transplanted 
mice, the ‘cerebellar-corrected hippocampal rCBV’ was defined as the ratio of 
hippocampal:cerebellar rCBV values. This measure was compared across transplant groups with 
independent (Student’s) t-tests.  
  
Hp#
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In vivo single-unit recordings of dopamine neurons: 
Stereotaxic surgery and single-unit extracellular recording and neuron sampling methods were 
adapted from Moore et al (Moore et al., 1998) for the mouse. Mice were anesthetized with 
chloral hydrate. Electrodes pulled from glass pipettes (tip diameter approximately 1 µm; 
impedance 4-10 MΩ) were filled with 2M NaCl and stereotaxically lowered into the ventral 
tegmental area (VTA) using the following target coordinates (relative to Bregma and dural 
surface: 3.3 mm posterior (AP), 0.8 mm lateral (L) and 3.6-4.2 mm ventral (DV). The electrode 
was lowered slowly through the midbrain to detect and characterize spontaneously active 
neurons. The signals from individual neurons were processed with previously-described 
recording methods (Moore et al., 1998). DA neurons were identified by the long-duration, 
triphasic waveform with the “somatodendritic notch” on the positive phase (Fig. 2D) and by their 
tonic irregular firing and intermittent bursts (Fig. S3B).  Bursts were defined as per the criteria of 
Grace et al (Grace and Bunney, 1984a; 1984b) and described in (Mameli-Engvall et al., 2006). 
The onset of bursts was marked by an inter-spike interval (ISI) less than 80 msec; the first spike 
thereafter preceded by an ISI of greater than 160 msec was considered the last spike in the burst. 
Within bursts on average, spike amplitudes decreased as ISI lengthened (Fig. S3B). DA neurons 
were sampled in 4 recording tracks arranged in 0.15 mm-spaced grid within the VTA. A coronal 
section from a representative case, showing histological evidence of several tracks at 
approximately 3.5 mm posterior to Bregma (Fig. S3A). DA neurons were defined as 
spontaneously active if spiking was detected prior to the electrode moving proximal to the 
neuron and if the firing rate of the neuron was stable for at least 2 min after discrimination.  The 
number of spontaneously active DA neurons per track and the average firing rate and proportion 
of spikes fired within bursts for each DA neuron were quantified.  Average spontaneously-active 
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DA cells per track was compared between cD2 –/– mice and their cD2+/+ littermates with an 
independent (Student’s) t-test.   
 
Behavioral experiments: 
cD2 –/– mice and sex matched CD2 +/+ littermates 2.5- 4 months of age were used for 
behavioral testing. Mice were habituated to handling but were otherwise behaviorally naïve for 
each experiment except for MGE transplant mice, for which contextual fear conditioning 
followed a few days after locomotor response.  
 
Open field: 
Locomotor activity was measured in a 17” x 17” open field box with clear walls and white floor, 
fitted with computer-interfaced infrared motion sensing system (Med Associates, St. Albans, 
VT). Mice were placed in open field for 30 minutes, after which, amphetamine (2 mg/kg 
dissolved in isotonic saline at 0.2 mg/ml) was injected i.p.) and activity was measured for 
another 60 minutes. Total activity for successive 5 min bins was analyzed. Two separate cohorts 
were tested many months apart and very similar results were obtained. 
A mixed ANOVA design followed by planned comparisons was used, with genotype and drug as 
factors, and time (before or after injection) as a repeated measure. Planned comparisons used 
independent (student’s) t-test. of genotypes within drug condition separately for baseline 
locomotion and locomotion after drug or saline injection. 
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Contextual fear conditioning:  
Mice were acclimated to the testing room 1 hour prior to the training/testing session. Two 
plexiglass chambers with shock grid floors placed within a white melamine sound-attenuating 
chamber were used as training/testing apparatus. Each chamber featured a distinctive set of 
visuospatial, tactile and odor cues, which together defined the context. For the training session, 
mice were placed in a distinct context (Context A). Conditioned stimulus (CS) consisting of pure 
tones (85 dB, 20 sec duration, 4.5 kHz) were presented at 300, 470, 580, 670 and 840 seconds. 
During the last second of each tone, a 0.7 mA scrambled current was delivered through the floor 
grid. Animals were returned to their home cages 980s after the start of the experiment.  
 
Figure 2-3: Summary of the overall design of the fear conditioning paradigm.  
A, B) Schematic representation of the overall experiment, showing training, test of tone and test of 
context phases of the experiment. Each auditory tone was 20 sec in duration and co-terminated with a 1 
sec electric shock. C) Fear conditioning experiment in which placement to shock interval was 
systematically varied during training 
 
Twenty-four hours later, each mouse was placed in a novel context (Context B) that was 
constructed with visual, tactile and olfactory cues with a high level of contrast with Context A. In 
Context B, mice were exposed to the conditioned tone (CS) only (without shock) at 300, 410, 
A 
B C 
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580, 670 and 830s. Six hour after being tested in the novel context B, mice were placed in the 
training context for 600s. During training and testing sessions, freezing was measured using an 
automated video monitoring system (Med Associates, St. Albans, VT). Freezing was defined as 
absence of movement except for respiration. Additional parameters for measuring freezing were 
bout duration of 0.25s and motion index threshold between 2 and 5.  
An average conditioned freezing response (the CR) was calculated for three retrieval “phases”: 
initial response to the tone CS+ (tone CR), freezing persisting from 40-100 sec following offset 
of the CS+ (post-tone CR) and freezing in response to the training context (context CR). For 
statistical analysis, a mixed ANOVA design was used with retrieval phase as the repeated 
measure and genotype as the between-subjects factor. 
 
Partial lesion of the caudal hippocampus or parietal cortex: 
Mice were anesthetized with isoflurane anesthesia and placed mounted on a stereotaxic frame.  
Following aseptic preparation of the skin and skull, small burr holes were drilled through the 
skull.  The coordinates used to target ventrocaudal CA1 in wild-type mice were (relative to 
bregma and skull surface) AP -3.0, L +/- 3.5, DV -2.9. For the cD2 –/– mice, coordinates were 
modified to adjust for smaller brain size; the coordinates were AP -2.9, L  +/- 3.3, DV -2.7. For 
parietal cortex cannulations, the coordinates used were AP -2.9, L +/- 3.5, DV -1.4 for CD2+/+ 
and AP -2.9, L +/- 3.3, DV -1.25 for cD2 –/–. To induce partial lesions to cortical regions, 
custom made steel cylindrical poles (outer diameter 0.64mm, BD, Franklin Lakes, NJ) were 
lowered to the right depth through the skull hole and tissue was mechanically disrupted by a 
cannula that was then held in place using dental cement. The cannulae were left in place for 1 
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week prior to behavioral testing. Pilot experiments showed that this manipulation led to a 
consistent and selective lesion of the hippocampus. The lesion sites were confirmed 
histologically.   
 
Figure 2-4: Coronal section of the hippocampus showing a representative example of 
hippocampus lesion.  
 
 
Dissection, dissociation and transplantation of progenitor cells from the MGE 
Transgenic mice expressing Green Fluorescent Protein (GFP) driven by chicken β-actin 
promoter (FVB.Cg-Tg(CAG-EGFP)B5Nagy/J Stock Number 003516) (Hadjantonakis et al., 
1998), were obtained from Jackson Laboratories (Bar Harbor, ME) and maintained on a CD1 
background. Breeding pairs, a homozygous pan-Green Fluorescent Protein expressing (GFP+) 
male and a wild type female were placed in the mating cages at 17:00 and separated the next 
morning, (9 AM designated as embryonic day 0.5, E 0.5). FDams were sacrificed on E 15.5 by 
cervical dislocation. GFP+ pups, identified by fluorescence under 488nm light, were placed in 
Hanks' balanced salt solution (Gibco/ Invitrogen, Grand Island, NY). The brains were removed 
and embedded in 4% low melting point Agarose (Invitrogen) in PBS and sliced at 250 µm thick 
coronal sections on a vibrating microtome (Thermo Scientific HM650V, Waltham MA). MGE 
was identified visually and slabs of tissue corresponding to the ventral two thirds of the MGE 
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regions were dissociated using fine forceps (Fig. 4A).  Samples obtained from both hemispheres 
of two slices from two embryos were combined and considered an individual experiment for 
statistical purposes. Donor cells were dissociated by trituration, centrifuged at 500g for 5 min, 
resuspended in 15-30µl of NB/B27 medium (Gibco/ Invitrogen).  A density of 6 x 103 live 
cells/µl was obtained. For killed cell control transplants, cells (obtained as described above) were 
killed by repeated freeze thaw cycle (-80o C, 1 minute x 3) immediately prior to transplantation.  
Killed-cell or live-cell suspensions were injected into the brain using a glass pipette with a 50 µm 
outer tip diameter connected to a nano-injector (Drummond Scientific, Broomall, PA).  
   
Figure 2-5: Photomicrograph showing MGE dissection: 
Coronal section through the mouse brain at embryonic day 15.5. Representative dissections of the MGE 
used for GABAergic progenitor isolation are shown by the arrow. 
 
The internal surface of glass pipettes were first coated with mineral oil, following which, 
suspensions containing the cells were forward filled. The glass pipette was then connected to the 
injector mounted on a stereotaxic carrier.  The suspended cells were transplanted bilaterally into 
the hippocampi of mice aged 6-8 weeks. The surgical techniques and target coordinates for the 
caudo-ventral CA1 described above were used.  The electrode was lowered slowly into the brain, 
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taking several minutes to reach the target region, then a volume of 3.5 µl of the suspension was 
ejected over 5 min in 70 nl steps, for a total deposit of 2.0 X 104 cells per hemisphere. 
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Section II: Studies in Genetic Mouse Models of 
Cerebral Cortical Parvalbumin+ Interneuron 
Deficits 
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Chapter 3:  Anatomical and Electrophysiological 
Characterization of the cD2 Null Mouse: 
Evidence for Hippocampal Disinhibition 
 
Introduction: 
Stereological quantification of PV+ interneuron density in the somatosensory and motor cortices 
and the hippocampus and the DG by Glickstein et al showed a 30- 40 % reduction, respectively, 
in the cD2 null as compared to the WT mice (Glickstein et al., 2007). Although it was not within 
the scope of Glickstein et al (2007) to compare the size of the PV+ interneuron deficit across 
cortical regions, heterogeneity could be observed. Moreover, the medial prefrontal cortex, a 
region of particular importance for the cognitive dysfunction in schizophrenia (Lewis et al., 
2012), had not been examined. I thus aimed to confirm and extend the findings of Glickstein et al 
(2007) by first quantifying PV+ interneuron density across the CA1 region of the hippocampus 
and the medial prefrontal cortex in the same brains.  I then determined if reductions in PV+ 
interneurons predicted a decrease in GABA-mediated synaptic inhibition onto pyramidal cells in 
these regions and, ultimately, evidence for hippocampal disinhibition in vivo. For the last 
measure, we used measurements of cerebral blood volume as a proxy for basal metabolic activity 
and in order to test whether a deficit in synaptic inhibition can manifest as hyper-perfusion (and 
presumably hypermetabolism) of the affected brain region.  
The following experiments were conducted in cyclin D2 null mutants and their age- and sex-
matched littermates: 
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1. Stereological quantification of PV+ interneurons in hippocampus and PFC 
2. Measurement of GABAergic and Glutamatergic synaptic inputs onto pyramidal cells 
3. Estimation of metabolic activity in the hippocampus by measurement of relative cerebral 




Disruption of interneuron development in the MGE in the cyclin D2 will lead to loss of PV+ 
interneurons in the cortex including the hippocampus, and this will in turn be associated 
with loss of GABAergic inhibition onto pyramidal cells and signs of cortical disinhibition. 
 
Anatomical characterization of the PV+ interneuron deficit 
in the cD2 null mouse 
Brief Methods:  
Coronal sections were cut from formalin fixed brains from cD2 null and WT mice. Forty micron 
thick sections were cut on a vibratome, and 1 in every 5 sections was stained for PV using anti-
parvalbumin antibody (figure 3-1). Contours were drawn around the regions of interest (ROI). 
For the hippocampus ROI, CA1 region was encircled, using Paxinos atlas. Both dorsal as well as 
ventral hippocampus was included in the analysis. PV+ interneurons were counted in the entire 
   71 
ROI. The density measure was obtained by factoring in the area of ROI - found using the 
Cavelieri method. (See also Materials and Methods) 
Results:  
cD2 null mice show mild microcephaly: Consistent with previous findings (Kowalczyk et al., 
2004; Glickstein et al., 2009) (Glickstein et al., 2007), I found evidence for mild microcephaly in 
the cD2 nulls. On visual inspection the cD2 null brain differed from the WT in having more 
visible colliculi, as a result of reduction in cortical volume. The brain is narrower and shorter 
than the WT. In slices, there was evidence for mild cortical thinning in most areas. On 
systematically measuring the area of the hippocampus and the PFC (cingulate, Pre-limbic and 
infra-limbic regions), we found significant reductions in the total area of these regions.  
 
Figure 3-1: Comparison between a cD2 null and a WT brain. 
A) cD2 null mice show mild microcephaly. Notice the more exposed colliculi in the cD2 null brain. B) 
Hippocampal CA1 area measured by the Cavalieri method is reduced by about 40% in the cD2 null. P < 
0.01 independent (Student’s) t-test. 
 
Reduced PV+ interneuron density in the hippocampus but not in the PFC. We found that that the 
cD2 null mice showed a reduction of around 45% in PV-IR cell density in the CA1 region 
(figure 3-2 c). This is in line with the findings of Glickstein at al (Glickstein et al., 2007), who 
reported a similar deficit when the entire hippocampus was considered as a whole. Although the 
density of PV cells in other regions of the hippocampal formation, such as the CA3, DG and 
A B 
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Subiculum were not measured in this study; qualitatively the CA1 region appeared to show the 
most profound deficit.  Qualitatively, a reduction was found in PV+ neurite density, which 
corresponded with the reduction in PV+ cell bodies.  
 
 
Figure 3-2: Reduced hippocampal PV+ interneuron density in the cD2 null. 
A) Representative brain sections of rostral hippocampus, stained for parvalbumin. Right panels show 
higher-magnification image of PV+ cell density in CA1. B) PV+IN density in CA1, quantified by 
unbiased methods, is reduced in cD2–/– mice (t6 = 3.8, p < 0.01; n=4). 
 
In the PFC, an ROI was drawn to include the cingulate, Pre limbic and Infra-limbic regions. In 
contrast to the hippocampus, PV+ interneuron was not reduced in the PFC (figure 3-3).  
 
Figure 3-3: Prefrontal Cortical PV+IN density is not reduced in the cD2 null. 
A) Representative coronal sections of the Prefrontal cortex, stained for Parvalbumin. B) PV+IN density in 
PFC, quantified by unbiased methods, is not affected in the cD2–/– mouse. Student's ttest (p > 0.05; n=5). 
A B 
A B +/+ -­‐/-­‐ 
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GABAergic synaptic neurotransmission in the cD2 null 
cortex 
Brief Methods: 
I measured miniature inhibitory post synaptic currents in pyramidal cells in the hippocampus and 
the PFC. A mIPSC represents a post synaptic response due to action potential independent, 
stochastic release of a single GABA vesicle. mIPSC frequency is a close approximation of the 
density of GABAergic synapse on pyramidal cells in organotypic cultures (Hartman et al., 2006; 
Swanwick et al., 2006). Whole cell voltage clamp recordings were used to measure miniature 
inhibitory post synaptic currents from CA1 pyramidal cells. A holding potential of -70mV was 
used. All recordings were conducted in the presence of TTX (to block fast Na channels), APV 
(to block NMDA) and CNQX (to block AMPA channels). The recording electrode contained 
Potassium gluconate or Cesium Chloride to block leak potassium channels. Resting membrane 
properties and action potential discharge properties of hippocampal pyramidal neurons were 
measured under current-clamp conditions.  (See Materials and Methods section for details.) 
Results: 
CD2null mice show reduced GABAergic currents onto hippocampal CA1 pyramidal cells, but 
not in the PFC. Corresponding to the reduction in PV+ interneuron density, cD2 null mice 
showed a reduction in mIPSC frequency in CA1 pyramidal cells (t19 = 2.7, p < 0.05; n= 9-12)  
(figure 3-4 b). However, there was no difference in mIPSC amplitude or kinetics across 
genotypes. As cD2 –/– cells did not differ significantly from cD2 +/+ cells in mean amplitude (t17 
= 0.11, p > 0.05) (figure 3-4 c), or decay time (t17=0.15 p > 0.05) (figure 3-4 d) of mIPSC (n=9-
10). GABAergic nature of mIPSCs was confirmed in a subset of recordings by bath infusion of 
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Bicuculline, a GABAAR antagonist, which eliminated all events. The mIPSC events showed 
reversal at around -65mV. No change was found in the series resistance, capacitance and other 
recording parameters between the genotypes.  
 
Figure 3-4: Reduced GABAergic synaptic neurotransmission in the hippocampus in the 
cD2 null.  
A) Representative trace showing miniature IPSCs from the cD2 null and WT mice in the CA1 pyramidal 
cells. B) GABAergic mIPSC frequency in CA1 pyramidal cells is reduced in the cD2 null mice. C, D) 
mIPSC amplitude or decay time was not altered in the cD2 null.  
 
Consistent with our finding that the cD2 null did not show a statistically significant reduction in 
PV+ interneuron density in the prefrontal cortex, we did not find a statistically significant 
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Figure 3-5: GABAergic currents are not reduced at pyramidal cells in the Prefrontal cortex 
in the cD2 null. 
No difference in mIPSC frequency was found in PFC Pyramidal cells between cD2 null and WT mice 
 
Glutamatergic currents at pyramidal cells are not different in the cD2 null.   To determine if the 
changes in synaptic transmission observed in the hippocampus were specific to GABA-mediated 
inhibitory events, we looked for alterations in excitatory synaptic neurotransmission in the 
hippocampus in the cD2 null mice. Pyramidal cells receive excitatory glutamatergic synaptic 
inputs from other cortical pyramidal neurons and from sub cortical structures. We reasoned that a 
developmental loss of inhibition may lead to homeostatic tuning to reduce excitatory 
glutamatergic neurotransmission in the hippocampus.  
Action potential independent miniature excitatory post synaptic currents were measured from 
CA1 pyramidal cells using voltage clamp recordings. The glutamate dependency of these 
currents was shown by complete block of these currents by AMPA and NMDA blockers CNQX 
and APV, respectively. No differences were found in the frequency, amplitude (t17 = 0.11, p > 
0.05) or decay kinetics (t17=0.15 p > 0.05) of mIPSC (n=9-10) of miniature excitatory post 
synaptic currents onto CA1 pyramidal cells (figure 3-6). This measurement likely includes both 
AMPA as well as NMDA Receptor currents.  
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Figure 3-6: Excitatory synaptic inputs to the CA1 Pyramidal cells were not changed in the 
cD2 null.  
A) Sample trace showing miniature excitatory post synaptic current (mEPSC) recorded in CA1 pyramidal 
cells. B) Glutamatergic mEPSC frequency in CA1 pyramidal cells. C, D) mEPSC amplitude or decay 
time were not different between the cD2 null and WT mice.  
 
CA1 pyramidal cells in cD2 null show slight but significant reduction in excitability in response 
to depolarizing currents: Although there was a trend towards a more depolarized resting 
membrane potential in CA1 neurons of cD2 nulls, these neurons paradoxically showed a 
significantly increased current threshold (rheobase) and reduced spike frequency in response to 
current injection. No significant differences were found in the input resistance or Ih current.  
A B 
C D 
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Figure 3-7 Reduced pyramidal excitability in the hippocampus in the cD2 null. 
A) Representative traces from the cD2 null (red) and WT (blue) hippocampal pyramidal cells on injection 
of hyperpolarizing and depolarizing currents under current clamp conditions. B) Latency to 1st action 
potential spike and C) number of spikes in response to depolarizing current pulses. CD2 null show 
increased latency to spike and reduced spikes at a particular current step. 
 
Discussion 
Taken together, these findings show that cD2 null mice show loss of GABAergic inhibition in 
the hippocampus as evidenced by: 1) Reduced PV+ interneuron density in the CA1 region, 2) 
deficit in GABAergic synaptic transmission at CA1 pyramidal cells. This deficit is regionally 
heterogeneous and does not affect all regions of the cortex equally; we failed to find evidence for 
either reduction in PV+ interneuron or reduced mIPSCs in the PFC. Moreover, there was little or 
no evidence for compensation for the PV+ interneuron deficit, as we observed an equal-sized 
deficit in GABA-mediated inhibitory synaptic events, with no changes in post-synaptic aspects 
of GABA-mediated synaptic transmission or in excitatory synaptic transmission at hippocampal 
projection neurons.   
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PV+ interneuron deficit is regionally heterogeneous: varies across cortical 
regions: Taken together with the previous reports (Glickstein et al., 2007), these data show that 
there are regional differences in PV+ interneuron loss in the cD2 null mice. A loss of around 
40% was found in the hippocampus compared to about 30% in the somatosensory and motor 
cortical regions. There are laminar differences in PV+ interneuron deficit in the cD2, such that 
the superficial layers are more severely affected (42% for layer I – III vs 31% for IV – VI) layers 
of cortex (Glickstein et al., 2007).  
Although a vast majority of PV+ interneurons in different neo-cortical and hippocampal regions 
share their origins from the MGE, different sets of progenitors within the MGE, may give rise to 
interneurons that migrate to and populate different regions of the brain. CD2 null mutation may 
differentially affect these progenitors within the MGE, thus explaining the heterogeneous 
distribution of PV+ interneurons within the cortex. Alternatively, temporal differences in origin 
of interneurons may explain these differences; cD2 null mutation is known to affect later born 
neurons (Glickstein et al., 2007; 2009), the areas of the brain, that receive most of their 
interneurons relatively late during development may be most severely affected by the mutation. 
Tricoire et al showed that there is a spatio temporal division in the development of interneurons 
that inhabit different layers of the hippocampus, so that the CGE-derived interneurons primarily 
localize to strata lacunosum moleculare and deep radiatum, while MGE-derived interneurons 
show preference for strata pyramidale and oriens (Tricoire et al., 2011).  
We hypothesize that the PV+ cells of the PFC, the somatosensory cortex and the hippocampus 
originate from different sets of progenitors, which are differentially affected by the loss of cD2, 
hence leading to heterogeneity of PV+ cell density in different parts of the cortex. These findings 
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are also consistent with reports of other interneuron deficit models that showed regional 
selectivity in interneuron loss in the neocortex (Powell et al., 2003). 
 
Little evidence for compensatory changes in the GABAergic system: Although the 
cD2 null mutation affects the GABAergic system during development, there is a persistent and 
lifelong deficit in GABAergic inhibition. Glickstein at al found that PV+ interneuron deficit in 
the cD2 null is static and does not increase with age (Glickstein et al., 2007). In many instances, 
developmental deficits are accompanied by homeostatic compensatory processes; surprisingly, 
we didn’t find evidence for compensation in the inhibitory system in these mice. Qualitatively, I 
observed a decrease PV+ basket like structures forming around the pyramidal cells 
corresponding to the loss of PV+ cell bodies in the cD2 null. Moreover, the decrease in mIPSC 
frequency, a measure thought to reflect the presynaptic component of GABA transmission, was 
not compensated by any changes in post-synaptic GABA transmission as reflected by no 
increase in the amplitude or change in kinetics of mIPSC.  This suggests that the cD2 null, in the 
presense of reduced PV density, do not show a compensatory increase in connectivity by 
sprouting more dendrites and axonal endings. 
I have also examined the possibility of compensations in the excitability and glutamate inputs to 
pyramidal cells. While I found that glutamate-mediated excitatory currents onto pyramidal cells 
in CA1 were not altered in the cD2 null, I did observe a reduction in intrinsic membrane 
excitability in response to current injection. These findings are similar to the findings from the 
DLX1 null mouse, another developmental model of interneuron loss. DLX1 null mice loss of a 
subset of hippocampal and neocortical somatostatin-, NPY-, VIP-, and calretinin-positive 
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interneurons at around one month of age, is followed by a the onset of onset of epilepsy (Cobos 
et al., 2005). These mice show also decreased excitability of CA1 pyramidal neurons (assessed in 
current-clamp recordings of input resistance and rheobase)(Howard et al., 2012) 
 
Are different subtypes of PV+ cells differentially affected in cD2 nulls? In this 
study, we have not addressed the question: whether different subtypes of PV expressing 
interneurons are differentially affected in the cD2 null mice. There is no histological marker or 
antibody that could distinguish between these two classes. These cells are also identical in their 
electrical properties, and are derived from the same progenitors during development. Factors that 
may facilitate the speciation of chandelier cell phenotype as opposed to the basket are not 
understood well, however some evidence points to temporal differences in this speciation (Inan 
et al., 2013) 
 
Conclusion 
These data show that the cD2 null show a regionally selective deficit in the density of PV+ 
interneurons, the magnitude of which is greater in the hippocampus, as compared to other 
regions we studied in the cortex. This loss of PV+ interneurons corresponds with reduced 
GABAergic inhibition in these regions. The cD2 null, hence gives us a suitable model to test the 
hypothesis about the relationship between loss of PV+ interneuron function and hippocampal 
disinhibition and this in turn leading to dysregulation of the ventral tegmental dopamine system.  
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Activity in the cortex is often conceptualized as a balance between excitation and inhibition. A 
possible consequence of reduced inhibition in the cD2 null can be increased excitation exhibited 
as epileptiform/ seizure activity. We examine this possibility in Chapter 4. In Chapter 5, I 
examine whether cD2 null show increased cerebral blood flow or volume – which is thought to 
correlate with neural activity- and has frequently been shown to be elevated in patients with 
schizophrenia. 
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Chapter 4: MRI of Cerebral Metabolic Activity 
in the cD2 Null: An In Vivo, Clinically Relevant 
Manifestation of Hippocampal Disinhibition? 
 
Introduction 
A large number of studies over the years have shown that cerebral blood flow (CBF) and cerebral blood 
volume (CBV) are correlates of brain function and metabolism (Small et al., 2011; Schobel et al., 2013). 
CBV and CBF can be estimated using functional magnetic resonance imaging (fMRI) .CBV provides 
sub-millimeter resolution for mapping relatively stable metabolic states within the hippocampal 
formation. As reviewed in the General Introduction, the hippocampus is one of the most affected 
regions in schizophrenia. Structural changes such as reduction in hippocampal volume have been 
noted in the hippocampus for a long time (Wright et al., 2000; Heckers and Konradi, 2010) for 
review see (Heckers and Konradi, 2010). More recently, changes in resting cerebral blood 
volume have also been found in both schizophrenia as well as its risk states (Schobel et al., 
2009). This increased blood flow can be used as a proxy for the ‘metabolic state’ of the 
hippocampus. 
Hypothesis: 
cD2 null mice will show increased cerebral blood volume in the hippocampus but will show 
normal CBV in the mPFC. 
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Brief Methods:  
We used a CBV based fMRI technique, identical to the one that have been used in human 
schizophrenia (Moreno et al., 2006; Schobel et al., 2009; 2013). Relative CBV (rCBV) values 
were calculated for the hippocampus (HIPP), the medial prefrontal cortex (mPFC), and the 
cerebellum (CBL). Cerebral blood volume measurements were conducted in anesthetized mice 
using isoflurane anesthesia. (For detailed methods see Materials and Methods) 
 
Results:  
The cD2 nulls showed hippocampal hyperactivity: 
cD2 null mice showed increased rCBV relative to the metabolic activity in the hippocampus  (t14 
= 3.3, p < 0.01) (Figure 4-1a). Consistent with the smaller (non-significant) decreases in PV+ 
interneuron number and synaptic inhibition in the PFC, cD2 null mice did not show an increase 
in basal prefrontal cortical rCBV (Figure 4-1 b).  Moreover, there was no difference between 
genotypes in basal rCBV in the cerebellum  (t14 = 0.3, p > 0.25) despite the reported alteration in 
cerebellar stellate interneuron number and function in cD2 null mice (Huard et al., 1999).  The 
increase in hippocampal rCBV in cD2 null mice remained significant when normalized for 
cerebellar (Figure 4-1 d) or overall brain (data not shown) resting rCBV.   
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Figure 4-1: Increased hippocampal rCBV (Normalized R2) in the cD2 null. 
A) cD2 null mice (n= 8) show hyper-metabolism as shown by relative cerebral blood volume 
measurements (rCBV) in the hippocampus (HIPP) but not in the medial Prefrontal cortex (mPFC) (B), or 
the cerebellum (CBL) (C). D) Hippocampal rCBV normalized for cerebellar CBV. 
Data expressed as means ± SEM. *p < 0.05, independent t-tests 
 
Discussion 
We found that loss of GABAergic inhibition in the cD2 null is accompanied by HIPP 
disinhibition in vivo, as evidenced by an increase in rCBV in the hippocampus. The 
hyperperfusion and presumed hypermetabolism was relatively selective for the hippocampus. 
The cD2 null did not differ in rCBV measurement in the mPFC, a region in which the PV+ 
interneuron deficit was found to be small and to lack impact on inhibitory synaptic inhibition.  
Notably, resting metabolism was also similar between genotypes in the cerebellum despite the 
fact that loss of cD2 leads to a deficits in cerebellar stellate neurons and deficits in evoked blood 
flow in this region (Yang et al., 2000). This suggests a pattern of hyper-metabolism specifically 
related to cerebral cortical PV+ interneuron deficits in which the hippocampus is 
disproportionately affected. Taken together with the finding that increases in glutamate can 
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induce and increase in rCBV in the hippocampus (Schobel et al., 2013), these data suggest that 
the hippocampus is abnormally activated in the cD2 null mice. 
CBV measurements have been used as a measure of neural activity, however it is presently not 
clear whether spiking activity or afferent synaptic activity accounts for changes in this signal. 
Some studies have suggested that out of these factors, incoming input and local neural signal 
processing (indicated by local field potential) and not spiking activity are better predictors of the 
hemodynamic response (blood flow or volume) (Logothetis, 2003). Other studies have shown 
that glutamate efflux induced by the psychomimetic drug ketamine can drive an increase in 
rCBV in the hippocampus (Schobel et al., 2013).  
In the context of our study, increased CBV corresponded to the relative reduction in PV+ 
interneuron density, being prominent in the hippocampus but not in the mPFC. The PV+ 
interneurons are the major source of GABAergic synaptic input to the cell body and axon hillock 
region of the pyramidal cells, and have a large influence on the spike firing activity of these 
cells. Hence in the cD2 null, a differential increase in CBV in regions that show PV+ loss  may 
reflect enhanced spike activity of pyramidal neurons.  On the other hand (or in addition), the 
possibility remains that increased CBV in the CA1 region of the hippocampus stems from an 
increase in afferent inputs. CA1 receives two major afferent inputs: the Schaffer Collateral input 
from the CA3, and the Perforant Path input from the entorhinal cortex. In the cD2 null, PV+ loss 
and in fact increased basal CBV was also found in the CA3 region. Hence it is possible that the 
increased CBV in the CA1 region reflects an increase in CA3 input to the CA1. In vivo 
electrophysiological methods can be utilized, in future studies to answer this question. 
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Chapter 5: Dysregulation of Mesolimbic 
Dopamine System Function in the cD2 Null 
 
Introduction  
As reviewed in the General Introduction, disinhibition or over-activation of the ventral 
hippocampus would be predicted to increase the activity of mesolimbic DA neurons and enhance 
responsiveness to amphetamine (AMPH). Specifically, ventral hippocampus activation leads to 
an increase in the number of spontaneously active DA neurons in the VTA (Floresco et al., 2001; 
2003; Lodge and Grace, 2007) and increased DA efflux in the nucleus accumbens (Blaha et al., 
1997; Legault and Wise, 1999; Howland et al., 2004). The locomotor response to AMPH, which 
depends on DA transmission within the ventral striatum (Kelly et al., 1975; Pijnenburg et al., 
1975; Kelly and Iversen, 1976), is also exaggerated when the ventral hippocampus is disinhibited 
or activated  (White et al., 2006; Lodge and Grace, 2007). Use of AMPH as a tool for these 
studies is particularly important, not only because it is a behavioral assay that is sensitive to 
ventral hippocampal disinhibition, but also because it is a psychostimulant which induces the 
positive symptoms of schizophrenia in humans (reviewed in (Lieberman et al., 1987).  
In this section, I describe the experiments undertaken to examine mesolimbic dopamine function 
in the cD2 null. First, I examined locomotor response to amphetamine, followed by the 
experiments to determine the role of ventral hippocampal activity in this behavior. Lastly, I 
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describe the experiments to study ventral tegmental DA cell activity - using in vivo recording 
techniques. 
 
Experiment 5.1: Amphetamine-induced locomotor activity in 
cD2 null mice 
 
Hypothesis: 
Impaired inhibition of hippocampal circuits (specifically projections from the ventral 
hippocampus) in cD2 –/– mice will lead to a hyper-responsiveness to amphetamine.  
 
Brief Methods:  
Mice are placed in a 17” x 17” open field box with a white floor. Movement of the mice is 
measured by the help of an automated setup and translated into distance. After 30 min of 
baseline activity, 2mg/kg amphetamine (dissolved in saline) is administered in an intraperitoneal 
(i.p.) injection. Activity is recorded for another 60 min, after which the mice are returned to their 
home cages. A separate cohort of mice, were pretreated with either saline or raclopride (0.5 
mg/kg) 30 minutes before injection of AMPH (2.0 mg/kg, i.p.) and locomotor activity was 
measured as described above. (See also Materials and Methods) 
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Results: 
 
Figure 5-1: Increased psychomotor response to amphetamine in the cD2 null. 
A) Locomotor activity pre- and post-injection of saline or amphetamine (AMPH; 2 mg/kg, i.p.)(n’s = 13 
and 4 per genotype for AMPH and saline, respectively); arrow indicates time of injection. B) Average 
locomotion after injection of amphetamine was significantly increased in the cD2 null mice. C) Basic 
design of the raclopride pretreatment experiment. D) Locomotor response to amphetamine with saline or 
raclopride pretreatment in cD2 null mice. (Student's t-test, * P < 0.05, n.s. P>0.05) 
 
CD2 nulls show increased locomotor activity to amphetamine: A marked increase in 
locomotion was observed in both groups with administration of amphetamine. However the cD2 
nulls showed a much greater response (figure 5-1). Prior to amphetamine injection, the mice 
showed gradual reduction in locomotor activity, perhaps showing habituation to the open field 
environment. I did not observe any difference in baseline locomotor activity. Similarly, saline 
A B 
C D 
   89 
injection did not elicit any change in locomotor activity in either group. A mixed ANOVA 
design with genotype and drug as factors, and time (before or after injection) as the repeated 
measure, was used. This was followed with planned Student’s t-test comparisons of genotypes 
within drug condition separately for baseline and post-injection locomotion. An interaction 
between genotype and drug (F1,29 = 6.0, p < 0.05); genotype and time (F1,29 = 11.2, p < 0.01); and a 
trend for a 3-way interaction (p = 0.078). Planned comparisons show no differences between 
genotypes prior to injection (t31 = 0.2, p > 0.25) or in the response to saline (t6 = 0.13, p > 0.25, 
drug groups combined). However there was a robust difference in response to amphetamine 
between the genotypes, with the cD2 null showing a much greater locomotion  (t23 = 4.5, p 
<0.001).  
Amphetamine response in the cD2 null is attenuated by blockade of DA D2 receptors: 
Locomotor response to amphetamine has been associated with increased dopamine release in the 
nucleus accumbens. We sought to find if locomotor response to amphetamine is dopamine 
dependent using pretreatment with raclopride, a selective D2 R antagonist (Ogren et al., 1986) . 
Mice were treated with intra-peritoneal injection of raclopride (0.5 mg/kg) at the beginning of 
the experiment, and immediately placed in an open field (figure 5-1 c). We observed that 
pretreatment with raclopride reduced amphetamine response in the cD2 nulls down to the level 
of the WT. While with saline pretreatment, the cD2 null continued to show hyper-locomotion 
(figure 5-1d). Raclopride also attenuated the baseline locomotor activity. 
These data are in agreement with previous studies that showed reversal of increased locomotor 
activity induced by amphetamine, along with suppression of spontaneous activity (O'Neill and 
Shaw, 1999). Raclopride, a selective D2 antagonist was only partially able to reduce 
amphetamine induced locomotion, which is consistent with the findings of other studies showing 
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that both D1 as well as D2 receptors are involved in locomotor response to this psycho-stimulant 
(O'Neill and Shaw, 1999). Attenuation of baseline locomotor activity indicates dopamine 
dependence of this behavior.  
 
Summary:  
These experiments show that the hippocampal disinhibition in the cD2 null is accompanied by 
increased locomotor response to amphetamine. 
 
Experiment 5.2: Ventral hippocampal modulation of 
AMPH-induced hyperlocomotion in the cD2 null 
Next we studied the involvement of the hippocampus in amphetamine response.  
 
Hypothesis: 
If disinhibition of the hippocampus contributes to increased sensitivity to amphetamine in the 
cD2 null through an excitatory drive, then a lesion of the ventral hippocampus should attenuate 
amphetamine response.  
 
Brief Methods: 
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Preliminary experiments showed that we could reliably induce selective lesions of the 
ventrocaudal hippocampus with placements of guide cannulae (with occluded lumina, made from 
0.6 mm outer diameter syringe needles) (figure 5-2 a). Using this method, bilateral guide 
cannulae were placed in the ventrocaudal hippocampus under general anesthesia. To control for 
any non-specific effect of the lesioning procedure, a separate group of mice received guide 
cannulae placements in the parietal cortex overlying the hippocampus. After allowing for 
recovery (typically a week), mice were tested for locomotor response to amphetamine using 
methods described above. Cannula placements were confirmed at the end of the experiment and 
any subject with non-specific damage or extensive extra-hippocampal lesions (for the 
hippocampal cannulation group) were not included in the analysis. 
Results:  
 
Figure 5-2: Effect of hippocampal lesion on amphetamine response in the cD2 null. 
A) Coronal section of the hippocampus showing a representative example of hippocampus lesion. B) 
Augmented response to amphetamine in cD2–/– mice is eliminated by partial lesions of the ventral 
hippocampus (HIPP) but not that of the overlying parietal cortex (PAR). 
 
A B 
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Locomotor response to amphetamine is attenuated by hippocampal lesions: I observed that 
while hippocampal lesions greatly attenuated amphetamine response in the cD2 null and 
eliminated the genotypic difference between the cD2 null and WT mice (effect of genotype, t20 = 
1.1, p > 0.25; n= 11) (figure 5-2).  This was not a non-specific effect to a brain lesion, as cD2 
null mice with lesions of the parietal cortex, continued to show hyperlocomotion as compared to 
WT mice  (effect of genotype, t14 = 2.2, p < 0.05; n = 7-9) (figure 5-2). 
Summary: 
The enhanced amphetamine-induced locomotor activity in cD2 null mutant mice, is eliminated 
by lesions of the caudoventral hippocampus, but not the overlying parietal cortex. This supports 
the hypothesis that the abnormally exaggerated response to amphetamine in cD2 null mutant 
mice is driven by disinhibition of the caudoventral hippocampal output. 
 
Experiment 5.3: VTA DA neuron activity 
Hippocampal activation can increase the population activity of dopamine (DA) neurons in the 
ventral midbrain via a disinhibitory GABA-GABA striato-pallidal circuit. To determine if the 
impairment in hippocampal inhibition in the cD2 –/– mice might increase DA neuron activity, 
we performed extracellular single-unit recordings in the ventral tegmental area (VTA). 
 
Hypothesis: 
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Reduction in GABAergic transmission and disinhibition of vHIPP circuits will lead to an 
increase in the number of spontaneously active DA neurons in the VTA. 
 
Brief Methods: 
Spontaneously active dopamine cells were recorded in chloral hydrate-anesthetized mice as 
described in Chapter 2, General Materials and Methods.  
Results: 
VTA dopamine cell population activity is increased in the cD2 null: We found that the cD2 null 
mice exhibited a significantly greater number of spontaneously active cells per recording track 
(t8.8 = 6.3, p < 0.01; n = 6-7) (figure 5-3). CD2 nulls showed an average of 3.4 (+/- SEM 0.1) 
spontaneously active DA neurons per track, while the WT litter mate controls showed an average 
of 1.7 (+/- SEM 0.25) Cells / track. No difference was found in the firing rate, frequency of burst 
firing, or number of spikes per burst.  
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Figure 5-3: Ventral tegmental dopamine cell population activity is increased in the cD2 
null. 
A) Representative coronal section showing recording tracks through the central and lateral VTA..Scale 
bar 1mm, corrected for shrinkage. B) Representative trace from an extracellular recording of a single unit. 
C) The unit exhibits waveform and burst-firing characteristics of a DA neuron. D) Average number of 
spontaneously active dopamine neurons is increased in the cD2 null mice.  
 
Summary: 
The cD2 null mice showed increased DA cell activity in the Ventral tegmental area. This is 
consistent with a disinhibited hippocampus. 
 
Discussion: 
We have found that cD2 nulls show an increase in population activity of VTA DA neurons, 
locomotor response to AMPH- a response mediated by DA projections from VTA to limbic 
striatum and largely normalized in cD2 nulls with a DA D2 blocker. The increased locomotor 
response is blocked by a lesion to the caudoventral HIPP indicating that HIPP output is 
necessary for this phenotype in the cD2 null.  
A B 
C D 
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These phenotypes are consistent with and further support the evidence for disinhibition of the 
ventral HIPP in the cD2 null mouse. These data are also consistent with dysregulation of the 
hippocampus-Nac pathway (Floresco et al., 2003) in the cD2 null. The cD2 null showed an 
elevation of spontaneously active Dopamine cells in the VTA. No elevation of firing rate or burst 
firing was observed, which has been seen to depend on pedunculopontine reticular system 
activity (Floresco et al., 2003). Future studies will test this hypothesized circuit by measuring 
electrical activity at the various nodes in the circuit, such as the hippocampus, nucleus 
accumbens and the ventral pallidum.  
Analysis of electrode tracks showed that the electrical recordings in our studies targeted the 
medial and central midbrain DA neurons.  
Although imaging studies in patients with schizophrenia have shown increased striatal dopamine, 
as shown by increased labeled L-DOPA, increase amphetamine induced displacement of D2 
ligands and increased baseline occupancy at dopamine receptors, it is not known whether the 
activity of DA cells, such as the firing rate or the number of spontaneously active DA cells is 
higher in these patients. 
Preliminary evidence from our study showed that systemic administration of amphetamine led to 
a decrease in firing in the VTA (data not shown). Since amphetamine leads to dopamine release 
by synaptic as well as other mechanisms, DA release is expected to lead to D1 receptor mediated 
auto-inhibition thus leading to depression of DA cell firing rate. This interpretation is also 
supported by data that showed that acute haloperidol injection activated non-firing DA neurons 
and conversely, DA microinjection inhibited DA cell firing. These data suggests that 
amphetamine leads to an increase in DA release and not an increase in dopamine cell firing. To 
test this idea further, DA can be directly measured by microdialysis. 
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Hippocampal modulation affects locomotor activity (Jarrard, 1968; Jarrard and Bunnell, 1968). 
Several studies have reported a baseline hyperactivity in mice supposed to have disinhibited 
hippocampi (Lodge and Grace, 2007; Bast et al., 2001a; Belforte et al., 2009). It is believed that 
novelty induced dopamine release contributes to this phenotype. In light of these previous 
findings, lack of baseline hyperactivity is intriguing in the cD2 null. We hypothesize that a 
possible reason may be some degree of compensation in response to a developmentally 
determined persistent disinhibition in the cD2 null. In a previous study, Jaholkowski et al. 
reported no difference in locomotor activity in the cD2 null (Jaholkowski et al., 2009). It is worth 
mentioning here that the same group reported baseline hyperactivity in the cD2 nulls in a recent 
study (Jedynak et al., 2012). Moreover, a colleague has found evidence for baseline hyperactivity 
in the cD2 null in a larger group of mice (Samuel Pasketwitz, personal communication). The 
conditions during which the cD2 null show enhanced baseline locomotion, and whether 
recruitment or dynamic differences in disinhibition under some conditions determine whether 
there is increased baseline locomotion need further study. 
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Chapter 6: Hippocampus and Prefrontal Cortical 
Dependent Cognition in the cD2 null mice 
 
Introduction: 
As reviewed in the General Introduction, patients with schizophrenia show a range of cognitive 
deficits (Sadock et al., 2007; Barch and Ceaser, 2012).  Modeling these deficits in rodent models 
is a high priority given their relationship to functional outcome (Sadock et al., 2007), and given 
that we currently have no effective pharmacological treatments for impaired cognition in 
schizophrenia.  Modeling these cognitive deficits in rodents is also tractable, given a rich 
cognitive neuroscience literature establishing conserved neurocognitive processes across rodents 
and humans (Moore and Robbins, 2008). Domains of cognition mediated by the medial temporal 
lobe (including the hippocampus), as well as those operations dependent upon the prefrontal 
cortex, are affected in schizophrenia, and these domains of cognition can be measured in the 
rodent.  
Assessing hippocampus-dependent associative learning in 
rodent models.: 
Tasks recruiting and dependent upon the hippocampus often encompass the encoding and 
association of “contexts” a spatiotemporal association of a set of cues (that form a gestalt 
context) with an event (Kim and Fanselow, 1992; Fanselow, 2000). Pavlovian fear conditioning 
experiment can be used to investigate both hippocampus dependent and hippocampus-
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independent forms of memory. In this experiment, an innocuous stimulus such as a tone or light 
(called conditional stimulus, CS) is presented concurrently with an aversive stimulus such as a 
foot shock (unconditional stimulus, US). The mouse forms an association between the CS and 
US. A subsequent presentation of either the US or CS, elicits a response which consists of 
cessation of all movement (except breathing) referred to as freezing.  
Lesion studies in rodents have shown that lesions of the hippocampus result in disruption of 
conditioning to compound stimuli such as the context (Kim and Fanselow, 1992). On the other 
hand, lesions of the amygdala leads to disruption of conditioning to discrete cues such as visual 
or auditory discrete cue conditioning (Campeau et al., 1995). In addition, the amygdala and the 
ventral peri-aqueductal grey (PAG) are important for the expression of fear response (as a 
behavioral response distal to cued or context conditioning) (Kim et al., 1993) (figure 6-1). 
The formation of the representation of the context requires NMDA receptor function as well as 
protein synthesis in the hippocampus. Also, the involvement of the hippocampus in contextual 
conditioning corresponds well with the finding that place fields form in the hippocampus during 
exploration of an environment (O'Keefe and Dostrovsky, 1971). 
 
Figure 6-1: Fear conditioning circuit. 
Schematic representation of the circuit thought to underlie hippocampus dependent fear conditioning. 
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Although the role of the dorsal hippocampus is best established in contextual conditioning and in 
trace conditioning, some reports have reported that the hippocampus contributes to freezing 
performance to a delay conditioned auditory stimulus when the strength of the association 
between the US and CS is relatively weak (fewer trials or low foot-shock intensity), but not 
when stronger conditioning parameters are used (Quinn et al., 2008)  
These results suggest the presence of two parallel memory systems: one that is hippocampus 
independent and contributes to a direct tone-foot shock association, and a hippocampus-
dependent memory system that maps a context or weak, discrete cue on to the unconditioned 
stimulus and response  (Quinn et al., 2008). 
Although lesion studies have focused on the role of dorsal hippocampus in contextual fear 
conditioning, some studies have reported that the ventral hippocampus/subiculum could also be 
involved in acquisition, retrieval and/or expression of conditioned fear (Maren, 1999; Richmond 
et al., 1999; Bast et al., 2001b). The connectivity of the ventral hippocampus corroborates with 
these findings, since the ventral hippocampus has intimate connections with the amygdala and 
the nucleus accumbens, which are involved in classical fear conditioning to explicit and 
contextual cues (Anagnostaras et al., 2001; Bast et al., 2001a). 
Assessing prefrontal cortex-dependent cognition in rodent 
models: 
One form of PFC-dependent cognition, captured in human neuropsychological testing by the 
Wisconsin Card Sorting Test (WCST) is cognitive flexibility or  ‘set-shifting’ ability. In set-
shifting tasks, the subject is required to make decisions based on one stimulus discrimination 
rule, then the rule (stimulus-outcome contingencies) spontaneously changes, and the subject 
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must adjust choices accordingly. Set-shifting can be testing in rodents by changing the relevance 
of stimulus modalities (e.g. olfactory versus tactile) cues. Lesion studies have shown that 
different aspects of this task have been shown to be dependent on different brain regions. 
Reversal learning (reversing the contingency for a given stimulus pair) recruits and depends on 
the orbitofrontal cortex while shifting responding to a new perceptual domain (extra-dimensional 
(ED) shift) depends on the dorsomedial frontal cortex in rodents (Birrell and Brown, 2000). 
We used multiple variations of contextual and cued fear conditioning to test hippocampus-
dependent cognition, and the rodent set-shifting paradigm to test PFC function, in the cyclin D2 
null mice. 
 
Experiment 6.1: Assessment of hippocampus-dependent 
learning and memory using contextual versus cued aversive 
conditioning  
Hypotheses: 
I imagined two competing scenarios with respect to hippocampus-dependent learning :  
1) PV+ interneuron deficit leads to increased activity but hippocampal function is not disrupted. 
In this possibility, fear conditioning will be normal, possibly enhanced in the cD2 null mice. 
2) PV+IN loss will leads to disruption of hippocampal function and consequently, fear 
conditioning will be disrupted. 
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Brief Methods: 
Mice were fear conditioned in a distinct context (context A) using five pairings of auditory tones 
(conditioned stimulus, CS+) and foot shock (unconditioned stimulus, US). On the following day, 
amygdala- and hippocampus-dependent conditioned fear responses were tested. First, in a novel 
context (Context B), we measured freezing to the first presentation of the tone CS+ (presented 
without shock), an amygdala-dependent response that does not require the hippocampus (20). 
Second, during repeated presentations of the CS+ in Context B, we monitored post-tone freezing. 
Six hours later, we measured the context-conditioned fear response (freezing in Context A 
without presentation of the tone CS+). 
For statistical analysis, a mixed ANOVA design was used with retrieval phase as the repeated 
measure and genotype as the between-subjects factor. Independent (Student’s) t-tests were used 
for planned comparisons to test the effect of genotype on each conditioned response type. 
 
Results: 
No difference in baseline freezing between the cD2 null and WT mice: There was no genotypic 
difference in freezing response at baseline. After administration of the foot shock, both cD2 null 
and WT mice responded by profound locomotor activity (the unconditional reaction, UR). 
Following the foot shock, there was an increase in freezing response. The overall freezing 
increased with each shock administration. The final level of freezing reached at the end of the 
training session did not differ significantly between the genotypes.  
   102 
These data suggest that the cD2 null were able to learn the association between the tone and the 
shock, showing normal acquisition of fear memory. In addition, it indicates that the cD2 null are 
not deficient in their freezing response. 
 
Figure 6-2: cD2 null show deficits in hippocampus dependent fear conditioning. 
A) Behavioral freezing to tone CS+ in a novel context (Context B) (arrows indicate times of CS+ 
presentation). B) Average post tone freezing in the novel context is decreased in the cD2 null. C) Freezing 
during re-exposure to the conditioned context (Context A). D) Effect of increased exposure to training 
context on behavioral freezing. CD2 null mice did not increase conditioning with increasing time in the 
context. Data expressed as means +- SEM. * p < 0.05, mixed repeated measures ANOVA and planned 
comparisons with independent t-tests. The overall statistical model (12) showed a significant effect of 
genotype (F1,16 = 14.4, p < 0.01; n = 9 per genotype)  
 
Differences in conditioning to discrete auditory stimuli in the cD2 null: The next day, the mice 
were placed in a novel context that differed from the training context in terms of olfactory, tactile 
and visual stimuli. The mice showed very little baseline freezing (figure 6-2a) indicating that 
A B 
C D 
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they were able to distinguish the novel context from the training context. Both groups show 
similarly robust conditioned responses to the first CS+ (arrowhead; average freezing during tone; 
t16 = 1.3, p > 0.25) (figure 6-2a,b). This suggests intact amygdala dependent memory and 
cognition. 
Subsequent administration of tones in the same context, showed diminished freezing response in 
the cD2 null during post-tone intervals in Context B (t15.8 = 2.3, p < 0.05) (figure 6-2 a,b).This is 
consistent with the findings of Quinn et al, who showed that hippocampus dependence of 
freezing response in this phase of the experiment (Quinn et al., 2008).   
CD2 null shows deficits in contextual conditioning: Six hours after placement in the novel 
context, the mice were placed in the original training context (context A). In contrast to the novel 
context, the mice showed a robust freezing response immediately after placement in the context, 
indicating conditioning to the context. The cD2 null showed greatly reduced freezing to the 
context  (t16 = 2.3, p < 0.05) (figure 6-2 c).  
These data indicate a robust deficit in contextual conditioning in the cD2 null. As described 
earlier, we did not find a deficit in learning or freezing performance in these mice. Additionally, 
a robust freezing response to the auditory tone and a clear ability to distinguish between the 
novel and the training context, rules out any strong sensory deficit, which could have interfered 
in recognition of the discrete stimuli. In addition, freezing at the end of the training period 
indicates normal acquisition of the task. 
Increased exposure to the conditioning context fails to improve learning in the cD2 null: Time 
spent in the conditioning context before the administration of the US is a critical determinant of 
conditioning. Increasing exposure to the conditioning context increases conditioning to the 
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training context (Fanselow, 1986,1990; Wiltgen et al., 2006). Previous work has shown that in 
hippocampus lesioned rodents, context conditioning can be increased by increased exposure to 
the conditioning context (Wiltgen et al., 2006).  
Hence we asked whether the cD2 will be able to improve context learning, if given more time in 
the conditioning context. We systematically varied the placement to shock interval, and then 
determined the effects on contextual conditioning.  
We observed that in WT mice contextual conditioning was enhanced by increasing the time the 
mice spent in the conditioning context before administration of the unconditional stimulus 
(shock) (figure 6-2 d). However, the cD2 nulls failed to show any benefit from increased 
exposure to the context (figure 6-2 d). A two way ANOVA revealed a significant main effect of 
genotype F(1,30) = 53; p<0.001, and placement to shock interval F(1,30) = 4.8; p<0.05, but no 
interaction. Post hoc comparisons showed increased conditioning within WT mice with longer 
placement to shock interval (t17=2.7; p< 0.05), but not in the cD2 nulls (t13=0.74; p>0.05). 
Summary: 
These experiments show that the cD2 null show deficits in hippocampal dependent fear learning 
and memory, however had relatively intact learning of discrete cues, which is hippocampus 
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Experiment 6.2: Assessment of PFC-dependent cognition 
using a cognitive set-shifting task  
Hypothesis: 
Given our finding of reduced PV+ interneuron density and GABAA-mediated inhibition and 
altered metabolic activity in the hippocampus but not in the prefrontal cortex, we hypothesized 
that in contrast to hippocampus-dependent cognition, tasks that have been shown to be sensitive 
to intact PFC function would not be disrupted in the cD2 null mice. We used attentional set 




Animals dug for food reward in bowls containing various digging media (such as cage bedding 
or gravel) scented with spices. The task consisted of several phases: Day 1) simple 
discriminations between odors and media, Day 2) compound discrimination (CD), intra-
dimensional shift 1 (ID1), Day 3) recall of ID1, reversal of ID1’s reward-contingencies, Day 4) 
ID2, ID3 and extra-dimensional shift (ED). In the CD, two spices were pseudo-randomly paired 
from trial to trial with two digging-media; the spices predicted reward. For each ID, the spice-
pair was changed; for the ED, all four stimuli were changed, and the digging-media predicted 
reward. Reversal learning in this paradigm has been shown to depend on the orbitofrontal cortex 
(Bissonette and Powell, 2012), and Extra-dimensional shift on the medial PFC. 
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Results: 
We determined if cD2 nulls differed in 1) ability to form a cognitive set (improvement across ID 
phases), 2) cognitive-affective flexibility (reversal of a specific stimulus-response contingency) 
or 3) ability to shift cognitive set (mapping contingencies onto a new modality in the ED). 
ANOVA showed significant effects of task-phase and genotype on errors to criterion, but no 
interaction. CD2 nulls made more errors across the whole task, but without specific deficits in 
reversal learning or the ED (figure 6-3).  
 
Figure 6-3: cD2 nulls show relative sparing of prefrontal cortical dependent cognitive set 
shifting task. 
Bar graph showing errors to criterion (nine consecutive correct trials) for each discrimination. CD2 null 
mice showed an overall learning deficit but no selective deficit in orbitofrontal or medial PFC dependent 
phase of the task.  
 
Each pair of bar is a phase in the task. There is a generalized learning deficit but no differential 
effect on the PFC dependent phases of the task the deficit doesn’t seem to be mediated by oFC 
(reversal) or mPFC (ED shift) . 
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Discussion: 
Given our findings that PV+ interneuron density is reduced in the hippocampus but not in the 
prefrontal cortex, we hypothesized that hippocampus dependent tasks will be disrupted in the 
cD2 null mice, with relative sparing of the prefrontal cortical dependent function. Alternatively, 
hippocampal dysregulation may disrupt prefrontal function because of heavy hippocampal 
afferents to this region (Rosene and Van Hoesen, 1977). In conclusion, cD2 nulls show deficits 
in hippocampus dependent fear memory and learning, a generalized learning deficit, but no 
specific deficit in PFC dependent cognition. The cD2 null show normal acquisition of fear and 
showed relatively intact freezing behavior. This rules out a severe generalized learning deficit in 
these mice. Our data support the hypothesis that even a small-to-moderate reduction of PV+ 
interneuron function such as that indicated by histopathological studies of schizophrenia, disrupts 
hippocampal function and cognitive operations that depend on hippocampal circuits.  
Contextual learning can be hippocampus-independent under some conditions: Recent 
studies parse out the conditions during which contextual and cued conditioning depends upon 
the hippocampus. The hippocampus is thought to increase the efficiency of conditioning so that 
it plays a role in contextual conditioning when the strength of associating between the US and 
CS is weak (Wiltgen et al., 2006). Various studies have shown that learning deficits in the 
presence of a long-standing hippocampal lesion can be overcome by more rigorous training 
(more frequent US-CS pairing or increasing the time spend in the conditioning context) (Wiltgen 
et al., 2006). In short, learning is inefficient in the absence of the hippocampus but still possible. 
This suggests that the deficits in the cD2 null mice are different from the mice with hippocampal 
lesions (see below).  
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Hippocampal disinhibition in cD2 null does not mimic a hippocampal lesion: Consistent 
with previous studies, which show deficits in contextual conditioning in the presence of a 
hippocampal lesion immediately anterograde or retrograde (with respect to training) (for review 
see (Fanselow, 2000)), our study shows a selective deficit in hippocampus dependent contextual 
conditioning in the cD2 null.  
However, in contrast to the lesion studies, which showed that in the presence of a hippocampal 
lesion, contextual learning requires more rigorous training (Wiltgen et al., 2006), the deficits in 
the cD2 null could not be improved by multiple tone-shock pairing or by increasing the time 
spent in the training context. We hypothesize that a disinhibited hippocampus leads to persistent 
aberrant signaling - which may prevent the delegation of the task of contextual conditioning to a 
extra-hippocampal area. This hypothesis can be tested by lesioning of the hippocampus in the 
cD2 null, which is expected to improve the contextual learning deficit in these mice.  
Possible effect of hippocampal neurogenesis in fear conditioning in the cD2 null mice: 
Although a deficit in neurogenesis in the dentate has been related to deficits in contextual fear 
conditioning in some (Saxe et al., 2006; Drew et al., 2010) but not all studies (Clark et al., 2008), 
the magnitude of the deficit is small and the deficit is remediable by extensive training (Drew et 
al., 2010).  
Our findings differ from the findings of Jaholkowski and colleagues (Jaholkowski et al., 2009), 
who reported no difference in contextual fear conditioning between cD2 null and WT mice. 
Although the general methods in our study were similar to those used by Jaholkowshi et al, some 
differences are worth noting.  
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1) Jaholkowski et al used 3 tone-shock pairs for training (20 sec tone, co-terminating with a 1 sec 
0.7mA foot-shock), in comparison to 5 used in our study.  
2) In addition, we have used a longer placement to shock interval (300 s, compared to 120 in 
Jaholkowski et al).  
Consequently, we achieved a much higher freezing in WT mice in test of context (average 
freezing of over 60% compared to around 40% in Jaholkowshi et al.)  
It is possible, that the cD2 null are able to sub-optimally learn about the context (average 
hovered around 40% in our as well as Jaholkowshi et al), a stronger level of training in the WT 
increases learning, while the cD2 null fail to improve learning any further. Post-tone freezing in 
novel context may be more sensitive to disruption of hippocampal function (Quinn et al., 2008), 
hence would have been worth exploring in the study by Jaholkowski  and colleagues.   
Possible sparing of PFC-mediated functions 
The current results suggest that PFC-dependent cognitive flexibility may be spared cD2 nulls, 
relative to processes mediated by the temporal cortex. However, there are several caveats to this 
interpretation 
 The mice showed a discrimination learning deficit, indicating general deficits in 
striatal-based learning. It is difficult to interpret “sparing” of PFC function in the context 
of a possible deficit in striatal based learning 
 Future studies may investigate whether these animals show deficits in response-
inhibition. 
   110 
In summary, these data support the hypothesis that deficits in GABAergic inhibition in a certain 
cortical region disrupts the cognitive functions that depend on this region. For example, in 
schizophrenia, loss of PV+ interneuron function in the hippocampus is likely to contribute to 
cognitive deficits. Hence, efforts to normalize the GABAegic deficit may lead to improvement in 
the cognitive deficits in this disease. 
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Section III: A Study of Partial Restoration of 
Hippocampal Interneurons Using Progenitor Cell 
Transplantation 
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Chapter 7: Effects of Transplantation of 
Neuronal Precursors Derived from the Medial 
Ganglionic Eminence into the Hippocampus of 
the Adult cD2 Null 
 
Introduction: 
Survival and differentiation of MGE-derived interneuron precursors in recipient 
brain: 
 GABAergic precursor cells can be isolated from the developing MGE during embryonic life. 
These cells, when transplanted into the brains of young or adult recipient mice, migrate through 
the brain tissue (Wichterle et al., 1999; Alvarez-Dolado et al., 2006; Baraban et al., 2009) and 
differentiate into morphologically and functionally normal interneurons (Alvarez-Dolado et al., 
2006; Baraban et al., 2009). The transplanted cells are able to survive for a long time in the host 
brains; survival for as much as a year has been reported (Zipancic et al., 2010).  
 
Difference between MGE progenitors and stem cells: 
Stem cells are characterized by two important properties 1) the ability to generate differentiated 
cells and 2) the ability for self renewal. Division of stem cells result in a certain proportion of 
daughter cells failing to differentiate and maintaining a stem cell fate. Progenitor cells are cells 
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that like the stem cells have an ability for self renewal and giving rise to differentiated cells, 
however unlike stem cells - which show seemingly endless regeneration - progenitor cells are 
depleted after only a few cycles of cell division (Seaberg and van der Kooy, 2003). In addition, 
progenitor cells are more fate restricted in their developmental potential and usually give rise to 
only a handful of cell types or sometimes even a single cell type (Brady and George J Siegel, 
2011). Both stem cells and the more fate restricted progenitor cells are attractive candidates for 
cell based regenerative therapies to treat damage and disease. 
 
Functional effects of transplanted GABAergic cells: 
Several groups have reported successful MGE derived GABAergic cell transplant into neonate 
(Alvarez-Dolado et al., 2006; Baraban et al., 2009) (Southwell et al., 2010) as well as adult 
brains (Wichterle et al., 1999; Zipancic et al., 2010; la Cruz et al., 2011). Transplanted MGE 
cells form synaptic connections with pyramidal cells (Southwell et al., 2010), and enhance 
synaptic inhibition of the surrounding projection neurons (Alvarez-Dolado et al., 2006; Baraban 
et al., 2009; Zipancic et al., 2010).  Moreover, these transplants can block seizures (Alvarez-
Dolado et al., 2006; Baraban et al., 2009; Zipancic et al., 2010) and modulate the behavioral 
effects of NMDA receptor blockade (Tanaka et al., 2011).  
MGE derived cells are functionally integrated into the cortical circuit, where they make and 
receive synaptic connections (Southwell et al., 2010) and show signs of activation in response to 
behavioral tasks (Tanaka et al., 2011). Transplantation of MGE derived cells in the visual cortex 
has been shown to open a developmental critical window, thereby allowing ocular dominance 
plasticity (Southwell et al., 2010).  
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MGE derived cells several features that indicate normal development of these cells. For example, 
these cells express markers of GABAergic fate, such as GAD 67, PV, SST, CR, etc. These cells 
have been reported to show normal interneuron firing characteristics including the fast firing of 
the PV+ interneurons (Alvarez-Dolado et al., 2006; Baraban et al., 2009; Southwell et al., 2010). 
Gross morphological features of transplanted GABAergic interneurons are similar to native 
interneurons (Alvarez-Dolado et al., 2006). 
Lastly, and perhaps most importantly, MGE derived GABAergic cells have been shown to 
increase GABA-mediated synaptic and extra-synaptic inhibition onto host brain pyramidal 
neurons (Alvarez-Dolado et al., 2006; Baraban et al., 2009; Zipancic et al., 2010). 
 
Behavioral changes following MGE transplants: 
The potential therapeutic use of MGE derived GABAergic cells was first explored in seizure 
behavior in mice. In these studies, genetic (Baraban et al., 2009) or pharmacological 
manipulations (Zipancic et al., 2010) were used to induce seizure susceptibility. Transplantation 
of GABAergic cells was then performed to examine whether this procedure could ameliorate 
enhanced excitability (Baraban et al., 2009). Transplantation of MGE derived cells has also been 
shown to reduce anxiety like behavior in WT mice (Valente et al., 2012).  
 
Time period required for maturation of transplanted cells: 
The transplanted MGE derived cells may require time to reach functional maturation. De la Cruz 
et al found that the protective effect of MGE transplant on epileptogenesis was evident at 2.5 
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week post transplant but not at 1 week (la Cruz et al., 2011). Southwell et al reported that the 
transplants were not effective in increasing plasticity until over a month after the transplant 
(Southwell et al., 2010).  
 
Transplant of MGE derived GABAergic progenitors into vHIPP in cD2 null 
mice: 
In this series of experiments I sought to determine if live MGE-derived cells transplanted into the 
adult hippocampus could develop into new inhibitory interneurons and reverse the physiological 
and behavioral abnormalities hypothesized to be driven by hippocampal disinhibition in the cD2 
null mice. To test whether the physiological, and behavioral phenotypes in the cD2 null arise 
from deficits in GABAergic particularly PV+ interneuron-mediated inhibition, we replaced some 
to the lost GABAergic cells in the cD2 null hippocampus (described below in detail).  
Aims: 
1. Whether interneuron deficits in the HIPP is sufficient to produce the psychosis-relevant 
imaging, cognitive and behavioral phenotypes: Our experiment show that, deficit of PV 
interneurons is associated with disinhibiting and behavioral, cognitive abnormalities. However 
these do not show that GABAergic deficit is necessary for producing these alterations. CD2 null 
mice feature various deficits apart from reduction in PV+ interneuron density, which could 
possibly account for the observed phenotypes.   
2. To disambiguate the effects of PV-cell loss in HPP from that in other cortical areas: we 
increased PV+ cell density selectively in the hippocampus using GABAergic progenitor 
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transplant: Deficits in PV+ interneurons in the cD2 null is not restricted to the hippocampus, to 
isolate the contribution of hippocampal disinhibition in producing these deficits, we used 




If reduction in GABAergic transmission contributes to AMPH hypersensitivity in the cD2 mice, 
then augmenting GABA transmission in the hippocampus should reduce the locomotor response 
to amphetamine (Figure 7-1). 
 
Figure 7-1: MGE derived progenitor cell transplant to increase PV+ interneuron density in 
the cD2 null. 
Schematic of the basic hippocampal circuit, showing a pyramidal cell and its PV+ perisomatic 
GABAergic inhibitory interneurons. A portion of these neurons (indicated by cross signs) is lost in the 
cD2 null mice. We attempted to reverse the deficit with MGE derived progenitor cell transplants, which 
can develop into new PV+ interneurons (shown by the green cell). 
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Methods: 
MGE was identified in acute brain sections made from pan GFP expressing E15.5 embryos. 
MGE tissue was triturated and washed with Hanks buffer and suspended in neurobasal medium. 
Around 20,000 cells were injected into each caudo-ventral hippocampus, using a nano-injector. 
Behavioral and electrophysiological experiments were conducted 6-8 weeks after transplantation. 
Histological analyses were conducted as much as six months after transplant. 
 
Results: 
Localization of the MGE transplant to the ventral hippocampus: Localization of the injections 
was confirmed in post-mortem histological analysis (figure 7-2). The injection procedure caused 
minimal damage to the hippocampus. We did not find evidence for any inflammatory response in 
the hippocampus around the injection site. Gliosis was not observed around the site of injections 
either in nissel stained sections (figure 7-2c) or with GFAP immunostaining. Consistent with 
previous reports, no neoplastic structures were found within the transplanted brains. The control 
mice which received killed MGE cells showed no GFP+ cells. 
Survival and migration of MGE transplant cells in host brain We noticed that the transplanted 
GFP+ve cells survived in the host brain, An average of about 3706 GFP+ cells survived (± 573 
[S.E.M.]; n=4) in the host brain. This represents about 10% of the total cells transplanted into the 
brains of host mice. No GFP+ cells were observed in the killed MGE transplanted brains.    
MGE Progenitor transplant into the ventral hippocampus migrates throughout the 
hippocampus: Although the injection of the MGE derived progenitors was confirmed to be in 
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the caudo-ventral hippocampus, we observed that the transplanted GFP+ cells migrated 
throughout dorso ventral and rostro-caudal extent of the hippocampus  (figure 7-3). The density 
of the transplanted cells was highest around the injection site. The GFP+ cells however remained 




Figure 7-2: Injection site of MGE cells in the hippocampus. 
A,B,C) Coronal section of the caudo-ventral hippocampus showing injection track. The mouse was 
sacrificed 1 day post injection, peroxidase staining was done for GFP. C) The section was counter stained 
with cresyl violet.  
 
Transplanted Progenitor cells develop into GABAergic Interneurons: MGE derived progenitor 
cells differentiated into neurons that morphologically resembled normal interneurons (figure 7-
3a,c) and expressed markers of mature IN fate such as GABA, PV and SST (figure 7-4). 
A B 
C 
   119 
Quantitative analysis of GFP cells in sections co-immunostained for GFP and interneuronal 
markers showed that more than 95% of the cells were positive for GABA. A majority of cells 
also expressed either PV (56% of all GFP+ cells) or SST (35% of GFP+ cells)(figure 7-4 d).  
 
Figure 7-3: MGE-derived progenitors develop into interneurons in the host brain. 
A) GFP+ cells show interneuron like morphology. B) Hippocampal section from the adult host brain 
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Figure 7-4: MGE derived progenitors express markers of interneurons.  
(A, B, C) Transplanted GFP+ cells in the mature hippocampus showing co-expression of GABA (A), 
Parvalbumin (B), and somatostatin (C). D) Percentage of total GFP+ cells co-labeled with PV or SST. 
Co-labeling assessed separately for PV and SST, thus remaining portion likely includes a mixture of PV+, 
SST+ and other cell types 
 
MGE transplant normalizes hippocampal metabolism in the cD2 null:  First we looked at the 
effect of MGE progenitor transplant on the cerebral imaging phenotype in the cD2 null. 
Cerebellar (CBL)-corrected hippocampal CBV was calculated as described in Chapters 2 and 4. 
As shown in Chapter 4, hippocampal rCBV is higher in non-manipulated cD2–/– relative to cD2 
+/+ mice (t14= 2.2, p < 0.05)  (figure 7-5 a). We found that cD2 null mice that received the live 
MGE cell transplant showed reduced hippocampal metabolic activity relative to the control 
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group (con) transplanted with killed MGE cells (live-cell < killed-cell: t2 = 21, p < 0.01)  (figure 
7-5 b). 
 
Figure 7-5: MGE transplant normalize hippocampal hypermetabolism  
A) Cerebellar (CBL)-corrected CBV in the hippocampus in non-manipulated cD2 null. B) Hippocampal 
metabolic activity in cD2–/– mice with live-MGE cells (live) and the control group (con) 
 
MGE transplants reduce VTA dopamine cell activity: Dysregulation of VTA dopamine cell 
activity is a sensitive measure of disinhibition in the hippocampus. We hypothesized that MGE-
derived progenitor transplants would normalize enhanced population activity of dopamine 
neurons in the VTA. Consistent with this hypothesis, cD2 null mice that received live MGE cells 
showed a reduction in spontaneously active DA neurons  (figure 7-6). On the other hand those 
that received killed MGE cells (controls) continued to show a greater number of spontaneously 
active cells in the VTA. No significant change was seen in the WT with either live or killed cell 
transplants  (figure 7-6). 
A B 
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Figure 7-6: Normalization of enhanced dopamine cell activity by MGE transplants in the 
cD2 null.  
Spontaneously active Dopamine cells in the VTA in cD2 null and WT mice with MGE progenitor cell 
transplant (live) and killed MGE cells (control). 
 
MGE transplants normalize amphetamine hypersensitivity in the cD2 null:  We hypothesized 
that if reduction in GABAergic transmission contributes to AMPH hypersensitivity in the cD2 
mice, then augmenting GABA transmission by MGE transplants in the hippocampus would 
reduce the locomotor response to amphetamine. Consistent with this hypothesis, we found that 
cD2 null mice that received the live MGE transplant showed reduction of amphetamine response 
(t12 = 2.4, p < 0.05), while the cD2 null that received killed MGE cells continued to show a high 
locomotor response (figure 7-7). 
  




Figure 7-7: Normalization of amphetamine hypersensitivity by MGE transplants in cD2 
null mice.  
A) Average locomotor response to amphetamine in cD2 nulls receiving live MGE cells (live) was 
significantly decreased as compared to the controls (con), cD2 null mice that received killed MGE cells. 
B) Time course of locomotor activity in live-cell transplanted (dashed gray) and transplant controls 
(dashed red) with overlay of expected values for intact WT (solid blue) and cD2 null (solid red) mice; 
arrow indicates time of injection 
 
MGE transplant improves hippocampus dependent fear conditioning in the cD2 null: Both the 
dorsal as well as the ventral HIPP have been implicated in contextual fear conditioning. The cD2 
null mice show evidence for deficits in contextual fear and has deficits in both ventral and dorsal 
HIPP. Although we targeted the transplants to the vHIPP, the transplanted cells migrated 
extensively throughout the hippocampus.  
CD2 null mice that received MGE transplants showed improved hippocampus dependent 
memory as evidenced by increased post tone freezing response (Average, t10 = 3.3, p <0.01), as 
well as increased conditioned freezing in the training context (t10 = 2.6, p < 0.05)  (figure 7-8).  
A B 
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The overall statistical model revealed a significant effect of transplant condition (F1, 11 = 5.3, p 
< 0.05). 
 
Figure 7-8 MGE transplants improve fear conditioning 
 A) Cue-conditioned freezing (arrow) in live-cell and control-transplanted cD2 null mice is similarly 
robust, but post-tone freezing is stronger in live-cell transplanted mice. B) Average post tone freezing in 
novel context in MGE transplanted (live) and control (con) mice. C) Average contextual freezing in novel 
context in MGE transplanted (live) and control (con) mice. 
 
Discussion: 
These data show that partial restoration of GABAergic interneurons to the adult hippocampus in 
a PV+ interneuron deficient mouse model leads to normalization of hypermetabolic imaging 
phenotype, normalization of VTA dopamine cell activity, normalization of amphetamine 
sensitivity and improvement in hippocampus dependent learning and memory. 
A B C 
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These results raise the possibility that GABAergic transplants to the hippocampus could 
normalize hippocampal hyperactivity, improve cognitive deficits and positive symptoms of 
schizophrenia.  
A small number of transplanted cells have a large impact: Some data suggests that the 
transplanted GABAergic cells make and receive three times as many connections as host 
inhibitory neurons (Southwell et al., 2010), which may partially explain how a small number of 
surviving transplanted cells may rescue behavioral deficits in the cD2 null mice. Surprisingly this 
study found that although the transplanted cells showed more connectivity, both excitatory 
synapses made on the transplanted cells, as well as inhibitory synapses made by the transplanted 
cells were weaker than those of host GABAergic cells (Southwell et al., 2010). In another study, 
De la Cruz et al found no relationship between the density of grafted cells and the degree of 
seizure attenuation (la Cruz et al., 2011). In light of these studies, the disproportionate impact of 
a small number of transplanted GABAergic cells on behavior remains unclear.  
A preliminary analysis showed that, there was no increase in the number of PV+ GFP -ve cells 
following MGE transplant, ruling out the possibility that MGE transplant leads to a direct 
proliferative effect on GABAergic cell population or GABAergic precursors. Moreover, adult 
neurogenesis in the dentate gyrus was not increased in cD2 nulls that received MGE transplants. 
We noticed that while the cD2 null mice showed deficits in only PV+ cell population, MGE 
transplant led to the development of both PV+ as well as Somatostain+ve GABAergic cells. To 
observe whether rescue of behavioral deficits in the cD2 is specific to increase in PV+ cells and 
not due to another non-specific effect of the MGE transplant, future studies may use transplant of 
the caudal GE. I hypothesize that such transplant will not reverse the behavioral deficits in the 
cD2 null.       
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Taken together, these experiments show that the grafted MGE-derived progenitor cells 
successfully developed into GABAergic interneurons with normal morphology in the cD2 null 
hippocampus. CD2 null mice that received MGE transplants showed reversal of metabolic 
hyperactivity in the hippocampus. Functionally, MGE transplants reversed hyper-responsivity to 
amphetamine and improved hippocampus dependent learning in the cD2 null. Finally, transplant 
of MGE derived GABAergic cells normalized increased Dopamine population activity in the 
cD2 null.  
Unanswered questions about GABAergic precursor transplant: Several questions remain 
unanswered about the MGE derived GABAergic transplants. For example, the mechanisms 
through which the transplanted GABAergic cells impact the circuit is far from clear. For 
example, it remains to be seen:   
1) Whether the pattern of connectivity of the transplanted cells that express a certain marker such 
as PV, corresponds with the characteristic connectivity of these cells in native conditions.  
2) Whether increase in GABAergic neurotransmission alone is responsible for the rescue of the 
behavioral phenotype in the MGE transplanted mice (in seizure models and in the cD2 null 
mouse). Genetic strategies that allow for termination of GABA release (for example, see 
(Murray et al., 2011)) - in MGE transplant derived GABAergic cells - may be used to answer 
this question.  
3) Whether the survival, connectivity, speciation or function of the transplanted progenitor cells 
change with activity in the transplanted area, and if this process is affected by the disease state of 
the recipient mouse.  
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The effects of the MGE transplants in the adult cD2 null mouse support the rationale for 
targeting GABA neurotransmission within the hippocampus to treat psychosis. Understanding of 
the mechanisms through which these cells mediate their effect can open new vistas in the search 
for better therapeutic approaches in schizophrenia. 
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Section IV General Discussion and References 
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Chapter 8: General Discussion 
 
In this thesis, I used an animal model of a disruption of cortical PV+ interneuron development to 
test whether the resulting PV+ interneuron deficits can give rise to persistent hippocampal 
disinhibition and ultimately lead to physiological and behavioral phenotypes analogous to brain 
imaging, cognitive, and behavioral abnormalities linked to hippocampal and DA system 
dysfunction in psychosis.  This study also provides a rationale for designing new therapeutic 
interventions for psychosis that are aimed at the GABAergic neurotransmission in general and 
hippocampal interneurons in particular. In this section, I discuss implications of the findings of 
this thesis for the pathophysiology of psychosis and the potential of cortical interneuron-targeted, 
stem cell-based therapeutic strategies for this disorder. 
 
A circuit-based model for a role for hippocampal PV+ 
interneurons in psychosis 
To summarize the major rationale for the study, various lines of research implicate altered 
hippocampal function in the pathophysiology of psychosis in schizophrenia. Imaging studies 
have shown that the hippocampus in schizophrenia is marked by hyperactivity; yet cognitive 
studies have documented an apparent hypofunction. Patients with schizophrenia exhibit a 
hyperperfusion of the hippocampus (interpreted as increased metabolism) under resting 
conditions (Heckers et al., 1998; Heckers, 2001b; 2001a; Schobel et al., 2009; 2013) (figure 8-
1).  This basal hippocampal hypermetabolism is predictive of psychosis in individuals at risk for 
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psychosis and correlates with the severity of psychotic symptoms (Friston et al., 1992; Liddle et 
al., 1992; Schobel et al., 2009; 2013). This baseline hyperactivity also corresponds with a less 
robust recruitment of the hippocampus (i.e. a decrease in the relative increase in metabolic 
activity) during performance of cognitive tasks that depend on the hippocampus (Heckers et al., 
1998; Heckers, 2001b). Postmortem studies have offered a possible neural mechanism 
underlying this hypermetabolic phenotype by showing alterations in the GABAergic system, 
particularly in the PV+ interneurons, which implies deficits in GABAergic neurotransmission.  
However, at the onset of the current studies, it was unknown if PV+ interneuron dysfunction can 
lead to the hippocampal hypermetabolic phenotype observed in imaging studies in schizophrenia. 
Moreover, it was unknown whether such a form of hippocampal disinhibition would disruption 
cognitive function. However, a number of studies have established the importance of PV+ 
interneurons in regulating patterning and synchronization of neuronal activity within cerebral 
cortical network, including the hippocampus (Klausberger and Somogyi, 2008; Buzsáki, 
2009),and have linked these PV+ interneuron-modulated ‘rhythms’ to cognitive function (Wang, 
2010).Thus, I predicted that loss of PV+ interneurons in the hippocampus would result in 
disruption of hippocampus-mediated cognitive operations (figure 8-2).  
Similarly, hippocampal hypermetabolism and excess striatal dopamine have been found to 
correlate with positive symptoms of psychosis, but in separate lines of studies.  Work in rodent 
models has offered evidence of a neural circuit mechanism that might connect these two neural 
correlates of psychosis: abnormal hippocampal regulation of striatal dopamine 
neurotransmission. These studies show that the hippocampus 1) modulates the activity of 
subcortical dopamine systems particularly of the DA cells in the ventral tegmental area (figure 
8-2) and 2) increases dopamine efflux in response to amphetamine, thus providing a possible link 
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between hippocampal hyperactivity and increased striatal dopamine in patients with 
schizophrenia (figure 8-1).  Specifically, reduction in hippocampal PV+ interneuron is proposed 
to lead to a loss inhibitory input to hippocampal projection neurons. This, in turn, leads to 
excessive, abnormally-patterned activity and abnormal excitatory signals from the hippocampus 
to its target regions within the basal ganglia, including nucleus accumbens and ventral pallidum. 
Through a circuit that has not been entirely characterized, excess hippocampal output to these 
limbic basal ganglia nodes disinhibits ventral tegmental DA neurons (figure 8-2).  This model, 
along with existing empirical data, also predicts that disinhibition of the caudoventral 
hippocampus increases amphetamine-mediated striatal dopamine efflux and locomotion.  
The overarching goal of this thesis was to determine if the above hypotheses might be inter-
related and testable in an animal model. I aimed to examine first whether a loss of number or/and 
function of PV+ interneurons in the hippocampus could lead to disinhibition of the hippocampus 
and a hypermetabolic phenotype, observed as increased cerebral blood flow in with magnetic 
resonance imaging method. I then aimed to determine whether this condition could ultimately be 
related to disruptions of hippocampal-dependent cognition and mesostriatal dopamine system 
function similar to those characteristic of psychosis.  The neural circuitry I hypothesized to 
mediate these effects of hippocampal disihnhibition is shown in figure 8-2. 
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Figure 8-1: Schematic of the probable circuit through which hippocampal PV+ interneuron 
deficit can drive cognitive and behavioral abnormalities characteristic of psychosis.  
NAc, nucleus accumbens, VTA, ventral tegmental area, VP, ventral pallidum, Hc, hippocampus. Figure 
adapted from (Mikell et al., 2009). 
 
Direct test of this hypothesis is however not possible in humans due to various practical and 
ethical concerns, however, animal models can establish the plausibility of a hypothesis/ theory 
about pathogenesis or pathophysiology, originally devised from human findings. Animal models 
can be used to create a specific alteration in the cortical circuit, and then study the effect of this 
manipulation on the physiology and behavior. Hence, testing of the aforementioned hypothesis 
required the availability of an animal model with a selective deficit in the PV+ IN in the 
hippocampus.  
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Figure 8-2: Conceptual model of the overall hypothesis of the study.  
Loss of hippocampal PV+ interneurons produces cognitive deficits and physiological and behavioral 
phenotype characteristic of psychosis in the Interneuron deficit models. Summary of the behavioral 
findings in the cD2 null and the effect of MGE transplants 
Generation of animal model of PV+ interneuron deficits 
Deficits in PV+ interneurons can be produced in an animal model by various possible strategies.  
Modeling of schizophrenia risk alleles in mice:  
Several of the prominent risk alleles of schizophrenia, such as the Neuregulin/ ErbB4 and DISC 
1, have been shown to regulate GABAergic function (see below). Neuregulin and its receptor 
ErbB4 have been shown to regulate interneuron migration in the cortex (Flames et al., 2004). 
Similarly, reductions in PV+ IN density was reported in the mPFC in a dominant-negative form 
of DISC1 (DN-DISC1) (Hikida et al., 2007). A recent study however reported an increase in 
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PV+ interneurons in the hippocampus in a DISC1 mutant mouse (Lee et al., 2013), most likely 
due to abnormal migration (Steinecke et al., 2012). More studies need to be conducted to 
understand the possible relation between schizophrenia susceptibility genes and GABAergic 
interneuron development and function. However, in general, the effect of these manipulations is 
not limited to the GABAergic system. In fact, the alterations in the GABAergic system were 
subtle as compared to that in other systems (Cobos et al., 2005; Hikida et al., 2007; Murray et al., 
2011). In addition, mice models of schizophrenia risk alleles show a multitude of effects on 
various cell types, only some of which are currently understood (Thomson et al., 2013). Thus 
complicating the interpretations drawn from these models.  
Approaches that disrupt interneuronal synaptic input or output: This approach involves 
manipulation of synaptic inputs or outputs of interneurons; hence affecting the functional role of 
these cells in the cortical circuit. This approach has been used to disrupt glutamatergic synaptic 
neurotransmission (Fuchs et al., 2007), and disruption of synaptic release machinery of 
interneurons (Murray et al., 2011) which can effectively disrupt the synaptic output of these 
cells. However, these studies have not adequately answered the question whether deficits in PV+ 
interneuron function leads to hippocampal hyperactivity in a way that’s analogous to that seen in 
patients with schizophrenia. Furthermore the effect of these manipulations on hippocampal 
control of mesostriatal dopamine system has not been explored. For example, Fuchs and 
colleagues (Fuchs et al., 2007) generated mice with conditional ablation of the AMPA receptor 
subunit GluR-A subunit in PV+ interneurons. These mice exhibited disruption of gamma band 
oscillations and impairment of spatial working memory. Overall hippocampal metabolism and 
regulation of the mesostriatal dopamine was not explored in these studies. Similarly, this 
question was not studied by Murray and colleagues (Murray et al., 2011) who ablated GABA 
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release machinery in PV+ cells. In conclusion, the mice models with selected targeting of inputs 
or outputs of PV+ interneurons have increased understanding of the role of these neurons in the 
cortical circuit, however they have been insufficiently explored in testing hypotheses about 
schizophrenia pathophysiology.   
Other approaches that disrupt interneuron development: These models used genetic or toxic 
interventions to disrupt the development of the interneurons. A targeted ablation of specific 
interneuronal populations is possible at least in theory because of the spatial and temporal 
separation of their progenitors and by the virtue of the fact that specific sets of developmental 
genes operate within different types of progenitors. Manipulation of these genes can help create 
mouse models with deficits in specific interneuron subclasses (Powell et al., 2003; Cobos et al., 
2005; Moore et al., 2006; Penschuck et al., 2006; Fuchs et al., 2007; Glickstein et al., 2007; Xu 
et al., 2010). In practice however, this approach often gives rise to deficits in multiple 
GABAergic populations, a spontaneous seizure phenotype, and frequent embryonic or early life 
lethality, which prevents the use of these models in studies of psychosis-relevant behaviors. 
It is notable that a number of developmental perturbations originally discovered to model other 
aspects of schizophrenia also affect interneuron development.  One prominent model in this 
category is administration of the DNA alkylator methylazoxymethanol acetate at gestation day 
17, the “ MAM E17 model” (Moore et al., 2006).  This model recapitulates the excess striatal 
dopamine transmission and related behavioral abnormalities, and also shows some hippocampus-
dependent cognitive deficits (Lodge et al., 2009). Similar to the mouse models used in this thesis, 
the MAM E17 rat shows a significant decrease in the density of PV+ interneurons in the 
hippocampus, with apparent sparing of the somatostatin-expressing subpopulation (Penschuck et 
al., 2006).  
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In addition to developmental approaches, repeated exposure to ketamine or phencyclidine, 
NMDA antagonists known to induce psychosis in humans, also down-regulates PV+ 
interneurons in the hippocampus and other cerebral cortical regions (Behrens et al., 2007) 
(Schobel et al., 2013).  
Importantly, in these developmental or pharmacological “animal models of psychosis” a direct 
link between the PV+ interneuron deficits and the cognitive and DA-system phenotypes has not 
been fully established.  
Mutant mice models with developmental deficits of cortical PV+ interneurons  
The above rodent models can be categorized as models of schizophrenia etiology or 
pathophysiology that also show interneuron deficits, or models of interneuron deficits that may 
have some phenotypes relevant to schizophrenia.  However, the circuit model shown in figure 8-
2 had not been explicitly tested in these models.  To address this gap,  
I used mice with genetic mutations that directly affect interneuron development via well-
characterized mechanisms operating in the MGE (Glickstein et al., 2007; 2009; Xu et al., 2010). 
I chose to study models featuring a prominent and relatively selective PV+ interneuron deficit in 
the since this is perhaps the most replicated interneuron deficit in post mortem studies of 
schizophrenia (Lisman et al., 2008; Konradi et al., 2011; Lewis et al., 2012). Moreover, although 
direct comparisons of studies using different patient cohorts can not be compared, the effect sizes 
of the PV+ interneuron deficit in post-mortem studies of the hippocampus are, in general, larger 
than those of prefrontal cortical regions. Consistent with this, I had begun to observe anecdotally 
that in the cyclin D2 and Six3Cre;Smof/f models, the PV+ interneuron deficit seemed especially 
reliable in the hippocampus.  
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Using the methodology outlined above, I conducted a multi-level analysis of the histological, 
metabolic, physiological, and behavioral changes arising from disruption of PV+ interneuron 
development in the cD2 null mutant (Chapters 3-7) and the Six3Cre;Smof/f mice (Appendix 2). 
Initial anatomical and physiological results showed a persistent deficit in GABAergic inhibition 
in the hippocampus, ruling out any significant compensation in these developmental models. 
While this result does not speak to the question of whether the deficit in PV+ interneurons in 
schizophrenia is developmental or adult onset, it does demonstrate that a developmental etiology 
of such a deficit is certainly possible, as it would persist into adulthood and produce persistent 
disinhibition.  
PV+ interneuron deficits and a “hypermetabolic” MRI  phenotype 
Following this, we found that loss of PV+ interneurons led to hippocampal hypermetabolism as 
shown by functional imaging (fMRI). We used an imaging technique very similar to what has 
been used in patients with schizophrenia. Cerebral blood volume (CBV) closely correlates with 
brain function and metabolism (Small et al., 2011), hence increased CBV suggests increased 
metabolism in the hippocampus.  
Hippocampal disinhibiton disrupts cognition 
As mentioned previously, hyperactivity of the hippocampus in schizophrenia corresponds with 
an apparent hypofunctionality in performing cognitive operations .I found that the cD2 null mice 
also showed robust deficits in hippocampus dependent fear conditioning. Interestingly, the 
deficit in these mice was unlike the effect of a hippocampal lesion (Wiltgen et al., 2006). While 
learning of contextual fear – which usually requires the hippocampus - continues albeit less 
efficiently in the presence of an (anterograde) lesion of the hippocampus, the cD2 null showed 
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no such effect. This again suggested the presence of a hyperactive hippocampus with overdrive 
of its output structures (such as the PFC and the amygdala). 
Hippocampal disinhibition leads to excessive activity in the mesolimbic DA system 
Next I studied dopamine cell activity in the ventral tegmental area.  Patients with schizophrenia 
are highly sensitive to the psychotomimetic effects of amphetamine (reviewed in (Lieberman et 
al., 1987)) - which is linked to striatal dopamine efflux. In rodents, the behavioral readout of this 
phenomenon is hyperlocomotion.  Moreover, various studies have shown that pharmacological 
activation of the hippocampus leads to increase in the number of spontaneously active dopamine 
neurons. I predicted that hippocampal hyperactivity would lead to enhanced mesolimbic DA 
neuron population activity and locomotor response to amphetamine in the hippocampal PV+ 
interneuron deficit models.   
As predicted, an increase in activity of the VTA DA cells was found (figure 8-2), strongly 
suggesting dysregulation of the mesostriatal dopamine system. Previous literature has generally 
found a correspondence between increased DA activity, and enhanced amphetamine sensitivity. 
Hence, I predicted that the PV+ interneuron deficit models would show enhanced locomotor 
response to amphetamine. This effect was dopamine neurotransmission dependent, and required 
intact hippocampal activity, as hippocampal lesion eliminated the effect.  
Further testing of the model of disrupted hippocampal circuit function using 
transplantation of neural stem cells from the MGE 
The above results showed an overwhelming agreement with the hypothesis that loss of PV+ 
interneurons in the hippocampus in these mutant mice models led to hippocampal hyperactivity, 
cognitive deficits and behavioral and physiological phenotypes analogous to psychosis. 
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However, the question remained whether it was the PV+ interneuron deficit that led to these 
phenotypes. Both the cyclin D2 null mutation and MGE-selective knock out of Smoothened 
affect PV+ interneuron populations in other cortical regions. To address whether hippocampal 
interneuron function was critical to the phenotypes we observed, we adopted a novel approach 
that involved replacing PV+ interneurons to the hippocampus using transplantation of MGE 
derived progenitor cells. We showed that restoring GABAergic interneurons to the hippocampus 
normalized hippocampal hyperactivity, and, in turn, attenuated the excess activity in the 
mesolimbic DA system and improved hippocampus-dependent cognition (figure 8-2).  
These results tested the plausibility of the circuit model (figures 8-1 and 8-2) that attempts to 
explain the relation between a disinhibited hippocampus and dysregulation of mesostiatal 
dopamine system function on one hand, and disruption of hippocampal circuits mediating 
contextual and episodic learning and memory on the other. Demonstration of this link, 
previously only hypothesized, not only tests and affirms the model of hippocampal control of the 
mesolimbic dopamine pathway, but also provides clear potential targets for therapeutic 
interventions in schizophrenia, as discussed below. 
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Transplantation of MGE-derived interneuron precursors: 
implications for novel treatment strategies for schizophrenia 
Antipsychotic medications have minimal effect on negative symptoms and cognitive deficits of 
schizophrenia and inadequately control positive symptoms in as many as a third of all patients 
(Sadock et al., 2007). Consequently, improved therapeutic interventions are desperately needed 
for schizophrenia. Identification of novel therapeutic targets may facilitate the development of 
drugs that are more efficacious and are beneficial for negative symptoms and cognitive deficits. 
While various neurotransmitter systems have been implicated, all presently known drugs target 
the dopamine system.  
GABAergic cell transplants as a potential treatment for schizophrenia 
These results of this study show that partial restoration of GABAergic interneurons to the adult 
hippocampus in a PV+ interneuron deficient mouse model led to normalization of 
hypermetabolic imaging phenotype, normalization of VTA dopamine cell activity, normalization 
of amphetamine sensitivity and improvement in hippocampus dependent learning and memory. 
These results raise the possibility that GABAergic transplants to the hippocampus could 
normalize hippocampal hyperactivity, improve cognitive deficits and positive symptoms of 
schizophrenia.  
Possible mechanisms of action of MGE derived cell transplants:  
Previous studies had shown the efficacy of GABArgic progenitor cell transplants in controlling 
cortical disinhibition (Alvarez-Dolado et al., 2006; Baraban et al., 2009; Zipancic et al., 2010; la 
Cruz et al., 2011). Recent findings from several groups suggest that MGE derived progenitors 
cells that are destined to become GABAergic interneurons- when transplanted into the cortex of 
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another mouse, survive, migrate in the host tissue and develop into morphologically and 
functionally mature interneurons. Moreover, the transplanted cells may form functional synapses 
with the host neurons (Southwell et al., 2010), and enhance GABAergic neurotransmission 
(Alvarez-Dolado et al., 2006; Baraban et al., 2009; Zipancic et al., 2010). These characteristics 
suggest that the transplant of GABAergic cells may restore excitation/ inhibition balance in mice 
models of disinhibition (Alvarez-Dolado et al., 2006; Baraban et al., 2009; Zipancic et al., 2010). 
Whether this is the only (or primary) mechanism by which MGE derived progenitor cells may 
mediate their action remains to be seen. For example, some studies have shown that embryonic 
stem cells may promote functional recovery after brain injury by secreting growth factors. 
 
Embryonic stem cells as a potential source of GABAergic cells 
The use of human embryonic tissue is fraught with ethical and legal issues, and can be obtained 
only in limited amounts, which makes it unsuitable for large-scale clinical application. A 
potential solution to this problem may lie in the use of alternative sources of GABAergic 
interneurons. One suitable candidate is an embryonic stem (ES) cell. ES cells are derived from 
the early and have the broadest developmental potential. That is, theoretically, they can develop 
into any cell type. In reality however, directing ES cells to a certain fate remains a challenging 
problem. Recently, some groups have shown success in generating GABAergic interneurons 
from ES cells (Liu et al., 2013). The success of such efforts may be instrumental for the clinical 
application of GABAergic cell transplants.  
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Other potential therapeutic approaches targeting the GABAergic system  
Apart from GABAergic progenitor cell transplants, other therapeutic modalities can potentially 
be used to control hippocampal hyperactivity in schizophrenia. Pharmacological agents, which 
are active at the GABAergic receptor, can be used to enhance or inhibit GABAergic transmission 
and henceforth study its role on hippocampal function and the effect on hippocampal outputs to 
the mesolimbic DA system. One of these, the benzodiazepine class of drugs, has a long history 
of use, as a combination therapy in schizophrenia (Wolkowitz and Pickar, 1991). The use of 
benzodiazepines is however limited by their non-selectivity for the various types of GABAA 
receptors - with different subunit composition. A GABAergic modulator that selectively targets 
the hippocampus could augment GABAergic activity and control hippocampal hyperactivity. A 
promising development has been the use of a benzodiazepine positive allosteric modulator 
(PAM) that is relatively selective for the α5 containing receptors, which have a high level of 
expression in the hippocampus (Gill et al., 2011). Hence agonist at this receptor can be used 
systemically with limited non-selective effects. Gill at al studied the effect of this α5 selective 
PAM on hippocampal activity and mesolimbic dopamine function in the MAM E17 model. 
Treatment with this drug reduced the number of spontaneously active DA neurons in the VTA of 
MAM animals and lowered locomotor response to amphetamine, consistent with the idea that 
positive modulation of GABA receptors in the hippocampus leads to increase in inhibition and a 
reduction of hippocampal hyperactivity and attenuation of hippocampal hyperdrive of the 
mesostriatal dopamine system in this model.  These interesting findings await further studies to 
understand the therapeutic potential of this drug.  
Another interesting candidate is MK0777, a benzodiazepine-like agent with selective activity at 
GABAA receptors containing α2 or α3 subunits. Lewis and colleagues (Lewis et al., 2008) 
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reported improved in a cognitive task in a group of patients with schizophrenia with this drug. A 
subsequent larger randomized clinical trial however failed to find an improvement in cognitive 
deficits in patients with schizophrenia with the use of this drug (Buchanan et al., 2011). 
 
General Conclusion 
The studies described in this thesis provide strong evidence for the hypothesis that deficits in 
PV+ GABAergic synaptic neurotransmission in the hippocampus leads to hippocampal 
hyperactivity, and dysregulation of its output; the mesostriatal dopamine system. These effects 
may underlie some of the cognitive and positive symptoms of schizophrenia. These results also 
suggest that therapeutic interventions that target the GABAergic system – particularly the 
transplantation of GABAergic progenitor/ stem cells may be effective in ameliorating cognitive 
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Seizure and Epilepsy  
An epileptic seizure is a paroxysmal uncontrolled neural activity in the brain. The simplified 
model of epileptic seizures states that there is a balance of inhibition and excitation in the cortex, 
somewhat like brakes and accelerator in an engine, which when disturbed, leads to seizure 
activity. The relation between GABA and seizures came out of the knowledge that in many 
animal and human preparations, antagonists at the GABA receptors can lead to seizures, while its 
agonists can control seizures. Several studies have shown that the loss of GABAergic 
interneurons is accompanied by seizures or epilepsy (Cobos et al., 2005), (Powell et al., 2003) 
Immediate early gene expression can be used to estimate neuronal activation: 
Cellular fos, is a proto-onco gene, which is the cellular counter part of the viral oncogene, v-fos. 
cfos is rapidly and transiently expressed in many tissues following growth activation. In the 
neurons cfos is expressed in response to synaptic or electrical activation (Sagar et al., 1988). c-
fos codes for a transcriptional factor, which couples extracellular signals to long term changes in 
cellular phenotype by affecting gene expression (Kovács, 1998). C-Fos expression has been used 
as a functional marker of activated neurons (Sagar et al., 1988; Kovács, 1998), and used as a tool 
to delineate individual neurons as well as extended circuits responsible to a wide variety of 
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external stimuli. Some data suggests that, cFos activity is sensitive to temporal features of action 
potential patterns, and may show self-regulation of its threshold of expression so that it is 
activated by ‘supra-normal’ stimuli (for review see (Kovács, 1998)). A loss of GABAergic 
inhibition would be expected to lead to an increased excitation of pyramidal cells in the 
hippocampus.  
To reveal hyperexcitability of hippocampal neurons and seizure susceptibility secondary to loss 
of GABA neurotransmission, we administered the GABAA-benzodiazepeine receptor  (BZR) 
inverse agonist, DMCM (methyl 6,7-dimethoxy-4-ethyl-beta-carboline- 3-carboxylate), a drug 
that reduces the efficacy of GABAA receptors without blocking the GABA binding site (Chebib 
and Johnston, 2000). DMCM (and other benzodiazepine inverse agonists) reduces the affinity of 
the GABA binding site for GABA and reduce the frequency of opening of the chloride channel 
while GABA is bound; thus, their effect interacts with the level of endogenous GABA available 
to bind to the receptor. In these experiments we examined induced c-fos expression and seizure 
behavior under conditions in which GABA neurotransmission has been reduced with GABAA-
benzodiazepeine receptor  (BZR) negative modulator. 
 
Hypotheses: 
Loss of GABAergic inhibition in the cD2 null will be reflected as increased c-fos expression in 
the hippocampus and increased seizure susceptibility following administration of a GABAA-BZR 
negative modulator.  
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Methods:  
Cyclin D2 null, hemizygous for cD2 (het) or WT mice were tested in age, sex and dose-matched 
sets.  DMCM was dissolved at 0.25-0.5 mg/ml, in a solvent of 2-hydroxypropyl-b-cyclodextrin 
(HBC; 50 mg/ml in saline). 
To assess DMCM-induced c-fos expression, DMCM was given at a dose sub threshold for 
seizures, to reveal patterns of excitation in excitatory frontal and limbic corticofugal pathways 
hypothesized to be affected in genetic models of Pv+ interneuron deficits. Mice were given Intra-
peritoneal injections of DMCM (1.5-2.5 mg/kg in yolked pairs). Previous research has shown 
that c-fos mRNA is induced within couple of minutes after acute challenge and peaks between 
30 and 60 min. Hence we perfused the mice at 60 min after drug administration. Perfusion, 
fixation and tissue processing used standard methods.  
To assess seizures, DMCM was injected at 2 to 10 ml/kg to achieve 3 doses: 0.4 mg/kg, 4 mg/kg, 
8 mg/kg. Behavior was videotaped and scored for 20 min post-injection. Onset latency, 
frequency and duration of seizures, were scored. 
 
Results 
CD2 nulls show greater cfos expression in the hippocampus in response to negative GABA 
receptor modulator: Consistent with the evidence for lack of spontaneous seizures in the cD2 
null, no differences in cfos expression were found between the genotypes under baseline 
conditions. However, when given DMCM, the cD2 nulls showed robust cfos expression in 
several areas of the brain including the hippocampal formation most notably in the DG.  
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Appendix A1-1: Greater hippocampal activation in cD2 null as shown by cfos expression. 
Coronal sections of the dorsal hippocampus, showing immuno-labeling for cfos. The mice were injected 
with sub-convulsant dose of DMCM and sacrificed 1 hour later. 
 
Lack of spontaneous seizures in the cD2 null: The mice were observed in their home cages for 
spontaneous seizures/ convulsions at various ages. We did not observe any spontaneous seizures.   
CD2 nulls show increased susceptibility to negative modulators of GABA receptor: 
Consistent with our hypothesis, we saw that both cD2 nulls as well as WT mice showed seizes in 
administration of DMCM. The threshold DMCM dose to induce seizure was significantly lower 
for cD2 nulls, relative to WT, while the heterozygotes (+/-) exhibited an intermediate 
distribution. At each dose, cD2 nulls had a significantly shorter latency than wild types (p < 
0.05). Heterozygotes differed from wild types at the 8 mg/kg dose (KS test p’s < 0.05). 
In order to see if seizure susceptibility in the cD2 null was specific to the GABAergic system, we 
observed the effects of strychnine- a glycine receptor antagonist. Both cD2 nulls as well as WT 
showed no difference in seizure latency or threshold with strychnine (data not shown).  
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Figure  A1-2: Increased seizure susceptibility in the cD2 null.  
CD2 null showed reduced latency to seizures, as compared to WT on administration of DMCM, a 




The cD2 null mutant mouse shows greater hippocampal cell activation as indicated by cFos 
expression, and greater susceptibility to seizures, in response to administration of a negative 
modulator of GABA activity.  
The increased cell activation was demonstrated at doses of a GABAA-BZR negative modulator 
that are sub-threshold for inducing seizures. The induced cFos activity was greatest in the dentate 
gyrus, a region thought to be involved in generation of spontaneous and evoked seizures (Houser 
et al., 2012).  These data are consistent with a deficit in PV+ interneuron density (Glickstein et 
al., 2007) and a decrease in GABAergic tone in this region. Consistent with the cell activation 
pattern, the cD2 null mutant also shows a seizure susceptibility that can be revealed when GABA 
neurotransmission is partially compromised with the negative allosteric modulation of the 
GABAA-BZR.  
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These data are consistent with a previous report (Glickstein et al., 2007) in which the cD2 nulls 
showed intermittent bursts of faster frequency discharges in cortical EEG recordings, and a shift 
in the power spectral density towards a higher frequency. The presence of this abnormal activity 
in the context of absence of spontaneous seizures may indicate that the cD2 null have a cortical 
irritability phenotype with abnormal electric activity that falls short of spreading widely to 
produce overt seizures. Absence of spontaneous seizures has also been observed in several other 
models of interneuron deficit (for example, see (Murray et al., 2011) (Belforte et al., 2009), It is 
possible that the GABA interneuron deficit is not sufficient to bring GABA tone below the 
threshold necessary to induce seizure activity.  
Alternatively, a developmental loss of GABAergic interneurons during development may lead to 
compensatory changes in the cortical circuit that reduce the probability of seizure activity. It is 
important to remember that in most cases compensation is often insufficient to fully counteract 
the effects of the primary perturbation. Some of the possible compensatory changes have been 
explored in the cD2 null. The structural and functional studies of Chapter 3 indicated little 
compensation in the GABAergic innervation of the pyramidal neurons. The deficit in PV+ cell 
bodies was paralleled by an apparent reduction in PV+ axonal baskets around pyramidal neurons. 
Functionally, there was little evidence for compensations in GABA input, as evidenced by the 
deficit in mIPSC frequency with no post-synaptic changes (i.e. in mIPSC amplitude or kinetics). 
Finally, a previous study showed no change in the density of somatostatin, VIP, NPY expressing 
cells (Glickstein et al., 2007).  
 I have also examined the possibility of compensations in the excitability and glutamate inputs to 
pyramidal cells. While I found that glutamate-mediated excitatory currents onto pyramidal cells 
in CA1 were not altered in the cD2 null mutant, I did observe a reduction in intrinsic membrane 
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excitability in response to current injection. These findings are similar to the findings from the 
DLX1 null mouse, another developmental model of interneuron loss. DLX1 null mice loss of a 
subset of hippocampal and neocortical somatostatin-, NPY-, VIP-, and calretinin-positive 
interneurons at around one month of age, is followed by the onset of onset of epilepsy (Cobos et 
al., 2005). These mice show decreased excitability of CA1 pyramidal neurons (assessed in 
current-clamp recordings of input resistance and rheobase). 
Overall, these data show that a developmental loss of PV+ interneurons and the associated 
reduction in GABAergic neurotransmission is associated with increased cell excitation and 
seizure activity under conditions when GABA neurotransmission is further compromised. 
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Appendix 2: Studies In an MGE-Specific 
Knockout of the Sonic Hedgehog Effector 




In addition to our studies with the cD2 null mice, we used an alternate model of a PV+ 
interneuron deficit for convergent validity. In this chapter, I introduce the Six3Cre; smo f/f 
mouse, a conditional mutant of sonic hedge hodge receptor - smoothened and describe the results 
of experiments performed on this model. 
Development of the Six3Cre; smo f/f mouse model 
Sonic hedgehog signaling is an important regulator of cell fate. The genesis of PV+ and SST+ 
interneurons requires the expression of NKX2.1, which is maintained by SHH signaling during 
neurogenesis. In the Six 3 Cre smof/f model, the elimination in the medial ganglionic eminence 
(MGE) of Smo, a key effector of SHH signaling, leads to conversion of some MGE progenitors 
to a caudal ganglionic eminence-like, bipolar calretinin- expressing cell fate. In addition, a higher 
level of SHH signaling promotes the generation of the somatostatin-expressing inter- neuron at 
the expense of a PV+ interneuron subgroup. These results indicate that cortical interneuron 
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diversity, a major determinant of cortical function, is critically influenced by differential levels 
of SHH signaling within the ventral telencephalon.  
Selective reduction in PV+ interneurons in the Six3Cre;Smof/f 
In the Six3Cre;Smof/f features a selective reduction in PV+ interneuron density and a subtle 
increase in a sub class of Calretinin expressing cells. Xu et al (Xu et al., 2010) proposed that a 
combination of cell autonomous and cell non autonomous effects results in selective reduction in 
PV+ cells in the cortex, while the number of SST+ cells remains unchanged.  
In this model, Cre recombinase is expressed in a striped pattern with in the MGE, leading to 
excision of SHH effector Smoothened in a subset of MGE cells. As a result, Shh signaling is 
severely affected in these cells. Disruption of SHH signaling leads to loss of Nkx2.1 expression, 
resulting in severe disruption of further development along the PV or SST pathways. In turn, 
these cells show ectopic expression of GSX2, a homeodomain transcription factor, normally 
enriched in the dorsal LGE and in the CGE. This results in reduction of PV+ and SST+ 
populations that are normally produced y these progenitors, and increase in a subset of 
Calretinin+ cells.  
In contrast to these cells, the adjacent cells that do not recombine Smo respond by up-regulating 
SHH signaling (as shown by increased Gli1, Ptch1, and Hhip1 expression). These transcripts are 
normally enriched in the dMGE.  
As a result of these cell autonomous and cell non-autonomous processes, the overall density of 
SST+ cells is not altered in the Six3Cre; Smo f/f mutants. Accordingly, there is a cell-non 
autonomous expansion of SST production by MGE progenitors in this mutant. These results 
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suggested that SHH signaling is important for ventral patterning of the ganglionic eminence, 
while the development of the dorsal pallidal fates (LGE and CGE) is SHH independent. 
Six3Cre; smo f/f show normal brain size and no reduction in cell density in the 
cortex 
Six3Cre;Smof/f show no reduction in brain size and normal cortical thickness (Xu et al., 2010). 
Cortical lamination is intact and there are no gross changes in cell density (as determined by Tbr 
or NeuN immune-staining). These data show that the Six3Cre; smo f/f shows a much selective 
deficit than the cD2 null mouse.  
Differences between Six3Cre:Smof/f and cD2 null models  
Six3Cre:Smof/f mutants differ from cyclin D2 mutants in a few important ways. Firstly, this 
model features a much selective manipulation of sonic hedgehog (Shh) signaling. Shh signaling 
deficit is limited to the ganglionic eminence, instead of the global knockout of cD2 gene in the 
cD2 nulls. This suggests limited off target effects in this model. 
Secondly, microcephaly present in the cD2 null mice is absent in the Six3Cre;smof/f. Thirdly, 
Six3Cre;smof/f mutants show an up-regulation in the calretinin-expressing interneurons, a 
subpopulation that synapses on other inhibitory interneurons that, in turn, synapse on dendrites 
of cortical pyramidal neurons (Freund and Buzsaki, 1996). This implies that whereas both the 
Six3Cre:Smof/f and cyclin D2 mutants may model a loss of perisomatic GABAergic inhibition 
to cortical pyramidal neurons, the Six3Cre:Smof/f mouse may additionally feature some 
disinhibition affecting the inputs to distal dendrites. 
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These data show that Six3Cre; smo f/f model features a developmental deficit in cortical PV+ 
interneurons. However, mechanism of the interneuron deficit is different in the conditional 
smoothened model as compared to the cD2 null. We reasoned that a correspondence between the 
results of the two models would argue that the phenotype stems from the PV+ interneuron deficit 
- which is shared by these two models- and not from a non-specific effect of the two mutations, 
which will be different in the two models. 
 
Experiment A2-1: Stereological quantification of PV+ 
interneuron deficit in the hippocampus 
Hypothesis: 
Six3Cre smo f/f will show reduction in PV+ interneurons in the hippocampus.  
 
Brief Methods: 
Coronal sections were cut from formalin fixed brains from Six3Cre;Smof/f and control mice 
Six3Cre;Smof/+. Forty micron thick sections were cut on a vibratome, and 1 in every 5 sections 
were stained for PV using anti-parvalbumin antibody (figure A2-1). Contours were drawn 
around the CA1 region using standard atlas (Paxinos and Franklin, 2001). Both dorsal as well as 
ventral hippocampus was included in the analysis. PV+ interneurons were counted in the entire 
ROI. The density measure was obtained by factoring in the area of ROI - found using the 
Cavelieri method. (See also Materials and Methods) 
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Results:  
Six3Cre;Smof/f shows reduced cortical PV-cell density: Stereological counting of PV-IR cell 
bodies in the CA1 region of the hippocampus showed that the Six3Cre;Smof/f mice showed a 
reduction in PV+ interneuron density in this region. (t3=3.6, p=0.037; n=3). 
 
Figure A2-1: Reduced PV+ interneuron density in the hippocampus in Six3Cre;Smof/f 
mice. 
A) Coronal sections of the dorsal hippocampus immunostained for PV. B) Average PV+ interneuron 
density in CA1 region of the hippocampus. 
 
Experiment A2-2: GABAergic inhibitory neurotransmission 
Hypothesis: 
Six3Cre;Smof/f will show reduction in GABAergic synaptic neurotransmission at pyramidal 
cells in the hippocampus. 
 
Brief Methods: 
I measured miniature inhibitory post synaptic currents in pyramidal cells in the hippocampus and 
the PFC. A mIPSC represents a post synaptic response due to action potential independent, 
A B 
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stochastic release of a single GABA vesicle. mIPSC frequency is a close approximation of the 
density of GABAergic synapse on pyramidal cells in organotypic cultures (Hartman et al., 2006; 
Swanwick et al., 2006). Whole cell voltage clamp recordings were used to measure miniature 
inhibitory post-synaptic currents from CA1 pyramidal cells. A holding potential of -70mV was 
used. All recordings were conducted in the presence of TTX (to block fast Na channels), APV 
(to block NMDA) and CNQX (to block AMPA channels). The recording electrode contained 




Six3Cre;Smof/f shows reduced GABAergic inhibition To study if a reduction in PV+ 
interneuron density in the hippocampus is associated with reduced GABAergic 
neurotransmission, we measured mIPSCs in voltage clamped pyramidal cells of CA1 region. We 
found that mIPSC frequency is reduced in CA1 pyramidal cells in Six3Cre;Smof/f. (ttest df 18 p 
< 0.05 n=12 ko (4 mice), 8 wt (3 mice). No difference was seen in the amplitude, rise time or 
decay time characteristics of these currents. 
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Figure A2-2: Reduced GABAergic synaptic neurotransmission in the hippocampus in 
Six3Cre;Smof/f mice.  
Average GABAergic mIPSC frequency in CA1 pyramidal cells is reduced in the Six3Cre;Smof/f  
These data show that a reduction in PV+ interneuron density in the Six3Cre;Smof/f is 
accompanied by reduction in GABAergic inhibition in the hippocampus. 
 
Experiment A2-3: Amphetamine sensitivity in the Six3 Cre; 
smof/f mice 
Hypothesis: 
Six3 Cre; smo f/f mice will show enhanced locomotor response to amphetamine. 
Brief Methods: 
Mice are placed in a 17” x 17” open field box with a white floor. Movement of the mice is 
measured by the help of an automated setup and translated into distance. After 30 min of 
baseline activity, 2mg/kg amphetamine (dissolved in saline) is administered in an intra peritoneal 
injection. Activity is recorded for another 60 min, after which the mice are returned to their home 
cages. In a separate cohort, mice were pretreated with either saline or raclopride (0.5 mg/kg) 30 
   174 
minutes before injection of AMPH (2.0 mg/kg, i.p.) and locomotor activity was measured as 
described above. (See also Materials and Methods) 
 
Results: 
Six3Cre;Smof/f mice show greater locomotor response to amphetamine. 
Six3Cre;Smof/f mice showed an increase in baseline locomotor response and increased response 
to amphetamine. A mixed ANOVA model showed a main effect of time F(1,29) = 4.616 p=0.04 
and a genotype x locomotion interaction F(2,29) = 7.7 (p=0.002) (N=15 control, 16 smo 
ko)(figure A2-3) 
 
Figure A2-3: Enhanced amphetamine sensitivity in the Six3cre;Smof/f. 
Conditional smoothened knockout mice showed greater baseline locomotion and an increased response to 
amphetamine. Arrow indicates time point at which 2mg/kg amphetamine was administered.  
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Discussion 
These data show that Six3Cre:Smof/f mice show a reduction in PV+ interneuron density in the 
hippocampus. This deficit in associated with loss of GABAergic inhibition on hippocampal 
pyramidal cells. Loss of GABAergic inhibition predicts disinhibition in the hippocampus. As 
described earlier, a disinhibited hippocampus and hyper excitation of its outputs will lead to 
dysregulation of dopamine system - leading to enhanced psychomotor response to amphetamine.  
Taken together with the results from the cD2 null mouse, this data support the hypothesis that 
loss of PV+ interneurons can lead to disinhibition and dysregulation of the dopamine system. 
 
 
